0001965040-23-000043.txt : 20231113 0001965040-23-000043.hdr.sgml : 20231113 20231113171325 ACCESSION NUMBER: 0001965040-23-000043 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231113 DATE AS OF CHANGE: 20231113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fortrea Holdings Inc. CENTRAL INDEX KEY: 0001965040 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 922796441 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41704 FILM NUMBER: 231400020 BUSINESS ADDRESS: STREET 1: 8 MOORE DRIVE CITY: DURHAM STATE: NC ZIP: 27709 BUSINESS PHONE: 877-495-0816 MAIL ADDRESS: STREET 1: 8 MOORE DRIVE CITY: DURHAM STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: Silver Spinco Inc. DATE OF NAME CHANGE: 20230207 10-Q 1 ftre-20230930.htm 10-Q ftre-20230930
false0001965040Q3202312/31P1Y33333300019650402023-01-012023-09-3000019650402023-11-09xbrli:shares00019650402023-09-30iso4217:USD00019650402022-12-3100019650402023-07-012023-09-3000019650402022-07-012022-09-3000019650402022-01-012022-09-300001965040us-gaap:RelatedPartyMember2023-07-012023-09-300001965040us-gaap:RelatedPartyMember2022-07-012022-09-300001965040us-gaap:RelatedPartyMember2023-01-012023-09-300001965040us-gaap:RelatedPartyMember2022-01-012022-09-30iso4217:USDxbrli:shares0001965040us-gaap:CommonStockMember2022-12-310001965040us-gaap:AdditionalPaidInCapitalMember2022-12-310001965040ftre:ParentCompanyInvestmentMember2022-12-310001965040us-gaap:RetainedEarningsMember2022-12-310001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001965040ftre:ParentCompanyInvestmentMember2023-01-012023-03-3100019650402023-01-012023-03-310001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001965040us-gaap:CommonStockMember2023-03-310001965040us-gaap:AdditionalPaidInCapitalMember2023-03-310001965040ftre:ParentCompanyInvestmentMember2023-03-310001965040us-gaap:RetainedEarningsMember2023-03-310001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-3100019650402023-03-310001965040ftre:ParentCompanyInvestmentMember2023-04-012023-06-3000019650402023-04-012023-06-300001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001965040us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001965040us-gaap:CommonStockMember2023-04-012023-06-300001965040us-gaap:CommonStockMember2023-06-300001965040us-gaap:AdditionalPaidInCapitalMember2023-06-300001965040ftre:ParentCompanyInvestmentMember2023-06-300001965040us-gaap:RetainedEarningsMember2023-06-300001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-3000019650402023-06-300001965040us-gaap:RetainedEarningsMember2023-07-012023-09-300001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001965040us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001965040us-gaap:CommonStockMember2023-09-300001965040us-gaap:AdditionalPaidInCapitalMember2023-09-300001965040ftre:ParentCompanyInvestmentMember2023-09-300001965040us-gaap:RetainedEarningsMember2023-09-300001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001965040us-gaap:CommonStockMember2021-12-310001965040us-gaap:AdditionalPaidInCapitalMember2021-12-310001965040ftre:ParentCompanyInvestmentMember2021-12-310001965040us-gaap:RetainedEarningsMember2021-12-310001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-3100019650402021-12-310001965040ftre:ParentCompanyInvestmentMember2022-01-012022-03-3100019650402022-01-012022-03-310001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001965040us-gaap:CommonStockMember2022-03-310001965040us-gaap:AdditionalPaidInCapitalMember2022-03-310001965040ftre:ParentCompanyInvestmentMember2022-03-310001965040us-gaap:RetainedEarningsMember2022-03-310001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-3100019650402022-03-310001965040ftre:ParentCompanyInvestmentMember2022-04-012022-06-3000019650402022-04-012022-06-300001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001965040us-gaap:CommonStockMember2022-06-300001965040us-gaap:AdditionalPaidInCapitalMember2022-06-300001965040ftre:ParentCompanyInvestmentMember2022-06-300001965040us-gaap:RetainedEarningsMember2022-06-300001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-3000019650402022-06-300001965040ftre:ParentCompanyInvestmentMember2022-07-012022-09-300001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001965040us-gaap:CommonStockMember2022-09-300001965040us-gaap:AdditionalPaidInCapitalMember2022-09-300001965040ftre:ParentCompanyInvestmentMember2022-09-300001965040us-gaap:RetainedEarningsMember2022-09-300001965040us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-3000019650402022-09-30ftre:employeeftre:countryftre:segment0001965040ftre:OnePharmaceuticalCompanyMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-12-31xbrli:pure0001965040us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberftre:OneCustomerMember2023-07-012023-09-300001965040us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberftre:OneCustomerMember2023-01-012023-09-300001965040srt:NorthAmericaMemberftre:ClinicalServicesSegmentMember2023-07-012023-09-300001965040srt:EuropeMemberftre:ClinicalServicesSegmentMember2023-07-012023-09-300001965040ftre:OtherGeographicalAreasMemberftre:ClinicalServicesSegmentMember2023-07-012023-09-300001965040ftre:ClinicalServicesSegmentMember2023-07-012023-09-300001965040srt:NorthAmericaMemberftre:ClinicalServicesSegmentMember2022-07-012022-09-300001965040srt:EuropeMemberftre:ClinicalServicesSegmentMember2022-07-012022-09-300001965040ftre:OtherGeographicalAreasMemberftre:ClinicalServicesSegmentMember2022-07-012022-09-300001965040ftre:ClinicalServicesSegmentMember2022-07-012022-09-300001965040srt:NorthAmericaMemberftre:EnablingServicesSegmentMember2023-07-012023-09-300001965040srt:EuropeMemberftre:EnablingServicesSegmentMember2023-07-012023-09-300001965040ftre:EnablingServicesSegmentMemberftre:OtherGeographicalAreasMember2023-07-012023-09-300001965040ftre:EnablingServicesSegmentMember2023-07-012023-09-300001965040srt:NorthAmericaMemberftre:EnablingServicesSegmentMember2022-07-012022-09-300001965040srt:EuropeMemberftre:EnablingServicesSegmentMember2022-07-012022-09-300001965040ftre:EnablingServicesSegmentMemberftre:OtherGeographicalAreasMember2022-07-012022-09-300001965040ftre:EnablingServicesSegmentMember2022-07-012022-09-300001965040srt:NorthAmericaMember2023-07-012023-09-300001965040srt:EuropeMember2023-07-012023-09-300001965040ftre:OtherGeographicalAreasMember2023-07-012023-09-300001965040srt:NorthAmericaMember2022-07-012022-09-300001965040srt:EuropeMember2022-07-012022-09-300001965040ftre:OtherGeographicalAreasMember2022-07-012022-09-300001965040srt:NorthAmericaMemberftre:ClinicalServicesSegmentMember2023-01-012023-09-300001965040srt:EuropeMemberftre:ClinicalServicesSegmentMember2023-01-012023-09-300001965040ftre:OtherGeographicalAreasMemberftre:ClinicalServicesSegmentMember2023-01-012023-09-300001965040ftre:ClinicalServicesSegmentMember2023-01-012023-09-300001965040srt:NorthAmericaMemberftre:ClinicalServicesSegmentMember2022-01-012022-09-300001965040srt:EuropeMemberftre:ClinicalServicesSegmentMember2022-01-012022-09-300001965040ftre:OtherGeographicalAreasMemberftre:ClinicalServicesSegmentMember2022-01-012022-09-300001965040ftre:ClinicalServicesSegmentMember2022-01-012022-09-300001965040srt:NorthAmericaMemberftre:EnablingServicesSegmentMember2023-01-012023-09-300001965040srt:EuropeMemberftre:EnablingServicesSegmentMember2023-01-012023-09-300001965040ftre:EnablingServicesSegmentMemberftre:OtherGeographicalAreasMember2023-01-012023-09-300001965040ftre:EnablingServicesSegmentMember2023-01-012023-09-300001965040srt:NorthAmericaMemberftre:EnablingServicesSegmentMember2022-01-012022-09-300001965040srt:EuropeMemberftre:EnablingServicesSegmentMember2022-01-012022-09-300001965040ftre:EnablingServicesSegmentMemberftre:OtherGeographicalAreasMember2022-01-012022-09-300001965040ftre:EnablingServicesSegmentMember2022-01-012022-09-300001965040srt:NorthAmericaMember2023-01-012023-09-300001965040srt:EuropeMember2023-01-012023-09-300001965040ftre:OtherGeographicalAreasMember2023-01-012023-09-300001965040srt:NorthAmericaMember2022-01-012022-09-300001965040srt:EuropeMember2022-01-012022-09-300001965040ftre:OtherGeographicalAreasMember2022-01-012022-09-300001965040ftre:SalesCommissionAssetsMember2023-09-300001965040ftre:SalesCommissionAssetsMember2022-12-310001965040ftre:DeferredContractCostsMember2023-09-300001965040ftre:DeferredContractCostsMember2022-12-310001965040ftre:SalesCommissionAssetsMember2023-07-012023-09-300001965040ftre:SalesCommissionAssetsMember2022-07-012022-09-300001965040ftre:SalesCommissionAssetsMember2023-01-012023-09-300001965040ftre:SalesCommissionAssetsMember2022-01-012022-09-300001965040ftre:DeferredContractCostsMember2023-07-012023-09-300001965040ftre:DeferredContractCostsMember2022-07-012022-09-300001965040ftre:DeferredContractCostsMember2023-01-012023-09-300001965040ftre:DeferredContractCostsMember2022-01-012022-09-3000019650402023-10-012023-09-300001965040srt:MinimumMember2023-09-300001965040srt:MaximumMember2023-09-3000019650402023-06-230001965040us-gaap:EmployeeSeveranceMember2022-12-310001965040ftre:FacilityCostMember2022-12-310001965040us-gaap:EmployeeSeveranceMember2023-01-012023-09-300001965040ftre:FacilityCostMember2023-01-012023-09-300001965040us-gaap:EmployeeSeveranceMember2023-09-300001965040ftre:FacilityCostMember2023-09-300001965040us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001965040us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001965040us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001965040us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001965040us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001965040us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001965040us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001965040us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001965040ftre:ClinicalServicesSegmentMember2022-12-310001965040ftre:ClinicalServicesSegmentMember2021-12-310001965040ftre:EnablingServicesSegmentMember2022-12-310001965040ftre:EnablingServicesSegmentMember2021-12-310001965040ftre:ClinicalServicesSegmentMember2023-09-300001965040ftre:ClinicalServicesSegmentMember2022-09-300001965040ftre:EnablingServicesSegmentMember2023-09-300001965040ftre:EnablingServicesSegmentMember2022-09-300001965040us-gaap:CustomerRelationshipsMember2023-09-300001965040us-gaap:CustomerRelationshipsMember2022-12-310001965040us-gaap:TechnologyBasedIntangibleAssetsMember2023-09-300001965040us-gaap:TechnologyBasedIntangibleAssetsMember2022-12-310001965040us-gaap:OtherIntangibleAssetsMember2023-09-300001965040us-gaap:OtherIntangibleAssetsMember2022-12-310001965040us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberftre:SeniorSecuredTermLoanAFacilityDue2028Member2023-09-300001965040us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberftre:SeniorSecuredTermLoanAFacilityDue2028Member2022-12-310001965040us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberftre:SeniorSecuredTermLoanBFacilityDue2028Member2023-09-300001965040us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberftre:SeniorSecuredTermLoanBFacilityDue2028Member2022-12-310001965040ftre:A75SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2023-09-300001965040ftre:A75SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2022-12-310001965040ftre:A75SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2023-06-270001965040ftre:A75SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2023-06-272023-06-270001965040us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberftre:SeniorSecuredRevolvingCreditFacilityMember2023-06-300001965040us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberftre:SeniorSecuredTermLoanAFacilityDue2028Member2023-06-302023-06-300001965040us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberftre:SeniorSecuredTermLoanAFacilityDue2028Member2023-06-300001965040us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberftre:SeniorSecuredTermLoanBFacilityDue2028Member2023-06-302023-06-300001965040us-gaap:LineOfCreditMemberus-gaap:SecuredDebtMemberftre:SeniorSecuredTermLoanBFacilityDue2028Member2023-06-300001965040us-gaap:LineOfCreditMemberus-gaap:BridgeLoanMemberftre:SeniorSecuredRevolvingCreditFacilityMember2023-06-300001965040us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberftre:SeniorSecuredRevolvingCreditFacilityMember2023-06-300001965040us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberftre:SeniorSecuredRevolvingCreditFacilityMember2022-12-310001965040us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberftre:SeniorSecuredRevolvingCreditFacilityMember2023-09-300001965040us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberftre:SeniorSecuredRevolvingCreditFacilityMember2023-06-302023-06-300001965040us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-09-300001965040us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-12-310001965040us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2023-09-300001965040us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-12-310001965040us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2023-08-31ftre:derivative0001965040us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300001965040us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-012023-09-300001965040us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-09-300001965040us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300001965040us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300001965040us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300001965040us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001965040us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-09-300001965040us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001965040us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300001965040us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300001965040us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-09-300001965040us-gaap:RestrictedStockUnitsRSUMember2023-07-182023-07-180001965040us-gaap:PerformanceSharesMember2023-07-182023-07-180001965040ftre:FortreasOmnibusIncentivePlanMember2023-09-300001965040ftre:FortreasEmployeeStockPurchasePlanMember2023-09-300001965040us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001965040us-gaap:RestrictedStockUnitsRSUMember2023-06-300001965040us-gaap:PerformanceSharesMember2023-06-300001965040us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001965040us-gaap:PerformanceSharesMember2023-07-012023-09-300001965040us-gaap:RestrictedStockUnitsRSUMember2023-09-300001965040us-gaap:PerformanceSharesMember2023-09-300001965040us-gaap:CostOfSalesMember2023-07-012023-09-300001965040us-gaap:CostOfSalesMember2023-01-012023-09-300001965040us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001965040us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300001965040us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2023-01-012023-09-300001965040us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001965040us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2023-01-012023-09-300001965040ftre:DirectCostsRelatedPartyMember2023-07-012023-09-300001965040ftre:DirectCostsRelatedPartyMember2022-07-012022-09-300001965040ftre:DirectCostsRelatedPartyMember2023-01-012023-09-300001965040ftre:DirectCostsRelatedPartyMember2022-01-012022-09-300001965040ftre:SellingGeneralAndAdministrativeExpensesRelatedPartyMember2023-07-012023-09-300001965040ftre:SellingGeneralAndAdministrativeExpensesRelatedPartyMember2022-07-012022-09-300001965040ftre:SellingGeneralAndAdministrativeExpensesRelatedPartyMember2023-01-012023-09-300001965040ftre:SellingGeneralAndAdministrativeExpensesRelatedPartyMember2022-01-012022-09-300001965040ftre:RestructuringAndOtherChargesRelatedPartyMember2023-07-012023-09-300001965040ftre:RestructuringAndOtherChargesRelatedPartyMember2022-07-012022-09-300001965040ftre:RestructuringAndOtherChargesRelatedPartyMember2023-01-012023-09-300001965040ftre:RestructuringAndOtherChargesRelatedPartyMember2022-01-012022-09-300001965040ftre:ForeignExchangeGainLossRelatedPartyMember2023-07-012023-09-300001965040ftre:ForeignExchangeGainLossRelatedPartyMember2022-07-012022-09-300001965040ftre:ForeignExchangeGainLossRelatedPartyMember2023-01-012023-09-300001965040ftre:ForeignExchangeGainLossRelatedPartyMember2022-01-012022-09-300001965040ftre:GeneralFinancingActivitiesMember2023-07-012023-09-300001965040ftre:GeneralFinancingActivitiesMember2022-07-012022-09-300001965040ftre:GeneralFinancingActivitiesMember2023-01-012023-09-300001965040ftre:GeneralFinancingActivitiesMember2022-01-012022-09-300001965040ftre:CorporateAllocationsMember2023-07-012023-09-300001965040ftre:CorporateAllocationsMember2022-07-012022-09-300001965040ftre:CorporateAllocationsMember2023-01-012023-09-300001965040ftre:CorporateAllocationsMember2022-01-012022-09-300001965040ftre:SubcontractServicesMember2023-07-012023-09-300001965040ftre:SubcontractServicesMember2022-07-012022-09-300001965040ftre:SubcontractServicesMember2023-01-012023-09-300001965040ftre:SubcontractServicesMember2022-01-012022-09-300001965040us-gaap:RelatedPartyMemberftre:GeneralFinancingActivitiesMember2023-07-012023-09-300001965040us-gaap:RelatedPartyMemberftre:GeneralFinancingActivitiesMember2022-07-012022-09-300001965040us-gaap:RelatedPartyMemberftre:CorporateAllocationsMember2023-07-012023-09-300001965040us-gaap:RelatedPartyMemberftre:CorporateAllocationsMember2022-07-012022-09-300001965040us-gaap:RelatedPartyMemberftre:StockCompensationExpenseMember2023-07-012023-09-300001965040us-gaap:RelatedPartyMemberftre:StockCompensationExpenseMember2022-07-012022-09-300001965040ftre:SpecialPaymentToFormerParentMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001965040ftre:SpecialPaymentToFormerParentMemberus-gaap:RelatedPartyMember2022-01-012022-09-300001965040us-gaap:RelatedPartyMemberftre:GeneralFinancingActivitiesMember2023-01-012023-09-300001965040us-gaap:RelatedPartyMemberftre:GeneralFinancingActivitiesMember2022-01-012022-09-300001965040us-gaap:RelatedPartyMemberftre:CorporateAllocationsMember2023-01-012023-09-300001965040us-gaap:RelatedPartyMemberftre:CorporateAllocationsMember2022-01-012022-09-300001965040us-gaap:RelatedPartyMemberftre:StockCompensationExpenseMember2023-01-012023-09-300001965040us-gaap:RelatedPartyMemberftre:StockCompensationExpenseMember2022-01-012022-09-300001965040us-gaap:OperatingSegmentsMemberftre:ClinicalServicesSegmentMember2023-07-012023-09-300001965040us-gaap:OperatingSegmentsMemberftre:ClinicalServicesSegmentMember2022-07-012022-09-300001965040us-gaap:OperatingSegmentsMemberftre:ClinicalServicesSegmentMember2023-01-012023-09-300001965040us-gaap:OperatingSegmentsMemberftre:ClinicalServicesSegmentMember2022-01-012022-09-300001965040us-gaap:OperatingSegmentsMemberftre:EnablingServicesSegmentMember2023-07-012023-09-300001965040us-gaap:OperatingSegmentsMemberftre:EnablingServicesSegmentMember2022-07-012022-09-300001965040us-gaap:OperatingSegmentsMemberftre:EnablingServicesSegmentMember2023-01-012023-09-300001965040us-gaap:OperatingSegmentsMemberftre:EnablingServicesSegmentMember2022-01-012022-09-300001965040us-gaap:IntersegmentEliminationMemberftre:ClinicalServicesSegmentMember2023-07-012023-09-300001965040us-gaap:IntersegmentEliminationMemberftre:ClinicalServicesSegmentMember2022-07-012022-09-300001965040us-gaap:IntersegmentEliminationMemberftre:ClinicalServicesSegmentMember2023-01-012023-09-300001965040us-gaap:IntersegmentEliminationMemberftre:ClinicalServicesSegmentMember2022-01-012022-09-300001965040us-gaap:IntersegmentEliminationMemberftre:EnablingServicesSegmentMember2023-07-012023-09-300001965040us-gaap:IntersegmentEliminationMemberftre:EnablingServicesSegmentMember2022-07-012022-09-300001965040us-gaap:IntersegmentEliminationMemberftre:EnablingServicesSegmentMember2023-01-012023-09-300001965040us-gaap:IntersegmentEliminationMemberftre:EnablingServicesSegmentMember2022-01-012022-09-300001965040us-gaap:IntersegmentEliminationMember2023-07-012023-09-300001965040us-gaap:IntersegmentEliminationMember2022-07-012022-09-300001965040us-gaap:IntersegmentEliminationMember2023-01-012023-09-300001965040us-gaap:IntersegmentEliminationMember2022-01-012022-09-300001965040us-gaap:OperatingSegmentsMember2023-07-012023-09-300001965040us-gaap:OperatingSegmentsMember2022-07-012022-09-300001965040us-gaap:OperatingSegmentsMember2023-01-012023-09-300001965040us-gaap:OperatingSegmentsMember2022-01-012022-09-300001965040us-gaap:CorporateNonSegmentMember2023-07-012023-09-300001965040us-gaap:CorporateNonSegmentMember2022-07-012022-09-300001965040us-gaap:CorporateNonSegmentMember2023-01-012023-09-300001965040us-gaap:CorporateNonSegmentMember2022-01-012022-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission File Number 001-41704
FORTREA HOLDINGS INC.
(Exact name of registrant as specified in its charter)
Delaware
92-2796441
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer
Identification No.)
8 Moore Drive Durham, North Carolina
27709
(Address of principal executive offices)
(Zip Code)
(Registrant's telephone number, including area code) (480)-295-7600

Securities registered pursuant to Section 12(b) of the Act.
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value FTREThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer☐ Accelerated filero
Non-accelerated filerxSmaller reporting companyo
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The registrant had outstanding 88.8 million shares of common stock as of November 9, 2023.

INDEX
PART I. FINANCIAL INFORMATION
Item 1.
September 30, 2023 and December 31, 2022
Three and nine months ended September 30, 2023 and 2022
Three and nine months ended September 30, 2023 and 2022
Three and nine months ended September 30, 2023 and 2022
Nine months ended September 30, 2023 and 2022
PART II. OTHER INFORMATION
Item 5.
Other Information


1

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)
FORTREA HOLDINGS INC.
CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS
(in millions)
(unaudited)
September 30,
2023		December 31,
2022
ASSETS
Current assets:
Cash and cash equivalents$107.5 $112.0 
Accounts receivable and unbilled services, net1,047.1 1,022.2 
Prepaid expenses and other103.2 112.7 
Total current assets1,257.8 1,246.9 
Property, plant and equipment, net219.2 164.9 
Goodwill, net1,994.7 1,997.3 
Intangible assets, net773.7 823.3 
Deferred income taxes1.6 1.2 
Other assets, net69.7 54.3 
Total assets$4,316.7 $4,287.9 
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable$128.3 $81.5 
Accrued expenses and other current liabilities335.8 322.7 
Unearned revenue264.8 271.5 
Current portion of long-term debt26.1 — 
Short-term operating lease liabilities19.6 23.3 
Total current liabilities774.6 699.0 
Long-term debt, less current portion1,572.4 — 
Operating lease liabilities68.0 40.1 
Deferred income taxes and other tax liabilities171.7 184.5 
Other liabilities35.7 21.7 
Total liabilities$2,622.4 $945.3 
Commitments and contingent liabilities (Note 8)
Equity
Former parent investment— 3,618.6 
Common stock, 88.8 and 0.0 shares outstanding at September 30, 2023 and December 31, 2022, respectively
0.1 — 
Additional paid-in capital1,987.6 — 
Accumulated deficit(13.1)— 
Accumulated other comprehensive loss(280.3)(276.0)
Total equity1,694.3 3,342.6 
Total liabilities and equity$4,316.7 $4,287.9 
The accompanying notes are an integral part of these unaudited condensed consolidated and combined financial statements.
2

FORTREA HOLDINGS INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS
(in millions, except per share data)
(unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Revenues$776.4 $762.3 $2,333.6 $2,334.4 
Costs and expenses:
Direct costs, exclusive of depreciation and amortization (including costs incurred from related parties of $0.0, $21.6, $48.8 and $65.7 during the three and nine months ended September 30, 2023 and 2022, respectively)
647.3 594.8 1,932.9 1,847.6 
Selling, general and administrative expenses, exclusive of depreciation and amortization78.9 70.7 237.7 216.5 
Depreciation and amortization24.6 22.7 72.5 69.7 
Restructuring and other charges11.6 5.2 16.7 27.8 
Total costs and expenses762.4 693.4 2,259.8 2,161.6 
Operating income14.0 68.9 73.8 172.8 
Other income (expense):
Interest expense(34.6)— (35.3)— 
Foreign exchange gain (loss)(0.9)4.8 (1.0)21.1 
Other, net3.6 0.5 4.6 1.4 
Net income (loss) before income taxes(17.9)74.2 42.1 195.3 
Provision for (benefit from) income taxes(4.8)13.6 9.5 35.8 
Net income (loss)$(13.1)$60.6 $32.6 $159.5 
Earnings (loss) per common share
Basic
$(0.15)$0.68 $0.37 $1.80 
Diluted
$(0.15)$0.68 $0.37 $1.80 
The accompanying notes are an integral part of these unaudited condensed consolidated and combined financial statements.
3

FORTREA HOLDINGS INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in millions, except per share data)
(unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Net income (loss)$(13.1)$60.6 $32.6 $159.5 
Foreign currency translation adjustments(56.0)(96.6)(7.6)(216.8)
Net benefit plan adjustments— — 2.1 — 
Unrealized gain on derivative instruments
1.6 — 1.6 — 
Other comprehensive loss before tax
(54.4)(96.6)(3.9)(216.8)
Provision (benefit) for income tax related to items of comprehensive income(0.4)— (0.4)— 
Other comprehensive loss, net of tax
(54.8)(96.6)(4.3)(216.8)
Comprehensive income (loss)
$(67.9)$(36.0)$28.3 $(57.3)
The accompanying notes are an integral part of these unaudited condensed consolidated and combined financial statements.
4

FORTREA HOLDINGS INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY
(in millions)
(unaudited)
Common Stock
SharesAmountsAdditional Paid-in CapitalFormer Parent InvestmentAccumulated DeficitAccumulated
Other
Comprehensive
Loss		Total
Equity
Balance at December 31, 2022— $— $— $3,618.6 $— $(276.0)$3,342.6 
Net income
— — — 17.4 — — 17.4 
Other comprehensive income, net of tax
— — — — — 18.9 18.9 
Net transfers from Former Parent— — — 26.6 — — 26.6 
Balance at March 31, 2023— — — 3,662.6 — (257.1)3,405.5 
Net income
— — — 28.3 — — 28.3 
Other comprehensive income, net of tax
— — — — — 31.6 31.6 
Special payment to Former Parent— — — (1,595.0)— — (1,595.0)
Net transfers to Former Parent— — — (119.4)— — (119.4)
Reclassification of Former Parent investment to additional paid-in capital— — 1,976.5 (1,976.5)— — — 
Issuance of common stock88.8 0.1 — — — — 0.1 
Balance at June 30, 202388.8 0.1 1,976.5 — — (225.5)1,751.1 
Net loss
— — — — (13.1)— (13.1)
Other comprehensive loss, net of tax
— — — — — (54.8)(54.8)
Stock compensation
— — 11.1 — — — 11.1 
Balance at September 30, 202388.8 $0.1 $1,987.6 $— $(13.1)$(280.3)$1,694.3 
The accompanying notes are an integral part of these unaudited condensed consolidated and combined financial statements.
5

FORTREA HOLDINGS INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY
(in millions)
(unaudited)
Common Stock
SharesAmountsAdditional Paid-in CapitalFormer Parent InvestmentAccumulated DeficitAccumulated
Other
Comprehensive
Loss		Total
Equity
Balance at December 31, 2021— $— $— $3,409.0 $— $(148.4)$3,260.6 
Net income
— — — 32.5 — — 32.5 
Other comprehensive loss, net of tax
— — — — — (34.6)(34.6)
Net transfers from Former Parent
— — — 88.6 — — 88.6 
Balance at March 31, 2022— — — 3,530.1 — (183.0)3,347.1 
Net income
— — — 66.4 — — 66.4 
Other comprehensive loss, net of tax
— — — — — (85.6)(85.6)
Net transfers to Former Parent
— — — (29.3)— — (29.3)
Balance at June 30, 2022— — — 3,567.2 — (268.6)3,298.6 
Net income
— — — 60.6 — — 60.6 
Other comprehensive loss, net of tax
— — — — — (96.6)(96.6)
Net transfers to Former Parent
— — — (40.1)— — (40.1)
Balance at September 30, 2022— $— $— $3,587.7 $— $(365.2)$3,222.5 
The accompanying notes are an integral part of these unaudited condensed consolidated and combined financial statements.
6

FORTREA HOLDINGS INC.
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
Nine Months Ended September 30,
20232022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income
$32.6 $159.5 
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization72.5 69.7 
Stock compensation27.2 19.6 
Operating lease right-of-use asset expense20.9 19.0 
Deferred income taxes(12.7)(6.8)
Other, net3.5 3.4 
Changes in assets and liabilities:
Increase in accounts receivable and unbilled services, net(26.6)(72.7)
Increase in prepaid expenses and other
(3.1)(15.0)
Increase in accounts payable
47.3 23.5 
Decrease in unearned revenue
(6.5)(38.3)
Decrease in accrued expenses and other(0.1)(102.7)
Net cash provided by operating activities
155.0 59.2 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures(30.9)(36.0)
Proceeds from sale of assets8.1 0.4 
Net cash used for investing activities(22.8)(35.6)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit facilities24.0 — 
Payments on revolving credit facilities(24.0)— 
Proceeds from term loans1,061.4 — 
Proceeds from issuance of senior notes570.0 — 
Debt issuance costs(26.4)— 
Principal payments of long-term debt(7.7)— 
Special payment to Former Parent(1,595.0)— 
Net transfers to Former Parent(136.7)(0.4)
Net cash used for financing activities
(134.4)(0.4)
Effect of exchange rate changes on cash and cash equivalents(2.3)(10.3)
Net change in cash and cash equivalents(4.5)12.9 
Cash and cash equivalents at beginning of period112.0 94.6 
Cash and cash equivalents at end of period$107.5 $107.5 
The accompanying notes are an integral part of these unaudited condensed consolidated and combined financial statements.
7
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)

1.    BASIS OF FINANCIAL STATEMENT PRESENTATION
Description of Business
Fortrea Holdings Inc. ("Fortrea" or the “Company”), a Delaware corporation incorporated on January 31, 2023, is a leading global contract research organization (“CRO”) providing biopharmaceutical product and medical device development services, patient access solutions and other enabling services to pharmaceutical, biotechnology and medical device customers. The Company offers customers highly flexible delivery models that include Full Service, Functional Service Provider, and Hybrid Service structures. The Company has a rich history of providing clinical development services for over 30 years across more than 20 therapeutic areas, first as Covance and later as Labcorp Drug Development. On June 30, 2023, the Company completed a spin-off (the “Spin” or the “Separation”) from Laboratory Corporation of America Holdings (“Labcorp” or “Former Parent”). The Company leverages its global scale, clinical data insights, technology innovation, industry network and decades of experience as a standalone company and as a business unit prior to the Spin to deliver tailored solutions to its customers. With what the Company believes is a distinctive market offering, Fortrea meets growing global demand for clinical development services.
The team of approximately 19,000 employees conducts operations in more than 90 countries and delivers comprehensive phase I – IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services for our customers. The Company’s offering is scaled to deliver focused and agile solutions to customers globally, streamlining the biopharmaceutical product and medical device development process. Additionally, Fortrea successfully utilizes enabling technologies to optimize processes and evolve with a dynamic marketplace.
The Company manages its business in two reportable segments - Clinical Services and Enabling Services. The Clinical Services segment provides services across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. For further financial information about these segments, see Note 14, Business Segment Information to the condensed consolidated and combined financial statements.
The Company has established access to all key markets worldwide through a strategic footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Agreements with Labcorp
On June 30, 2023, the Company completed the Spin from Labcorp. The Company has entered into several agreements with Labcorp that govern the relationship of the parties following the Separation, including the Separation and Distribution Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and the Transition Services Agreement, which are described in the Company’s Registration Statement on Form 10, as amended (“Form 10”), as filed with the Securities and Exchange Commission (the “SEC”). Under the terms of the Transition Services Agreement, the Company and Labcorp agreed to provide each other certain transitional services. The services and assets to be provided to Fortrea by Labcorp support the Company’s enterprise functions, most notably IT applications, network and security support and hosting as well as finance, human resources, marketing and other administrative support.
Basis of Financial Statement Presentation
Prior to June 30, 2023, Fortrea existed and functioned as part of the consolidated business of Former Parent. The Company’s financial statements for periods through the Spin reflect the historical financial position, results of operations and cash flows of the Company, for the periods presented, prepared on a “carve-out” basis and have been derived from the condensed consolidated financial statements and accounting records of Labcorp using the historical results of operations and historical basis of assets and liabilities of the Company and reflect Labcorp’s net investment in the Company. The Company’s balance sheet as of September 30, 2023 is a consolidated balance sheet based on the financial position of Fortrea as a standalone company. The three months ended September 30, 2023
8
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
includes condensed consolidated financial statements, whereas all prior periods included combined financial statements. The Company’s unaudited condensed consolidated and combined financial statements for all periods presented are referred to throughout this document as “financial statements.”
The Company’s condensed consolidated and combined financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated and combined financial statements do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the prior periods presented.
The accompanying condensed consolidated and combined financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated and combined balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The condensed consolidated and combined financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company’s fiscal year 2022 reporting included within the Form 10. Therefore, these interim statements should be read in conjunction with the combined financial statements and notes thereto contained in the Form 10.
The condensed combined statements of operations include all revenues and costs directly attributable to our business. The condensed combined statements of operations for prior periods also include costs for certain centralized functions and programs provided and administered by Labcorp that were allocated to Fortrea. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation.
These expenses were allocated to Fortrea based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues or headcount or other reasonable driver, as applicable. Fortrea considers the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, Fortrea during the prior periods presented. However, the allocations may not reflect the expenses Fortrea would have incurred as an independent company for the prior periods presented. Actual costs that may have been incurred if Fortrea had been a standalone company would depend on a number of factors, including, but not limited to, the organizational structure, whether functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. For a period following the Spin some of these functions are provided by Labcorp as discussed within the Agreements with Labcorp section above.
Labcorp utilizes a centralized approach to cash management and financing of its operations. The cash and cash equivalents held by Labcorp at the corporate level were not specifically identifiable to Fortrea and therefore have not been reflected in the Company’s condensed combined balance sheet as of December 31, 2022. Cash and cash equivalents in the condensed consolidated and combined balance sheets represent cash and cash equivalents held by the Company.
As of December 31, 2022, the condensed combined financial statements include certain assets and liabilities that have historically been held at the Labcorp corporate level but are specifically identifiable or otherwise attributable to Fortrea. Labcorp’s third-party long-term debt and the related interest expense have not been allocated to Fortrea for any of the periods presented because Fortrea was not the legal obligor of such debt.
As of December 31, 2022, a Former Parent investment is shown in lieu of common stock and retained earnings accounts in the condensed combined financial statements. The total net effect of the settlement of the transactions between the Company and Labcorp, exclusive of those historically settled in cash, is reflected in the condensed combined statements of cash flows in cash flows from financing activities as net transfers (to) from Former Parent and in the condensed consolidated and combined balance sheets as Former Parent investment.
9
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
All intercompany transactions within the Company have been eliminated. All transactions between the Company and Former Parent have been included in these condensed consolidated and combined financial statements. For those transactions between the Company and Former Parent that were historically settled in cash, the Company has reflected such balances in the condensed consolidated and combined balance sheets as due from related parties or due to related parties. The Former Parent investment and all due from or due to Former Parent were settled at the time of the Spin. Refer to Note 12, Transactions with Former Parent for further information.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and unbilled services.
The Company maintains cash and cash equivalents with various major financial institutions. These financial institutions are generally highly rated and geographically dispersed. The Company evaluates the relative credit standing of these financial institutions and has not sustained credit losses from instruments held at financial institutions.
Substantially all the Company’s accounts receivable and unbilled services are with companies in the pharmaceutical, biotechnology and medical device industries. As of September 30, 2023, no customer accounted for more than 10% of the Company's combined gross accounts receivable and unbilled services. As of December 31, 2022, one pharmaceutical company accounted for approximately 10.5% of the Company's combined gross accounts receivable and unbilled services. Additionally, for the three months and nine months ended September 30, 2023, one customer accounted for approximately 13.5% and 10.2% of revenues, respectively. For the three and nine months ended September 30, 2022, no customer accounted for more than 10% of revenues. Concentrations of credit risk are mitigated due to the number of the Company’s customers as well as their dispersion across many different geographic regions. Additionally, the Company applies assumptions and judgments, including historical collection experience and reasonable and supportable forecasts, for assessing collectability and determining allowances for doubtful accounts.

2.    REVENUES
The Company’s revenues by segment and geography for the three and nine months ended September 30, 2023 and 2022 are as follows:
Three Months Ended September 30, 2023Three Months Ended September 30, 2022
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Clinical Services$347.4 $204.3 $160.0 $711.7 $355.3 $196.0 $145.9 $697.2 
Enabling Services64.4 — 0.3 64.7 64.6 — 0.5 65.1 
Total$411.8 $204.3 $160.3 $776.4 $419.9 $196.0 $146.4 $762.3 
Nine Months Ended September 30, 2023Nine Months Ended September 30, 2022
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Clinical Services$1,070.6 $600.7 $458.5 $2,129.8 $1,047.0 $642.6 $438.0 $2,127.6 
Enabling Services202.9 — 0.9 203.8 205.2 — 1.6 206.8 
Total$1,273.5 $600.7 $459.4 $2,333.6 $1,252.2 $642.6 $439.6 $2,334.4 
10
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
Revenue from the United States comprises substantially all revenue in North America.
Contract Costs
The following table provides information about contract asset balances:
September 30, 2023December 31, 2022
Sales commission assets$16.5 $18.6 
Deferred contract costs13.2 14.8
Total$29.7 $33.4 
Amortization related to sales commission assets for the three months ended September 30, 2023 and 2022 was $2.3 and $3.7, respectively, and for the nine months ended September 30, 2023 and 2022 was $10.2 and $10.2, respectively. Amortization related to deferred contract costs for the three months ended September 30, 2023 and 2022 was $2.2 and $3.1, respectively, and for the nine months ended September 30, 2023 and 2022 was $6.9 and $9.1, respectively. The Company does not recognize the effect of financing in its contracts with customers when the difference in timing of payment and performance is one year or less.
Accounts Receivable, Unbilled Services and Unearned Revenue
The following table provides information about accounts receivable, unbilled services and unearned revenue from contracts with customers:
September 30, 2023December 31, 2022
Accounts receivable$468.7 $449.2 
Gross unbilled services606.7 585.7 
Less: Allowance for credit losses(28.3)(12.7)
Total$1,047.1 $1,022.2 
Unearned revenue$264.8 $271.5 
Revenue recognized during the period included in the unearned revenue balance at the beginning of the period was $187.6 and $212.0 for the nine months ended September 30, 2023 and 2022, respectively.
Credit Loss Rollforward
The Company estimates future expected losses on accounts receivable and unbilled services over the remaining collection period of the instrument.
The rollforward for the allowance for credit losses for the nine months ended September 30, 2023 is as follows:
Accounts Receivable
Allowance for credit losses as of December, 2022$12.7 
Credit loss expense21.9 
Write-offs(6.3)
Allowance for credit losses as of September 30, 2023$28.3 
Performance Obligations Under Long-Term Contracts
As of September 30, 2023, approximately $4,958.2 of revenues are expected to be recognized from remaining long-term performance obligations. The Company expects to recognize approximately 29% of the existing
11
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
performance obligations as of September 30, 2023 as revenue over the next 12 months and the remaining balance thereafter. The Company's long-term contracts generally range from one to eight years.
During the three and nine months ended September 30, 2023, there were reductions of approximately $15.6 and $48.5, respectively, in the Company’s revenues related to performance obligations partially satisfied in previous periods. These reductions primarily relate to changes in scope. The gross and net amounts of revenue recognized solely from changes in estimates were not material.
Accounts Receivable Purchase Program
On June 23, 2023, Fortrea entered into an accounts receivable purchase program (“ARPP”) with a financial institution (the "Financial Institution"). The ARPP establishes a receivables factoring facility whereby the Company may sell up to $80.0 in customer receivables based on the availability of certain eligible receivables and the satisfaction of certain conditions. Under the facility, the Company may sell eligible receivables and retains no interest in the transferred receivables other than collection and administrative functions for the Financial Institution.
The Company accounts for these receivable transfers as sales and derecognizes the sold receivables from its balance sheets. The fair value of the sold receivables approximated their book value due to their short-term nature. The Company continues to service, administer and collect the receivables on behalf of the Financial Institution and does not receive a servicing fee as part of the arrangement. During the three months ended September 30, 2023, no receivables were sold. During the nine months ended September 30, 2023, $17.5 of receivables were sold with net proceeds of $17.3.

3.    RESTRUCTURING AND OTHER CHARGES
In the three months ended September 30, 2023, the Company took actions to reduce overcapacity, align resources, and restructure certain operations. These actions included eliminating redundant positions and aligning resources for cost improvement and to meet customer requirements. These restructuring actions are expected to continue throughout 2023 and 2024.
The following summarizes a component of the Company’s restructuring and other charges:
Severance and Other Employee CostsFacility CostsTotal
Balance as of December 31, 2022$1.9 $5.0 $6.9 
Expense12.0 1.0 13.0 
Cash payments(10.5)(1.5)(12.0)
Balance as of September 30, 2023$3.4 $4.5 $7.9 
The Company expects the restructuring and other charges accrued as of September 30, 2023 will be paid within the next twelve months and are included within accrued expenses and other current liabilities on the accompanying condensed consolidated and combined balance sheets. Restructuring costs are not allocated to the Company’s reportable segments as they are not part of the segment performance measures regularly reviewed by management.

4.    EARNINGS (LOSS) PER SHARE
On June 30, 2023, the Separation from Labcorp was effected through a pro-rata distribution of one share of the Company's common stock for every share of Labcorp common stock held at the close of business on the record date of June 20, 2023. As a result, on June 30, 2023, the Company had 88.8 shares of common stock outstanding. This share amount is being utilized for the calculation of basic earnings per share for all periods presented through the Separation date. As of the Separation date, actual outstanding shares are used to calculate basic weighted average common shares outstanding. Basic earnings per share is computed by dividing net earnings attributable to the Company by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common
12
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company’s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.
The following represents a reconciliation of basic earnings per share to diluted earnings per share.
Three Months Ended September 30,
20232022
Earnings
Shares
Per Share Amount
Earnings
Shares
Per Share Amount
Basic earnings (loss) per share:
Net earnings (loss)
$(13.1)88.8 $(0.15)$60.6 88.8 $0.68 
Dilutive effect of employee stock options and awards
— — — — — — 
Net earnings (loss) including impact of dilutive adjustments$(13.1)$88.8 $(0.15)$60.6 88.8$0.68 
Nine Months Ended September 30,
20232022
Earnings
Shares
Per Share Amount
Earnings
Shares
Per Share Amount
Basic earnings (loss) per share:
Net earnings (loss)
$32.6 88.8 $0.37 $159.5 88.8 $1.80 
Dilutive effect of employee stock options and awards
— 0.2 — — — — 
Net earnings (loss) including impact of dilutive adjustments$32.6 89.0 $0.37 $159.5 88.8 $1.80 
Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. Potential common shares are also considered antidilutive in the event of a net loss from operations.
The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Employee stock options and awards0.5 — 1.5 — 
Antidilutive employee stock options and awards excluded based on reporting a net loss for the period0.4 — — — 

5.    GOODWILL AND INTANGIBLE ASSETS
The Company's goodwill and intangible assets are the result of historical acquisitions; primarily the acquisition of Covance in 2015 by Labcorp. Subsequent acquisitions of businesses were allocated to the clinical development and commercialization services business of Fortrea based on the inclusion of the business activities using valuations at the time of acquisition.
13
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
The changes in the carrying amount of goodwill for the nine months ended September 30, 2023 and 2022 are as follows:
Clinical ServicesEnabling ServicesTotal
September 30, 2023September 30, 2022September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Balance as of December 31$1,707.4 $1,791.0 $289.9 $289.9 $1,997.3 $2,080.9 
Goodwill acquired during the period— — — — — — 
Foreign currency impact(2.6)(143.7)— — (2.6)(143.7)
Balance as of September 30$1,704.8 $1,647.3 $289.9 $289.9 $1,994.7 $1,937.2 
The Company assesses goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.
Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable and appropriate, the Company’s business could be impacted by unfavorable changes, including those that impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions; primarily a worsening economic environment and protracted economic downturn and related impacts, including delays in revenue from new customers, increases in customer termination activity, or increases in operating costs.
Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance.
The Company will continue to monitor the financial performance of and assumptions for its reporting units. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin or substantial reductions in end markets and volume assumptions could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations.
The components of identifiable intangible assets are as follows:
September 30, 2023December 31, 2022
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$1,188.2 $(420.3)$767.9 $1,191.1 $(376.7)$814.4 
Technology53.7 (49.8)3.9 53.7 (47.8)5.9 
Other13.3 (11.4)1.9 13.3 (10.3)3.0 
Total$1,255.2 $(481.5)$773.7 $1,258.1 $(434.8)$823.3 
Amortization of intangible assets for the three and nine months ended September 30, 2023 was $16.0 and $47.9, respectively. For the three and nine months ended September 30, 2022, amortization was $16.2 and $49.7, respectively. Amortization expense of intangible assets is estimated to be $15.8 for the remainder of 2023, $62.8 in 2024, $60.0 in 2025, $59.1 in 2026, $59.1 in 2027 and $516.9 thereafter.
6.    DEBT
In connection with the Spin, Fortrea incurred indebtedness in an aggregate principal amount of approximately $1,640.0, which consisted of borrowings under senior secured term loan facilities and senior secured notes. Fortrea also entered into a $450.0 senior secured revolving credit facility. Fortrea used the proceeds from
14
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
these debt transactions to make a cash distribution to Labcorp as consideration for the assets that were contributed to the Company in connection with the Spin.
The current portion of long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:
September 30, 2023December 31, 2022
Current portion of senior secured term loan A facility due 2028$25.0 $— 
Current portion of senior secured term loan B facility due 20305.7 — 
Debt issuance discount and fees(4.6)— 
Total short-term borrowings and current portion of long-term debt$26.1 $— 
Long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:
September 30, 2023December 31, 2022
7.5% senior notes due 2030
$570.0 $— 
Senior secured term loan A due 2028468.8 — 
Senior secured term loan B due 2030562.9 — 
Debt issuance discount and fees(29.3)— 
Total long-term debt$1,572.4 $— 
Senior Notes
On June 27, 2023, the Company issued $570.0 aggregate principal amount of 7.50% senior notes due 2030 (the “Notes"). Interest on these notes is payable semi-annually on January 1 and July 1 of each year. Net proceeds from the offering of the Notes were $560.2 after deducting expenses of the offering.
Credit Facilities
On June 30, 2023, Fortrea entered into a credit agreement (the “Credit Agreement”) providing for (i) a senior secured revolving credit facility in the principal amount of up to $450.0; (ii) a five-year $500.0 first lien senior secured term A loan facility; and (iii) a seven-year $570.0 first lien senior secured term B loan facility. The initial revolving facility includes a $75.0 swingline sub-facility and a $75.0 letter of credit sub-facility.
The Company drew on the term A and term B loans on June 30, 2023. The net proceeds received for the term A and term B loans were $491.8 and $552.9, respectively after deducting underwriting discounts and other expenses. The term A and term B loans will mature on June 30, 2028 and June 30, 2030, respectively. The term loans accrue interest at a per annum rate equal to the sum of, at the option of the Company, a Base Rate or a Term SOFR Rate and the Applicable Margin as defined by the Credit Agreement. As of September 30, 2023, the effective interest rate on the term A loan and term B loan was 7.57% and 9.07%, respectively.
The revolving credit facility is permitted, subject to certain covenant restrictions, to be used for general corporate purposes, including working capital and capital expenditures. There were no balances outstanding on the Company's current revolving credit facility as of September 30, 2023 and December 31, 2022. As of September 30, 2023, the effective interest rate on the revolving credit facility, assuming one month borrowing, was 7.57%. There is a commitment fee associated with the revolving credit facility of 0.35% (per annum and paid quarterly) and an annual $0.1 agency fee (paid in quarterly installments). The credit facility matures on June 30, 2028.
Under the Credit Agreement, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for similarly rated borrowers, and the Company is required to maintain certain net leverage and interest coverage ratios. The Company is permitted to make adjustments, such as excluding certain costs, from the calculation of leverage and interest coverage ratios for compliance purposes. The Company was in compliance with all covenants in the Credit Agreement at September 30, 2023.
There were no outstanding letters of credit under the Credit Agreement as of September 30, 2023.
15
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)

7.    DERIVATIVE INSTRUMENTS AND HEDGING
Summary of Derivative Instruments
The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and foreign currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative instruments such as foreign currency forward contracts (see “Foreign Currency Forward Contracts” section below) and interest rate swap agreements (see “Interest Rate Swaps” section below). The Company does not hold or issue derivative instruments for trading purposes. The derivative instrument contracts are with major investment grade financial institutions and the Company does not anticipate any material non-performance by any of the counterparties. The Company does not believe that its exposure to market risk is material to the Company’s financial position or results of operations.
Interest rate swap agreements, which are used by the Company from time to time in the management of interest rate exposure, are accounted for at fair value. These derivative instruments are accounted for as cash flow hedges and recognized as assets and liabilities, as applicable, and classified as current or noncurrent based on the swap’s settlement dates. The derivative instruments have been assessed and are considered to be perfectly effective hedges and accordingly, changes in the fair value of the interest rate swaps are initially recorded in the condensed consolidated and combined statements of comprehensive income. Cash flows from the interest rate swaps are included in financing activities.
Foreign currency forward contracts, which are used by the Company to hedge the Company’s foreign currency exposure, are accounted for at fair value. As these contracts are short-term in nature and are not designated hedging instruments, changes in the fair value of the Company’s foreign currency forward contracts are recognized directly in earnings.
The fair value of the Company's interest rate swaps and foreign currency forward contracts are determined based on observable market inputs (Level 2). The table below presents the fair value of the Company’s derivatives on a gross basis and the balance sheet classification of those instruments:
Fair Value of Derivatives At
September 30, 2023December 31, 2022
Balance Sheet ClassificationAssetLiabilityAssetLiability
Derivatives designated as hedging instruments:
Interest rate swapsPrepaid expenses and other$2.2 $(0.6)$— $— 
Derivatives not designated as hedging instruments:
Foreign currency forward contractsPrepaid expenses and other$2.2 $— $— $— 
Derivative Contracts Designated as Hedges
Interest Rate Swaps
In August 2023, the Company entered into two fixed-to-variable interest rate swap agreements for its senior secured term A loan facilities to hedge the cash flow variability associated with the Company’s floating interest rate exposure. The interest rate swaps, both of which mature on December 31, 2026, had an aggregate notional amount of $150.0 at September 30, 2023, each had a fixed interest rate of 4.20%, and each return variable interest rates based on one-month SOFR. Because these derivative instruments meet the criteria for hedge accounting, all related gains and losses are accumulated within other comprehensive loss and are being reclassified to earnings as interest payments are recognized in the condensed consolidated and combined statements of operations.
Refer to Note 9, Preferred Stock and Common Shareholders' Equity for the impact of the Company’s derivative instruments included in accumulated other comprehensive loss.
Derivative Contracts Not Designated as Hedges
16
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
Foreign Currency Forward Contracts
The Company utilizes foreign currency forward contracts with external counterparties to hedge the Company’s exposure to foreign currencies with exposure predominantly to the Euro and British Pound. These contracts do not qualify for hedge accounting and are recognized as assets or liabilities at their fair value with changes in fair value recorded directly to earnings. The contracts are short-term in nature and the fair value of these contracts is based on market prices for comparable contracts. The aggregate notional value of these contracts was $406.3 at September 30, 2023.

8.    COMMITMENTS AND CONTINGENT LIABILITIES
The Company is involved from time to time in various claims and legal actions arising in the ordinary course of business. These matters may include commercial and contract disputes, employee-related matters, and professional liability claims. In accordance with FASB ASC 450, Contingencies, the Company establishes reserves for claims and legal actions when those matters present loss contingencies that are both probable and estimable. When loss contingencies are not both probable and estimable, the Company does not establish reserves. The Company does not believe that any liabilities related to such claims and legal actions will have a material effect on its financial condition, results of operations or cash flows.
The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its drug development support services. The drug development industry is, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, and/or additional liabilities from third-party claims.
Fortrea obtains insurance coverage for certain catastrophic exposures as well as those risks required to be insured by law or contract. The Company is covered by those policies but is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.

17
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
9.    PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY
The Company is authorized to issue up to 265.0 shares of common stock, par value $0.001 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.001 per share. There were no preferred shares outstanding as of September 30, 2023 and December 31, 2022.
Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss) are as follows:
Three months ended September 30, 2023
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at June 30, 2023$(218.8)$(6.7)$— $(225.5)
Current quarter foreign exchange adjustments(56.0)— — (56.0)
Unrealized gain on derivative instrument— — 1.6 1.6
Tax effect of adjustments— — (0.4)(0.4)
Balance at September 30, 2023$(274.8)$(6.7)$1.2 $(280.3)
Three months ended September 30, 2022
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at June 30, 2022$(260.4)$(8.2)$— $(268.6)
Current quarter foreign exchange adjustments(96.6)— — (96.6)
Tax effect of adjustments— — — — 
Balance at September 30, 2022$(357.0)$(8.2)$— $(365.2)
Nine months ended September 30, 2023
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022$(267.2)$(8.8)$— $(276.0)
Current quarter foreign exchange adjustments(7.6)— — (7.6)
Unrealized gain on derivative instrument— — 1.6 1.6
Tax effect of adjustments— — (0.4)(0.4)
Transfer from Former Parent— 2.1 — 2.1 
Balance at September 30, 2023$(274.8)$(6.7)$1.2 $(280.3)
Nine months ended September 30, 2022
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at December 31, 2021$(140.2)$(8.2)$— $(148.4)
Current quarter foreign exchange adjustments(216.8)— — (216.8)
Tax effect of adjustments— — — — 
Balance at September 30, 2022$(357.0)$(8.2)$— $(365.2)
18
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
10.    INCOME TAXES
Prior to the Separation, the Company’s operations were historically included in Labcorp’s U.S. combined federal, certain state and local, and foreign income tax returns. The income tax provision included in these combined financial statements has been calculated using the separate return basis as if the Company had filed separate tax returns. The Company believes the assumptions supporting its allocation and presentation of income taxes on a separate return basis are reasonable. The Company’s tax results, as presented in the combined financial statements, do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the periods presented. For the periods prior to the Separation, the income tax expense and deferred tax balances that are presented in these financial statements were calculated on a carve-out basis, which applied the accounting guidance as if the Company filed its own tax returns in each jurisdiction and included tax losses and tax credits that may not reflect tax positions taken by the Former Parent.
Applicable accounting standards provide that the Company may estimate an annual effective tax rate (“AETR method”) and apply that forecasted tax rate to year-to-date income for each interim period. However, the AETR method resulted in an unreliable estimate of the Company’s annual effective tax rate due to changes in the Company’s post spin-off operational forecast as well as the impact of certain components of the forecast which are not inherent in the Company’s results of operations for the nine months ended September 30, 2023. Therefore, the Company recorded its interim income tax provision through September 30, 2023 using the discrete method, as allowed under ASC 740-270, Income Taxes – Interim Reporting. Using the discrete method, the Company determined income tax expense as if the nine months ended September 30, 2023 were an annual period.
For the three months ended September 30, 2023, the Company’s effective tax rate was 26.8% compared to 18.3% for the three months ended September 30, 2022. The effective tax rate for the three months ended September 30, 2023 was higher than the Company’s statutory tax rate primarily due to earnings mix partially offset by U.S. taxes on foreign earnings. The effective tax rate for the three months ended September 30, 2022 was lower than the Company’s statutory tax rate primarily due to U.S. taxes on foreign earnings and domestic tax credits, partially offset by state taxes and additional tax deductions.
The effective income tax rate for the nine months ended September 30, 2023 was 22.6% compared to 18.3% for the nine months ended September 30, 2022. The effective tax rate for the nine months ended September 30, 2023 was higher than the statutory tax rate primarily due to earnings mix and foreign withholding taxes partially offset by U.S. taxes on foreign earnings. The effective tax rate for the nine months ended September 30, 2022 was lower than the statutory tax rate primarily due to U.S. taxes on foreign earnings and domestic tax credits, partially offset by state taxes and additional tax deductions.
The Company will file a consolidated U.S. federal income tax return, as well as separate and combined income tax returns in numerous state and international jurisdictions. The Company has not filed its initial consolidated U.S. federal income tax return and therefore there are no open IRS examinations. However, the Company is currently subject to examination by various U.S. state and international tax authorities where existing legal entities were transferred to the Company as part of the Separation. Management regularly assesses the potential outcomes of both ongoing and future examinations for the current and prior years and has concluded that the Company’s provision for income taxes is adequate. Management does not anticipate that ongoing audits or negotiations will conclude during the next 12 months.
During the nine months ended September 30, 2023, the amount of net unrecognized tax positions decreased by $0.3. Management believes that it is reasonably possible that the amount of unrecognized income tax benefits and interest may decrease during the next 12 months by approximately $1.0.

11.    STOCK COMPENSATION PLANS
Stock Incentive Plans
Prior to the Separation, certain Company employees were covered by the Former Parent-sponsored stock compensation arrangements. The stock compensation expense for the period prior to the Separation has been derived from the equity awards granted by Labcorp to the Company’s employees who are specifically identified in the plans, as well as an allocation of expense related to corporate employees of Labcorp. The Former Parent-sponsored stock compensation arrangements are approved under the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan (the “Labcorp Plan”).
19
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
In June of 2023, Fortrea’s Board of Directors approved Fortrea’s Omnibus Incentive Plan and Employee Stock Purchase Plan (the “Plans”) and the current Board of Directors of Fortrea ratified the Plans by a unanimous written consent dated July 3, 2023. Under the Plans, the Company may grant incentive stock options, restricted stock units, and performance shares, as well as other forms of stock-based compensation to the Company’s employees, officers, and non-employee directors.
On July 18, 2023, all Labcorp equity incentive awards held by Fortrea employees that were outstanding on the distribution date were converted to 2.5 shares of Fortrea restricted stock units and 0.1 shares of Fortrea performance shares. Additionally, during the three months ended September 30, 2023, the Company granted awards under the Plans, including restricted stock units, performance stock units, and stock options, as indicated below.
As of September 30, 2023, 11.0 and 1.8 shares were authorized for future grants under Fortrea’s Omnibus Incentive Plan and Employee Stock Purchase Plan, respectively.
The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock units (“RSUs”) is determined based on the number of shares granted and the quoted price of Fortrea’s common stock on the grant date. The grant date fair value of performance awards is based on a Monte Carlo simulated fair value for the relative (as compared to the peer companies) total shareholder return component of the performance awards. Such value is recognized as an expense over the service period, net of estimated forfeitures and Fortrea’s determination of whether it is probable that the performance targets will be achieved. At the end of each reporting period, the Company reassesses the probability of achieving performance targets. The estimation of equity awards that will ultimately vest requires judgment and Fortrea considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience.
Stock Options
The following table summarizes grants of non-qualified options made by the Company to officers, key employees, or non-employee directors under all plans. Stock options are generally granted at an exercise price equal to or greater than the fair market price per share on the date of grant. Options vest ratably over a period of 3 years on the anniversaries of the grant date and have a contractual exercise period of 10 years subject to their earlier expiration or termination.
Changes in options outstanding under the plans for the three months ended September 30, 2023, were as follows:
Number of OptionsWeighted-Average Exercise Price per OptionWeighted-Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at June 30, 2023—$— 
Granted0.8$26.52 
Exercised
—$— 
Cancelled—$— 
Outstanding at September 30, 20230.8$26.52 9.9 years$1.7 
Exercisable at September 30, 2023—$— 0.0 years$— 
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2023.
20
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
The Company uses the Black-Scholes model to calculate the fair value of stock options. The following table shows the weighted average grant-date fair values of options issued during the period and the weighted average assumptions that the Company used to develop the fair value estimates:
Three Months Ended September 30, 2023
Weighted-average grant date fair value per option$12.51 
Weighted-average expected life (in years)6.3
Risk free interest rate4.4 %
Expected volatility40.4 %
Expected dividend yield— %
The volatility used in the determination of the fair value of the stock options was based on analysis of the historical volatility of guideline public companies and factors specific to the Company.
Restricted Stock Units and Performance Shares
The Company grants RSUs to officers, key employees, and non-employee directors. RSUs typically vest annually in equal one-third increments beginning on the first anniversary of the grant (e.g., a share grant in 2023 represents a three-year award opportunity for the period of 2023-2025 and, if earned, vests fully (to the extent earned) in the first quarter of 2026).
The Company grants performance shares (non-vested shares) to officers and key employees. Performance share awards are subject to a 3 year cliff vesting period in addition to certain revenue and adjusted EBITDA targets, the achievement of which may increase or decrease the number of shares which the grantee earns and therefore receives upon vesting. Unearned RSU and performance share compensation is amortized to expense, when probable, over the applicable vesting periods.
The following table shows a summary of non-vested shares for the three months ended September 30, 2023:
Number of Shares
Weighted-Average Grant Date Fair Value
Restricted Stock UnitsPerformance SharesRestricted Stock UnitsPerformance Shares
Non-vested at June 30, 2023——$— $— 
Converted2.50.134.243.8
Granted0.6—27.3—
Vested————
Cancelled(0.1)—34.9—
Non-vested at September 30, 20233.00.1$32.9 $43.8 
All Plans
Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated and combined statements of operations were as follows:
Three Months Ended September 30, 2023Nine Months Ended September 30, 2023
Direct costs$7.0 $16.4 
Selling, general and administrative expenses4.110.8
Total stock compensation expense$11.1 $27.2 
Income tax benefits$0.2 $1.7 
21
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
Unrecognized Compensation Cost
As of September 30, 2023, there was $83.4 of total unrecognized compensation cost related to non-vested stock options, restricted stock units and performance share-based compensation arrangements granted under the Plans. That cost is expected to be recognized over a weighted average period of 2.0 years and will be included in cost of revenues and selling, general and administrative expenses.

12.    TRANSACTIONS WITH FORMER PARENT
Prior to the Separation on June 30, 2023, the condensed consolidated and combined financial statements were prepared on a standalone basis and were derived from the condensed consolidated financial statements and accounting records of Labcorp. The following discussion summarizes activity between the Company and Labcorp.
Allocation of General Corporate and Other Expenses
Prior to the Separation, the Company’s condensed consolidated and combined statements of operations included expenses for certain centralized functions and other programs provided and administered by Labcorp that are charged directly to the Company. In addition, for purposes of preparing these condensed consolidated and combined financial statements on a carve-out basis, a portion of Labcorp’s total corporate expenses were allocated to the Company. See Note 1, Basis of Financial Statement Presentation for a discussion of the methodology used to allocate corporate-related costs for purposes of preparing these financial statements on a carve-out basis.
The following table is a summary of corporate and other allocations for the three and nine months ended September 30, 2023 and 2022:
Three Months Ended September 30,Nine Months Ended September 30,
20232022
2023 1
2022
Direct costs$— $39.4 $86.6 $120.9 
Selling, general and administrative expenses— 55.7 105.0 160.9 
Restructuring and other charges— 0.1 0.2 0.7 
Foreign exchange gain (loss)— 5.2 2.2 13.2 
Corporate and other allocations$— $100.4 $194.0 $295.7 
1 Activity reflected through the Separation date
Included in the aforementioned amounts are $0.0 and $72.0 related to costs for certain centralized functions and programs provided and administered by Labcorp that are charged directly to the Company for the three months ended September 30, 2023 and 2022, respectively, and $147.6 and $214.8 for the nine months ended September 30, 2023 and 2022, respectively. In addition, a portion of Labcorp’s total corporate expenses has been allocated to the Company for services from Labcorp. These costs were $0.0 and $28.4 for the three months ended September 30, 2023 and 2022, respectively, and $46.4 and $80.9 for the nine months ended September 30, 2023 and 2022, respectively. The allocations of foreign exchange gain (loss) represent the allocation of the results of hedging activities performed by Labcorp on behalf of the Company.
The Company has arrangements with third parties where the services are subcontracted to Labcorp (and its affiliates that were not part of the transaction). The Company’s direct costs include services purchased from Labcorp for commercial contracts totaling $0.0 and $21.6 for the three months ended September 30, 2023 and 2022, respectively, and $48.8 and $65.7 for the nine months ended September 30, 2023 and 2022, respectively.
Hedging Activities
Prior to the Separation, the Company did not enter into any derivative contracts with external counterparties. However, foreign currency forward contracts with external counterparties were utilized to hedge certain foreign currency transactions with exposure predominantly to the Euro and British Pound. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. Earnings related to these contracts
22
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
were included in the condensed consolidated and combined statements of operations as part of corporate allocations. Refer to Note 7, Derivative Instruments and Hedging, for information regarding derivative contracts entered into after Separation.
Net Transfers To and From Labcorp
Net transfers to and from Labcorp are included within Former Parent company investment on the condensed consolidated and combined statements of changes in equity. The components of the transfers to and from Labcorp during the three and nine months ended September 30, 2023 and 2022 were as follows:
Three Months Ended September 30,
20232022
General financing activities$— $(140.5)
Corporate allocations— 94.0 
Stock compensation expense— 6.4 
Total net transfers (to) from Former Parent$— $(40.1)
Nine Months Ended September 30,
2023 1
2022
Special Payment to Former Parent$(1,595.0)$— 
General financing activities(286.8)(276.5)
Corporate allocations183.8 276.1 
Stock compensation expense10.2 19.6 
Total net transfers (to) from Former Parent$(1,687.8)$19.2 
1 Activity reflected through the Separation date.
13.    SUPPLEMENTAL CASH FLOW INFORMATION
Nine Months Ended September 30,
20232022
Supplemental schedule of cash flow information:
Cash paid during period for:
Interest$22.9 $0.2 
Income taxes, net of refunds21.9 20.0 
Disclosure of non-cash investing activities:
Change in accrued property, plant and equipment(1.5)2.3 
Disclosure of non-cash transfers to (from) Parent:
Change in right-of-use lease assets13.9 — 
Change in property, plant and equipment, net(27.7)— 
14.    BUSINESS SEGMENT INFORMATION
The following tables are a summary of segment information for the three and nine months ended September 30, 2023 and 2022. The segment information is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (“CODM”) for evaluating segment performance and deciding how to allocate resources to segments. The Fortrea chief executive officer has been identified as the CODM.
23
INDEX
FORTREA HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS
                (dollars and shares in millions, except per share data)
The CODM allocates resources and assesses performance based on the underlying businesses which determines the Company's operating segments. The Company reports its business in two reportable segments: Clinical Services, which provides phase I-IV clinical trials, including clinical pharmacology and comprehensive clinical development capabilities, and Enabling Services, which provides post-approval patient access services and technology enabled solutions to support clinical trials. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. The CODM evaluates performance using revenue and segment operating income. Segment asset information is not presented because it is not used by the CODM at the segment level.
Revenues from external customers by reportable segment were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Revenues from external customers:
Clinical Services$711.7 $697.2 $2,129.8 $2,127.6 
Enabling Services64.7 65.1 203.8 206.8 
Total revenues$776.4 $762.3 $2,333.6 $2,334.4 
Intersegment revenues, which are eliminated in consolidation, were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Intersegment revenues:
Clinical Services$0.3 $0.3 $0.9 $0.8 
Enabling Services2.5 1.8 6.9 7.1 
Total revenues$2.8 $2.1 $7.8 $7.9 
Through the Spin, the condensed combined statements of operations include costs for certain centralized functions and programs provided and administered by Labcorp that are charged directly to the Company. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation. These additional allocations were reported as “corporate costs not allocated to segments” in the table below. After the Separation, as a standalone public company, the Company has allocated costs for certain centralized functions and programs to the Clinical Services and Enabling Services segments based on appropriate metrics such as revenues or headcount. The Corporate costs not allocated to segments include the costs of centralized functions including corporate governance, executive management and related human resources, finance, legal, risk management, and information technology functions. Operating income of each segment represents revenues less directly identifiable expenses to arrive at operating income for the segment.
Operating income by reportable segment was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Operating Income:
Clinical Services$59.9 $108.5 $192.4 $299.8 
Enabling Services2.3 5.7 6.0 21.3 
Segment operating income:62.2 114.2 198.4 321.1 
Corporate costs not allocated to segments(20.6)(23.9)(60.0)(70.8)
Amortization(16.0)(16.2)(47.9)(49.7)
Restructuring and other(11.6)(5.2)(16.7)(27.8)
Total operating income$14.0 $68.9 $73.8 $172.8 
24
Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (in millions)
The following discussion and analysis is intended to provide a summary of significant factors relevant to the financial performance and condition of Fortrea Holdings Inc., which we refer to in this discussion and analysis as “Fortrea,” the “Company,” “our” and “we”. Prior to the spin-off (the “Spin” or “the Separation”), Fortrea existed and functioned as part of Laboratory Corporation of America Holdings, which we refer to in this discussion and analysis as “Labcorp” or “Former Parent.” The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our audited combined financial statements and corresponding notes and our unaudited condensed consolidated and combined financial statements and corresponding notes in Item 1. “Financial Statements.”
Cautionary Statement Concerning Forward-Looking Statements
This Form 10-Q and other materials we have filed or will file with the Securities and Exchange Commission (the “SEC”) include or will include forward-looking statements. Some of the forward-looking statements can be identified by the use of terms such as “believes,” “expects,” “may,” “will,” “should,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “anticipates,” or other comparable terms. These forward-looking statements include all matters that are not related to present facts or current conditions or that are not historical facts. They appear in a number of places throughout this Form 10-Q and include statements regarding our intentions, beliefs, or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects and growth strategies, and the industries in which we operate and include, without limitation, statements relating to our future performance.
Forward-looking statements are subject to known and unknown risks and uncertainties, many of which are beyond our control. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and industry development may differ materially from those made in or suggested by the forward-looking statements contained in this Form 10-Q. In addition, even if our results of operations, financial condition and liquidity, and industry development are consistent with the forward-looking statements contained in this Form 10-Q, those results or developments may not be indicative of results or developments in subsequent periods. A number of important factors could cause actual results to differ materially from those contained in or implied by the forward-looking statements, including the risks and uncertainties discussed in “Risk Factors” Section of our Information Statement filed with our Registration Statement on Form 10, as amended (the “Form 10”), as filed with the SEC. Factors that could cause actual results to differ from those reflected in forward-looking statements relating to our operations and business include, among other things: the risk that we may not realize some or all of the benefits expected to result from the Spin, or that such benefits are delayed; risks and consequences that are a result of the Spin; the impacts of becoming an independent public company; our reliance on Labcorp to provide financial reporting and other financial and accounting information for periods prior to the Spin through the end of the relevant transition agreements, as well as IT, accounting, finance, legal, human resources, and other services critical to our businesses; our dependence on third parties generally to provide services critical to our businesses throughout the transition period and beyond; the risk that establishment of our accounting, enterprise resource planning, and other management systems post the transition period could cost more or take longer than anticipated; the impact of the rebranding of the Company; our ability to successfully implement our business strategies and execute our long-term value creation strategy; risks and expenses associated with our international operations and currency fluctuations; our customer or therapeutic area concentrations; any further deterioration in the macroeconomic environment, which could lead to defaults or cancellations by our customers; the risk that our backlog and net new business may not rebound after the Spin to the extent or over the time period we anticipate, that such measures may not be indicative of our future revenues and that we might not realize all of the anticipated future revenue reflected in our backlog; our ability to generate sufficient net new business awards, or the risk that net new business awards are delayed, terminated, reduced in scope, or fail to go to contract; the risk that we may underprice our contracts, overrun our cost estimates, or fail to receive approval for, or experience delays in documentation of change orders; and other factors described in the Form 10 and from time to time in documents that we file with the SEC.
25
Table of Contents
All forward-looking statements are made only as of the date of this Form 10-Q and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments. Comparisons of results for current and any prior periods are not intended to express any future trends, or indications of future performance, unless expressed as such, and should only be viewed as historical data. For a further discussion of the risks relating to our business, see the “Risk Factors” section of our Information Statement filed with our Form 10.
Company Overview
Fortrea Holdings Inc. ("Fortrea" or the “Company”), a Delaware corporation incorporated on January 31, 2023, is a leading global contract research organization (“CRO”) providing biopharmaceutical product and medical device development services, patient access solutions and other enabling services to pharmaceutical, biotechnology and medical device customers. The Company offers customers highly flexible delivery models that include Full Service, Functional Service Provider (“FSP”), and Hybrid Service structures. We have a rich history of providing clinical development services for over 30 years across more than 20 therapeutic areas, first as Covance and later as Labcorp Drug Development. On June 30, 2023, we completed a spin-off (the “Spin” or the “Separation”) from Laboratory Corporation of America Holdings (“Labcorp” or “Former Parent”). We leverage our global scale, clinical data insights, technology innovation, industry network and decades of experience as a standalone company and as a business unit prior to the Spin to deliver tailored solutions to our customers. With what we believe is a distinctive market offering, Fortrea meets growing global demand for clinical development services.
Our team of approximately 19,000 employees conducts operations in more than 90 countries and delivers comprehensive phase I – IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services for our customers. Our offering is scaled to deliver focused and agile solutions to customers globally, streamlining the biopharmaceutical product and medical device development process. Additionally, we successfully utilize enabling technologies to optimize processes and evolve with a dynamic marketplace.
We manage our business in two reportable segments - Clinical Services and Enabling Services. The Clinical Services segment comprises services across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions.
Separation from Labcorp
On June 30, 2023, we completed the Spin from Labcorp through a pro-rata distribution of one share of Fortrea common stock for every share of Labcorp common stock held at the close of business on the record date of June 20, 2023. Fortrea began to trade as a separate public company (NASDAQ: FTRE) on July 3, 2023.
Incremental Independent Public Company Expenses
The condensed consolidated and combined statements of operations include costs for certain centralized functions and programs provided and administered by Labcorp that were allocated to us in the periods presented prior to the Spin. These centralized functions and programs include, but are not limited to, legal, tax, treasury, risk management, sales expenses, IT, human resources, finance, supply chain, executive leadership and stock-based compensation.
These expenses were allocated to us based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues or headcount or other reasonable driver, as applicable. We consider the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, us during the periods presented. However, the allocations may not reflect the expenses we would have incurred as an independent company for the periods presented. Actual costs that may have been incurred if we had been a standalone company would depend on a number of factors, including the organizational structure, whether functions were outsourced or performed by employees, and strategic decisions made in areas such as IT and infrastructure. For a period following the Separation, however, some of these functions will be provided by Labcorp under transition services agreements.
26
Table of Contents
The actual costs of services represented by these allocations may vary significantly from the amounts allocated to us in the accompanying financial statements.

RESULTS OF OPERATIONS
Three Months Ended September 30, 2023 compared with Three Months Ended September 30, 2022 and Nine Months Ended September 30, 2023 compared with Nine Months Ended September 30, 2022
The following tables present the financial measures that management considers to be the most significant indicators of the Company's performance.
Revenues
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Clinical Services
$711.7 $697.2 2.1 %$2,129.8 $2,127.6 0.1 %
Enabling Services
64.7 65.1 (0.6)%203.8206.8 (1.5)%
Total
$776.4 $762.3 1.8 %$2,333.6 $2,334.4 — %
The Company’s revenues for the three months ended September 30, 2023 were $776.4, an increase of 1.8% over revenues of $762.3 in the corresponding period in 2022. The change in revenues was due to an increase in organic revenues of 1.0% and favorable foreign currency translation of 0.8%. The Company defines organic growth as the change in revenues excluding the year over year impact of acquisitions, divestitures and currency. The 1.0% increase in organic revenues was primarily driven by an increase in pass through revenues offset by lower service revenues resulting from the mix and quantity of recent new business wins and the impact of a prior year FSP cancellation.
The Clinical Services segment’s revenues for the three months ended September 30, 2023 were $711.7, an increase of 2.1% compared to revenues of $697.2 in the corresponding period in 2022. The increase in revenues was driven by an increase in pass through revenues offset by lower service revenues resulting from the mix and quantity of recent new business wins and the impact of a prior year FSP cancellation.
The Enabling Services segment’s revenues for the three months ended September 30, 2023 were $64.7, a decrease of 0.6% compared to revenues of $65.1 in the corresponding period in 2022. The decrease in revenues was due to lower call center volume.
The Company’s revenues for the nine months ended September 30, 2023, were $2,333.6, essentially flat over revenues of $2,334.4 in the corresponding period in 2022. The change in revenues was due to an increase in organic revenues of 0.2% offset by unfavorable foreign currency translation of 0.2%. The 0.2% increase in organic revenues was primarily driven by an increase in pass through revenues offset by lower service revenues driven by the impact of a prior year FSP cancellation, a customer concession and the mix and quantity of recent new business wins.
The Clinical Services segment’s revenues for the nine months ended September 30, 2023 were $2,129.8, an increase of 0.1% compared to revenues of $2,127.6 in the corresponding period in 2022. The increase in revenues was driven by an increase in pass through revenues offset by lower service revenues resulting from the impact of a prior year FSP cancellation, a customer concession and the mix and quantity of recent new business wins.
The Enabling Services segment’s revenues for the nine months ended September 30, 2023 were $203.8, a decrease of 1.5% compared to revenues of $206.8 in the corresponding period in 2022. The decrease in revenues was due to customer cancellations and lower call center volume.
27
Table of Contents
Direct Costs, Exclusive of Depreciation and Amortization
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Direct costs
$647.3 $594.8 8.8 %$1,932.9 $1,847.6 4.6 %
Direct costs as a % of revenues
83.4 %78.0 %82.8 %79.1 %
Direct costs increased 8.8% during the three months ended September 30, 2023 as compared with the corresponding period in 2022. Direct costs increased as a percentage of revenues to 83.4% during the three months ended September 30, 2023 as compared to 78.0% in the corresponding period in 2022. Direct costs increased 4.6% during the nine months ended September 30, 2023 as compared with the corresponding period in 2022. Direct costs increased as a percentage of revenues to 82.8% during the nine months ended September 30, 2023 as compared to 79.1% in the corresponding period in 2022.The increase in direct costs in both periods was primarily due to higher pass through costs, transition services agreement costs and personnel costs partially offset by the removal of Former Parent corporate allocations and carve-out adjustments Fortrea received prior to the Spin. Pass through costs are paid by the customer resulting in revenue fully offset by these direct costs.
Selling, General and Administrative Expenses, Exclusive of Depreciation and Amortization
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Selling, general and administrative expenses
$78.9 $70.7 11.6 %$237.7 $216.5 9.8 %
Selling, general and administrative expenses consist primarily of administrative payroll and related benefits, advertising and promotional expenses, credit loss provision, professional fees, administrative travel, facility charges and certain IT costs, and other administrative expenses. Selling, general and administrative expenses increased by 11.6% during the three months ended September 30, 2023 as compared with the corresponding period in 2022. The increase was primarily due to an increase in personnel costs, transition service agreement costs, credit loss provisions, and professional fees partially offset by elimination of prior year Former Parent corporate allocations and carve-out adjustments Fortrea received prior to the Spin.
Selling, general and administrative expenses increased 9.8% during the nine months ended September 30, 2023 as compared with the corresponding period in 2022. The change in selling, general and administrative expenses was primarily due to an increase in personnel costs, credit loss provisions, transition service agreement costs and professional fees partially offset by elimination of prior year Former Parent corporate allocations and carve-out adjustments Fortrea received prior to the Spin.
28
Table of Contents
Depreciation Expense
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Depreciation expense
$8.6 $6.5 32.3 %$24.6 $20.0 23.0 %
The increase in depreciation expense for the three months and nine months ended September 30, 2023 as compared to the corresponding periods in 2022 was due to the increase of property, plant and equipment, primarily IT assets, when they were separated between Fortrea and the Former Parent at Spin.
Amortization Expense
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Amortization of intangibles and other assets
$16.0 $16.2 (1.2)%$47.9 $49.7 (3.6)%
The decrease in amortization of intangibles and other assets during the three months ended September 30, 2023, as compared to the corresponding period in 2022, was not significant.
The decrease in amortization of intangibles and other assets during the nine months ended September 30, 2023, as compared to the corresponding period in 2022, is primarily the result of the impairment of technology assets that occurred in the fourth quarter of 2022.
Restructuring and Other Charges
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Restructuring and other charges
$11.6 $5.2 123.1 %$16.7 $27.8 (39.9)%
During the three and nine months ended September 30, 2023, the Company recorded net restructuring charges of $11.6 and $16.7, respectively, which is reflected within restructuring and other charges in the condensed consolidated and combined statements of operations. These charges are associated with Company actions to reduce overcapacity, align resources, and restructure certain operations and included eliminating redundant positions and aligning resources for cost improvement and to meet customer requirements.
During the three and nine months ended September 30, 2022, the Company recorded net restructuring charges of $5.2 and $27.8, respectively. These costs were associated with general cost improvement and headcount reduction initiatives at various locations around the world.
Interest Expense
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Interest expense
$(34.6)$— 100 %$(35.3)$— 100 %
The increase in interest expense for the three and nine months ended September 30, 2023, as compared with the corresponding period in 2022, is primarily due to the incurrence of indebtedness, consisting of borrowings under senior secured term loan facilities and senior secured notes.
29
Table of Contents
Foreign Exchange Gain (Loss)
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Foreign exchange gain (loss)
$(0.9)$4.8 (118.8)%$(1.0)$21.1 (104.7)%
The change in foreign exchange gain (loss) for the three months ended September 30, 2023, as compared to the three months ended September 30, 2022, was primarily due to the relative weakening of the U.S. Dollar against the British Pound and the Euro resulting in $3.1 in foreign exchange losses offset by $2.2 of hedging gains from the Company’s hedging program for 2023. For the three months ended September 30, 2022, foreign exchange gains were $10.1 offset by $5.3 of hedging losses from the Former Parent hedging program.
The change in foreign exchange gain (loss) for the nine months ended September 30, 2023, as compared to the nine months ended September 30, 2022, was primarily due to the relative weakening of the U.S. Dollar against most major foreign currencies resulting in $1.1 in foreign exchange losses and $2.1 of allocated hedging losses from the Former Parent hedging program offset by $2.2 of hedged gains from the Company’s hedging program for 2023. For the nine months ended September 30, 2022, foreign exchange gains of $34.2 were offset by $13.1 of allocated hedging losses from the Former Parent hedging program.
Income Tax Expense
Three Months Ended September 30,Nine Months Ended
September 30,
2023202220232022
Income tax expense$(4.8)$13.6 $9.5 $35.8 
Income tax expense as a % of income before tax26.8 %18.3 %22.6 %18.3 %
For the three months ended September 30, 2023, the Company's effective tax rate was 26.8% compared to the 2022 tax rate of 18.3%. For the nine months ended September 30, 2023, the Company's effective tax rate was 22.6% compared to the 2022 tax rate of 18.3%. The fluctuations in the quarter-to-date and year-to-date periods were primarily due to earnings mix and application of available tax credits in various jurisdictions.
Operating Results by Segment
Three Months Ended September 30,Nine Months Ended
September 30,
20232022
Change
20232022
Change
Clinical Services operating income
$59.9 $108.5 (44.8)%$192.4 $299.8 (35.8)%
Enabling Services operating income
2.3 5.7 (59.6)%6.0 21.3 (71.8)%
Segment operating income
$62.2 $114.2 (45.5)%$198.4 $321.1 (38.2)%
Clinical Services operating income was $59.9 for the three months ended September 30, 2023, a decrease of 44.8% from operating income of $108.5 in the corresponding period of 2022. The decrease in operating income was primarily due to lower service revenues driven by the mix and quantity of recent new business wins and the impact of a prior year FSP cancellation.
Enabling Services operating income was $2.3 for the three months ended September 30, 2023, a decrease of 59.6% from operating income of $5.7 in the corresponding period of 2022. The decrease was driven by lower revenues combined with investments in resources related to servicing a recent new award.
Clinical Services operating income was $192.4 for the nine months ended September 30, 2023, a decrease of 35.8% from operating income of $299.8 in the corresponding period of 2022. The decrease in operating income was primarily due to lower service revenues driven by the impact of a prior year FSP cancellation, a customer
30
Table of Contents
concession, the mix and quantity of recent new business wins and an increased provision for credit losses. This was partially offset by decreased personnel costs.
Enabling Services operating income was $6.0 for the nine months ended September 30, 2023 a decrease of 71.8% from operating income of $21.3 in the corresponding period of 2022. The decrease was driven by lower revenues combined with investments in resources related to servicing a recent new award.

Liquidity, Capital Resources and Financial Position
The Company manages cash flow to fund and invest in operational growth, capital expenditures, and credit facility repayments. In connection with the Spin, we have incurred indebtedness in an aggregate principal amount of $1,640.0, which consists of borrowings under senior secured term loan facilities and senior secured notes. We have also entered into a senior secured revolving credit facility, which consists of a five-year facility in the principal amount of up to $450.0 as further discussed in Note 6, Debt to the condensed consolidated and combined financial statements above. We have also entered into an accounts receivable purchase program (“ARPP”), which establishes a receivables factoring facility that permits the Company to sell up to $80.0 in customer receivables to a financial institution based on the availability of certain eligible receivables and the satisfaction of certain conditions. As of September 30, 2023, the Company had no outstanding factored customer receivables.
We believe our existing cash and cash flows generated from operations, plus existing credit facilities, will be sufficient to cover the needs of our current and planned operations for at least the next 12 months. From time to time, we routinely evaluate strategic opportunities, including potential acquisitions, joint ventures or investments in complementary businesses. We may also access capital markets through the issuance of debt or equity, which we may use in connection with the acquisition of complimentary businesses or other significant assets, or for other strategic opportunities, or general corporate purposes.
Cash Flows for the nine months ended September 30, 2023 and 2022
In summary the Company's cash flows were as follows:
Nine Months Ended September 30,
20232022
Net cash provided by (used for) operating activities
$155.0 $59.2 
Net cash used for investing activities
(22.8)(35.6)
Net cash (used for) provided by financing activities
(134.4)(0.4)
Effect of exchange rate on changes in cash and cash equivalents
(2.3)(10.3)
Net change in cash and cash equivalents
$(4.5)$12.9 
Cash and Cash Equivalents
Cash and cash equivalents at September 30, 2023 and 2022 totaled $107.5 and $107.5, respectively. Cash and cash equivalents consist of highly liquid instruments, such as commercial paper, time deposits and other money market instruments, which have maturities when purchased of three months or less.
Cash Flows from Operating Activities
During the nine months ended September 30, 2023, the Company's operations provided $155.0 of cash as compared to $59.2 of cash during the nine months ended September 30, 2022. Net cash provided by operating activities increased by $95.8 for the nine months ended September 30, 2023 as compared to the nine months ended September 30, 2022. Cash flows from operating activities benefited from an improvement in unbilled services and deferred revenue and lower cash used for accrued expenses partially offset by a decrease in net income.
31
Table of Contents
Cash Flows from Investing Activities
Net cash used for investing activities for the nine months ended September 30, 2023 was $22.8 as compared to net cash used for investing activities of $35.6 for the nine months ended September 30, 2022. The $12.8 decrease in net cash used for investing activities for the nine months ended September 30, 2023, was primarily due to a year over year decrease in capital expenditures. Capital expenditures were $30.9 and $36.0 for the nine months ended September 30, 2023 and 2022, respectively. Capital expenditures in 2023 were 1.3% of revenues, primarily in connection with projects to support growth in the Company's core businesses. The Company intends to continue to pursue selective investments in key therapeutic areas and geographies to drive growth and to improve efficiency of the Company's operations. Such expenditures are expected to be funded by cash flow from operations.
Cash Flows from Financing Activities
Net cash used for financing activities for the nine months ended September 30, 2023 was $134.4 compared to cash used by financing activities of $0.4 for the nine months ended September 30, 2022. Cash provided by financing activities related to proceeds from term loans and senior note offerings was offset primarily by the net transfers to Former Parent.
Off-Balance Sheet Arrangements
The Company does not have transactions or relationships with “special purpose” entities, and the Company does not have any off-balance sheet financing other than normal operating leases and letters of credit.
Critical Accounting Policies and Estimates
We have chosen accounting policies that management believes are appropriate to accurately and fairly report our operating results and financial position in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). We apply these accounting policies in a consistent manner. Significant accounting policies are summarized in Note 2 to the combined financial statements included in the Form 10.
The application of these accounting policies require that we make estimates and assumptions about future events and apply judgments that affect the reported amounts of assets, liabilities, revenues, expenses, contingent assets and liabilities, and related disclosures. These estimates, assumptions and judgments are based on historical experience, current trends and other factors believed to be reasonable under circumstances. Management evaluates these estimates and assumptions on an ongoing basis. If actual results ultimately differ from previous estimates, the revisions are included in results of operations when the actual amounts become known.
The accounting policies that involve the most significant estimates, assumptions and management judgments used in preparation of the condensed consolidated and combined financial statements, or are the most sensitive to change due to outside factors, are discussed in Management's Discussion and Analysis in the Form 10. Except as disclosed in Note 1 to our condensed consolidated and combined financial statements in this Form 10-Q, pertaining to the adoption of new accounting pronouncements, there have been no material changes in these policies.

32
Table of Contents
Item 3. Quantitative and Qualitative Disclosures about Market Risk (in millions)
Market risk is the potential loss arising from adverse changes in market rates and prices, such as foreign currency exchange rates, interest rates and other relevant market rate or price changes. In the ordinary course of business, we are exposed to various market risks, including changes in foreign currency exchange and interest rates, and we regularly evaluate the exposure to such changes. We address our exposure to market risks, principally the market risks associated with changes in foreign currency exchange rates and interest rates, through a controlled program of risk management that may include, from time to time, the use of derivative financial instruments such as foreign currency forward contracts, cross currency swaps and interest rate swap agreements in an effort to manage or hedge some of our risk. We do not hold or issue derivative financial instruments for trading purposes. Refer to Note 7, Derivative Instruments and Hedging to the condensed consolidated and combined financial statements above for information on how the Company utilizes derivative financial instruments.
Foreign Currency Exchange Rates
Approximately 16.6% and 18.6% of our revenues for the nine months ended September 30, 2023 and 2022, respectively, were denominated in currencies other than the U.S. dollar (“USD”). Our financial statements are reported in USD and, accordingly, fluctuations in exchange rates will affect the translation of revenues and expenses denominated in foreign currencies into USD for purposes of reporting our condensed consolidated and combined financial results. In the third quarter of 2023 and the year ended December 31, 2022, the most significant currency exchange rate exposures were the Euro and British pound. Excluding the impacts from any outstanding or future hedging transactions, a hypothetical change of 10% in average exchange rates used to translate all foreign currencies to USD would have impacted income before income taxes for the nine months ended September 30, 2023 by approximately $1.2 and for the year ended December 31, 2022 by approximately $4.3. Gross accumulated currency translation adjustments recorded as a separate component of stockholders’ equity were $(7.6) and $(216.8) at September 30, 2023 and September 30, 2022, respectively. We do not have significant operations in countries in which the economy is considered to be highly inflationary.
We earn revenue from service contracts over a period of several months to many years. Accordingly, exchange rate fluctuations during this period may affect our profitability with respect to such contracts. We are also subject to foreign currency transaction risk for fluctuations in exchange rates during the period of time between the consummation and cash settlement of transactions. We do not enter into any derivative contracts with external counterparties. Starting in the quarter ended September 30, 2023, we entered into foreign currency forward contracts with external counterparties to hedge certain foreign currency transactions with exposure predominantly to the Euro and British Pound. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings.
Prior to the Spin, the Former Parent entered into foreign currency forward contracts with external counterparties to hedge certain foreign currency transactions with exposure predominantly to the Euro and British Pound. These contracts did not qualify for hedge accounting and the changes in fair value were recorded directly to earnings. Earnings related to these contracts were included in the combined statements of operations as part of corporate allocations.
Interest Rate Risk
We are exposed to market risks in the ordinary course of our business. The level of our interest rate risk is dependent on our debt exposure and is sensitive to changes in the general level of interest rates. Historical fluctuations in interest rates have not been significant for us; however, this may vary in the future as we have incurred certain indebtedness concurrent with the Spin and will incur additional indebtedness in the future.
In particular, we face the market risks associated with interest rate movements on our variable rate debt. We are significantly leveraged and incurred approximately $1,640.0 of long-term debt in connection with the Spin. A majority of this debt bears interest at a variable rate, and we entered into a floating-to-fixed interest rate swap with respect to some of our floating rate debt in August 2023. At September 30, 2023, we had $1,062.3 outstanding related to our variable rate debt. Excluding the impacts from any outstanding or future floating-to-fixed interest rate swap transactions, a hypothetical 1.00% increase in interest rates would result in increased interest expenses of $10.6. We expect to manage our interest rate risk but expect to be exposed to an element of market risk from changes to interest rates, including on any refinancing of debt. We expect to regularly assess market risks and to
33
Table of Contents
establish policies and business practices to protect against the adverse effects of these exposures. See “Description of Certain Indebtedness and Other Financing.”
34
Table of Contents
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Management of the Company, with the participation of its Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the period ending September 30, 2023. Based upon our evaluation, our CEO and our CFO have concluded that, as of the period ending September 30, 2023, our disclosure controls and procedures were effective and provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including our CEO and our CFO, as appropriate, to allow timely decisions regarding required disclosure.
Prior to the quarter ended June 30, 2023, Fortrea relied on certain material processes and internal controls over financial reporting performed by Labcorp.
Changes in Internal Control Over Financial Reporting
No changes in our internal controls over financial reporting during the quarter ended September 30, 2023 have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
See Note 8 (Commitments and Contingencies) to the Company’s condensed consolidated and combined financial statements, above, which is incorporated herein by reference.
Item 1A. Risk Factors
For a discussion of the risks relating to our business, see the “Risk Factors” section of our Form 10 and the “Cautionary Statement Concerning Forward-Looking Statements” set forth in Part I, Item 2 of this Form 10-Q.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable
Item 3. Defaults Upon Senior Securities
Not applicable
Item 4. Mine Safety Disclosures
Not applicable
Item 5. Other Information
None
35
Table of Contents

Item 6. Exhibits
The exhibits below are filed or furnished as a part of this report and are incorporated herein by reference.
INCORPORATED BY REFERENCE
EXHIBIT NO.DESCRIPTIONFiled HerewithFORMFile No.ExhibitFiling Date
8-K
001-41704
10.121-Aug-23
8-K
001-41704
10.221-Aug-23
X
X
X
X
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.X
101.SCHInline XBRL Taxonomy Extension Schema Document.X
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.X
101.DEFInline XBRL Taxonomy Extension Definition Document.X
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.X
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.X
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL Instance document included in Exhibit 101.X
36
Table of Contents
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Fortrea Holdings Inc.
By:/s/ JILL McCONNELL
Name:Jill McConnell
Title:Chief Financial Officer
(On behalf of the Registrant and as Principal Financial Officer)
Date: November 13, 2023
37
 EX-31.1 2 q323exhibit-311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Thomas Pike, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Fortrea Holdings Inc. (the “registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)[Omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a)];
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
    
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Thomas Pike
Date: November 13, 2023Thomas Pike
President and Chief Executive Officer
(Principal Executive Officer)

 EX-31.2 3 q323exhibit-312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Jill McConnell, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Fortrea Holdings Inc. (the “registrant”);
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)[Omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a)];
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
    
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Jill McConnell
Date: November 13, 2023Jill McConnell
Chief Financial Officer
(Principal Financial Officer)

 EX-32.1 4 q323exhibit321.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002


I, Thomas Pike, Chief Executive Officer of Fortrea Holdings Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

/s/ Thomas Pike
Date: November 13, 2023Thomas Pike
President and Chief Executive Officer
(Principal Executive Officer)

 EX-32.2 5 q323exhibit-322.htm EX-32.2 Document


Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002


I, Jill McConnell, Chief Financial Officer of Fortrea Holdings Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

/s/ Jill McConnell
Date: November 13, 2023Jill McConnell
Chief Financial Officer
(Principal Financial Officer)

 EX-101.SCH 6 ftre-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - COVER link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - REVENUES link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - RESTRUCTURING AND OTHER CHARGES link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - EARNINGS (LOSS) PER SHARE link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - STOCK COMPENSATION PLANS link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - TRANSACTIONS WITH FORMER PARENT link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - BUSINESS SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - REVENUES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - RESTRUCTURING AND OTHER CHARGES (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - STOCK COMPENSATION PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - TRANSACTIONS WITH FORMER PARENT (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - REVENUES - Summary of Revenue by Segment and Geography (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - REVENUES - Summary of Capitalized Contract Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - REVENUES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - REVENUES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - REVENUES - Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - REVENUES - Rollforward of Allowance for Credit Losses (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - RESTRUCTURING AND OTHER CHARGES (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - EARNINGS (LOSS) PER SHARE - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - EARNINGS (LOSS) PER SHARE - Reconciliation of Basic Earnings per Share to Diluted Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - EARNINGS (LOSS) PER SHARE - Antidilutive Securities Excluded from Computation (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Components of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - DEBT - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - DEBT - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING - Schedule of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - STOCK COMPENSATION PLANS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - STOCK COMPENSATION PLANS - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - STOCK COMPENSATION PLANS - Fair Value Estimates (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - STOCK COMPENSATION PLANS - Restricted Stock Units and Performance Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - STOCK COMPENSATION PLANS - Share-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Allocation of General Corporate and Other Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Net Transfers To and From Labcorp (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - BUSINESS SEGMENT INFORMATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - BUSINESS SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ftre-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 ftre-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 ftre-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Number of shares converted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued Upon Conversion Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued Upon Conversion Accrued expenses and other current liabilities Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Exercise period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Disclosure of non-cash transfers to (from) Parent: Disclosure Of Non-Cash Transfers To (From) Parent: [Abstract] Disclosure Of Non-Cash Transfers To (From) Parent: Award Type [Domain] Award Type [Domain] Remaining performance obligation, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Non-vested, beginning balance (in shares) Non-vested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Effective interest rate Line of Credit Facility, Interest Rate at Period End DEBT Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Number of countries in which entity operates (more than) Number of Countries in which Entity Operates Revolving credit facility Revolving Credit Facility [Member] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Performance Shares Performance Shares [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Exercisable, weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Tax effect of adjustments Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Commitments and contingent liabilities (Note 8) Commitments and Contingencies Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Cliff vesting period Share Based Compensation Arrangement By Share Based Payment Award, Cliff Vesting Period Share Based Compensation Arrangement By Share Based Payment Award, Cliff Vesting Period PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY Equity [Text Block] Liability Derivative Liability, Not Subject to Master Netting Arrangement Schedule of Goodwill [Table] Schedule of Goodwill [Table] Geographical [Axis] Geographical [Axis] INCOME TAXES Income Tax Disclosure [Text Block] Decrease in unearned revenue Increase (Decrease) in Contract with Customer, Liability Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Concentration Risk [Line Items] Concentration Risk [Line Items] Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Preferred stock, par value per share (in dollars per share) Preferred Stock, Par or Stated Value Per Share Intersegment eliminations Intersegment Eliminations [Member] Debt issuance discount and fees Debt Issuance Costs, Noncurrent, Net ARPP, maximum facility amount Accounts Receivable Purchase Program, Maximum Facility Amount Accounts Receivable Purchase Program, Maximum Facility Amount Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Diluted (in dollars per share) Per share amount, diluted (in dollars per share) Earnings Per Share, Diluted Reclassification of Former Parent investment to additional paid-in capital Adjustments To Additional Paid In Capital, Former Parent Investment Reclassification Adjustments To Additional Paid In Capital, Former Parent Investment Reclassification Goodwill [Roll Forward] Goodwill [Roll Forward] Supplemental Cash Flow Elements [Abstract] Line of credit Line of Credit [Member] Outstanding, beginning (in shares) Outstanding, ending (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Trading Symbol Trading Symbol Letters of credit outstanding Letters of Credit Outstanding, Amount Granted (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-average grant date fair value per option (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Net income (loss) Net income (loss) Net earnings (loss) Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Unrealized gain on derivative instruments Unrealized gain on derivative instrument Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent Other Other Intangible Assets [Member] Reconciliation of Basic Earnings per Share to Diluted Earnings per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Corporate and other allocations Direct costs Related Party Transaction, Amounts of Transaction Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Proceeds from sale of assets Proceeds from Sale of Productive Assets Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Converted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted in Period Exercised (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Goodwill, net Balance as of December 31 Balance as of September 30 Goodwill Equity Components [Axis] Equity Components [Axis] Decrease in accrued expenses and other Increase (Decrease) in Accrued Liabilities Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Estimated amortization expense, 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Letter of credit Letter of Credit [Member] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Derivative, notional amount Derivative, Notional Amount Accounts receivable and unbilled services Accounts Receivable [Member] One customer One Customer [Member] One Customer Operating lease liabilities Operating Lease, Liability, Noncurrent BASIS OF FINANCIAL STATEMENT PREPARATION Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Restricted Stock Units Restricted Stock Units (RSUs) [Member] Debt term Debt Instrument, Term Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Former parent investment Net Parent Investment Net Parent Investment Debt issuance costs Payments of Debt Issuance Costs Restructuring and other charges Restructuring, Settlement and Impairment Provisions Income Statement Location [Axis] Income Statement Location [Axis] Schedule of Debt Schedule of Long-Term Debt Instruments [Table Text Block] Foreign currency forward contracts Foreign Exchange Forward [Member] Europe Europe [Member] One pharmaceutical company One Pharmaceutical Company [Member] One Pharmaceutical Company Schedule of Antidilutive Securities Excluded from Computation Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Beginning balance Ending balance Restructuring Reserve Enabling Services Enabling Services Segment [Member] Enabling Services Segment Change in accrued property, plant and equipment Noncash Investing and Financing Activities, Change In Accrued Property, Plant And Equipment Noncash Investing and Financing Activities, Change In Accrued Property, Plant And Equipment Antidilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Granted (in share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Sales commission assets Sales Commission Assets [Member] Sales Commission Assets Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Disclosure of non-cash investing activities: Noncash Investing and Financing Items [Abstract] Interest expense Interest Expense Number of shares authorized for future issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Hedging Designation [Axis] Hedging Designation [Axis] Goodwill [Line Items] Goodwill [Line Items] Outstanding, weighted average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Estimated amortization expense, remainder of year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] TRANSACTIONS WITH FORMER PARENT Related Party Transactions Disclosure [Text Block] Performance obligation partially satisfied in previous period, revenue recognized Contract with Customer, Performance Obligation Satisfied in Previous Period Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Asset Derivative Asset, Not Subject to Master Netting Arrangement Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Foreign currency translation adjustments Current quarter foreign exchange adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent Short-term operating lease liabilities Operating Lease, Liability, Current Annual agency fee Line of Credit Facility, Annual Agency Fee Line of Credit Facility, Agency Fee Amortization of intangible assets Amortization of Intangible Assets Entity Shell Company Entity Shell Company Net Carrying Amount Finite-Lived Intangible Assets, Net Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period General financing activities General Financing Activities [Member] General Financing Activities Commitment fee Line of Credit Facility, Commitment Fee Percentage Unearned revenue Contract with Customer, Liability, Current Schedule of Fair Value Estimates Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Selling, general and administrative expenses, exclusive of depreciation and amortization Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Award vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Foreign Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Employee stock options and awards Stock Options Employee Stock Option [Member] DERIVATIVE INSTRUMENTS AND HEDGING Derivative Instruments and Hedging Activities Disclosure [Text Block] Unrecognized compensation cost, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Senior secured revolving credit facility Senior Secured Revolving Credit Facility [Member] Senior Secured Revolving Credit Facility Total costs and expenses Costs and Expenses Maximum Maximum [Member] Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule Of Restructuring and Other Charges Restructuring and Related Costs [Table Text Block] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Goodwill acquired during the period Goodwill, Acquired During Period Entity Address, Address Line One Entity Address, Address Line One Direct costs, exclusive of depreciation and amortization (including costs incurred from related parties of $0.0, $21.6, $48.8 and $65.7 during the three and nine months ended September 30, 2023 and 2022, respectively) Costs incurred from related parties Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] STOCK COMPENSATION PLANS Share-Based Payment Arrangement [Text Block] Total contract assets Capitalized Contract Cost, Net Basis of Financial Statement Presentation Basis of Accounting, Policy [Policy Text Block] Other, net Other Noncash Income (Expense) Weighted-Average Exercise Price per Option Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Net transfers (to) from Former Parent Net Transfers From (To) Parent, Excluding Special Payment. Net Transfers From (To) Parent, Excluding Special Payment. Remaining performance obligation, percentage Revenue, Remaining Performance Obligation, Percentage Less: Allowance for credit losses Allowance for credit losses as of December, 2022 Allowance for credit losses as of September 30, 2023 Accounts Receivable, Allowance for Credit Loss, Current Customer concentration risk Customer Concentration Risk [Member] Components of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Clinical Services Clinical Services Segment [Member] Clinical Services Segment Income Statement [Abstract] Income Statement [Abstract] Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Costs and expenses: Costs and Expenses [Abstract] Title of 12(b) Security Title of 12(b) Security Restructuring and Other Charges [Line Items] Restructuring Cost and Reserve [Line Items] Related Party, Type [Domain] Related Party, Type [Domain] Operating segments Operating Segments [Member] Non-vested, beginning balance (in dollars per share) Non-vested, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Derivative, fixed interest rate Derivative, Fixed Interest Rate Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Foreign currency impact Goodwill, Foreign Currency Translation Gain (Loss) Special payment to Former Parent Special Payment To Former Parent Special Payment To Former Parent Capitalized assets, amortization Capitalized Contract Cost, Amortization Change in right-of-use lease assets Transfer To (From) Parent, Change In Right-Of-Use Lease Asset Transfer To (From) Parent, Change In Right-Of-Use Lease Asset Other Other Geographical Areas [Member] Other Geographical Areas Statistical Measurement [Axis] Statistical Measurement [Axis] Direct costs Direct Costs, Related Party [Member] Direct Costs, Related Party Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Deferred income taxes and other tax liabilities Deferred Income Taxes and Other Tax Liabilities, Noncurrent Summary of Capitalized Contract Cost Capitalized Contract Cost [Table Text Block] Segments [Domain] Segments [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Consolidation Items [Domain] Consolidation Items [Domain] Accumulated deficit Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Aggregate principal amount issued Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Accounts receivable Accounts Receivable, before Allowance for Credit Loss, Current Entity Address, State or Province Entity Address, State or Province CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Debt issuance discount and fees Debt Issuance Costs, Current, Net Estimated amortization expense, 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Common stock, outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Corporate costs not allocated to segments Other Cost and Expense, Operating Increase in accounts receivable and unbilled services, net Increase (Decrease) In Accounts Receivable And Contract With Customer, Asset Increase (Decrease) In Accounts Receivable And Contract With Customer, Asset Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Common stock, par value per share (in dollars per share) Common Stock, Par or Stated Value Per Share Net cash used for investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Interest rate swaps Interest Rate Swap [Member] Debt Instrument [Axis] Debt Instrument [Axis] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Net benefit plan adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Converted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted in Period, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted in Period, Weighted Average Grant Date Fair Value Credit Facility [Axis] Credit Facility [Axis] Total liabilities Liabilities Vesting [Domain] Vesting [Domain] Increase in prepaid expenses and other Increase (Decrease) in Prepaid Expense and Other Assets Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Payments on revolving credit facilities Repayments of Long-Term Lines of Credit Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Net Benefit Plan Adjustments Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Plan Name [Axis] Plan Name [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] North America North America [Member] Related Party Transaction [Domain] Related Party Transaction [Domain] Income tax benefits Share-Based Payment Arrangement, Expense, Tax Benefit Number of reportable segments Number of Reportable Segments Earnings (loss) per common share Earnings Per Share [Abstract] Proceeds from issuance of senior notes Proceeds from Issuance of Senior Long-Term Debt Decrease in unrecognized tax benefits, reasonably possible Decrease in Unrecognized Tax Benefits is Reasonably Possible Common stock, 88.8 and 0.0 shares outstanding at September 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Former Parent Investment Parent Company Investment [Member] Parent Company Investment Provision (benefit) for income tax related to items of comprehensive income Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Organization, Consolidation and Presentation of Financial Statements [Abstract] Operating lease right-of-use asset expense Operating Lease, Right-of-Use Asset, Periodic Reduction Senior notes Senior Notes [Member] Total current assets Assets, Current Current portion of debt, gross Long-Term Debt, Gross, Current Maturities Long-Term Debt, Gross, Current Maturities Special payment to Former Parent Net Transfers To Parent, Special Payment Net Transfers To Parent, Special Payment Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Supplemental schedule of cash flow information: Supplemental Cash Flow Information [Abstract] Amortization Amortization Other, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Proceeds from term loans Proceeds from Issuance of Secured Debt Restructuring Reserve, by Type of Restructuring [Axis] Restructuring Type [Axis] Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Concentration risk, percentage Concentration Risk, Percentage Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Cancelled (in share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Current Portion of Long-Term Debt Short-Term Debt [Abstract] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Exercisable, aggregate intrinsic value (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Change in property, plant and equipment, net Transfer To (From) Parent, Change In Property, Plant And Equipment, Net Transfer To (From) Parent, Change In Property, Plant And Equipment, Net Corporate, non-segment Corporate, Non-Segment [Member] Depreciation and amortization Depreciation, Depletion and Amortization Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Senior secured term loan B due 2030 Senior Secured Term Loan B Facility, Due 2028 [Member] Senior Secured Term Loan B Facility, Due 2028 Total equity Beginning balance Ending balance Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Number of employees (more than) Entity Number of Employees Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Unearned revenue, revenue recognized Contract with Customer, Liability, Revenue Recognized Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Unrealized Gain (Loss) on Derivative Instruments Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Weighted-average expected life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Net income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Not designated as hedging instrument Not Designated as Hedging Instrument [Member] Senior secured term loan A due 2028 Senior Secured Term Loan A Facility, Due 2028 [Member] Senior Secured Term Loan A Facility, Due 2028 RESTRUCTURING AND OTHER CHARGES Restructuring and Related Activities Disclosure [Text Block] Hedging Designation [Domain] Hedging Designation [Domain] Capitalized Contract Cost [Axis] Capitalized Contract Cost [Axis] Entity Emerging Growth Company Entity Emerging Growth Company Capital expenditures Payments to Acquire Productive Assets Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Unrecognized tax benefits, decrease Unrecognized Tax Benefits, Period Increase (Decrease) Document Fiscal Period Focus Document Fiscal Period Focus Antidilutive Securities [Axis] Antidilutive Securities [Axis] Options, beginning (in dollar per share) Options, ending (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock compensation Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] Special Payment to Former Parent Special Payment To Former Parent [Member] Special Payment To Former Parent City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code EARNINGS (LOSS) PER SHARE Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Schedule of Restricted Stock Units and Performance Shares Schedule of Nonvested Share Activity [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Stock compensation expense Stock Compensation Expense [Member] Stock Compensation Expense Foreign exchange gain (loss) Foreign Exchange Gain (Loss), Related Party [Member] Foreign Exchange Gain (Loss), Related Party Capitalized Contract Cost [Line Items] Capitalized Contract Cost [Line Items] Minimum Minimum [Member] Property, plant and equipment, net Property, Plant and Equipment, Net Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Cash paid during period for: Interest And Income Taxes Paid [Abstract] Interest And Income Taxes Paid Foreign exchange gain (loss) Gain (Loss), Foreign Currency Transaction, before Tax Income taxes, net of refunds Income Taxes Paid, Net Restructuring and other charges Restructuring And Other Charges, Related Party [Member] Restructuring And Other Charges, Related Party Net cash used for financing activities Net Cash Provided by (Used in) Financing Activities Deferred income taxes Deferred Income Tax Assets, Net COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Contingencies Disclosure [Text Block] Gross unbilled services Contract with Customer, Asset, before Allowance for Credit Loss, Current Accumulated Deficit Retained Earnings [Member] Current portion of long-term debt Total short-term borrowings and current portion of long-term debt Long-Term Debt, Current Maturities Schedule of Share-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Total liabilities and equity Liabilities and Equity Other income (expense): Nonoperating Income (Expense) [Abstract] Other assets, net Other Assets, Noncurrent Risk free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Basic (in dollars per share) Per share amount, basic (in dollars per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Long-Term Debt Long-Term Debt and Lease Obligation [Abstract] Net earnings (loss) including impact of dilutive adjustments Net Income (Loss) Available to Common Stockholders, Diluted Entity Address, City or Town Entity Address, City or Town Schedule of Segment Reporting Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Related party Related Party [Member] Corporate allocations Corporate Allocations [Member] Corporate Allocations Fortrea’s Omnibus Incentive Plan Fortrea’s Omnibus Incentive Plan [Member] Fortrea’s Omnibus Incentive Plan Expense Restructuring and other Restructuring Charges Document Transition Report Document Transition Report Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Technology Technology-Based Intangible Assets [Member] Deferred contract costs Deferred Contract Costs [Member] Deferred Contract Costs Common stock, shares authorized (in shares) Common Stock, Shares Authorized Increase in accounts payable Increase (Decrease) in Accounts Payable Accounts receivable and unbilled services, net Total Accounts Receivable And Contract With Customer, Asset, After Allowance for Credit Loss, Current Accounts Receivable And Contract With Customer, Asset, After Allowance for Credit Loss, Current Derivative Instrument [Axis] Derivative Instrument [Axis] Adjustments to reconcile net income to net cash provided by (used for) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Related Party Transactions [Abstract] Swingline sub-facility Bridge Loan [Member] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Debt, gross Long-Term Debt, Gross, Excluding Current Maturities Long-Term Debt, Gross, Excluding Current Maturities Credit loss expense Accounts Receivable, Credit Loss Expense (Reversal) Additional paid-in capital Additional Paid in Capital Cancelled (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Deferred income taxes Deferred Income Tax Expense (Benefit) Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Year three Share-Based Payment Arrangement, Tranche Three [Member] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] SUPPLEMENTAL CASH FLOW INFORMATION Cash Flow, Supplemental Disclosures [Text Block] Prepaid expenses and other Prepaid Expense and Other Assets, Current Estimated amortization expense, 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Cancelled (in share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Related Party, Type [Axis] Related Party, Type [Axis] Outstanding, aggregate intrinsic value (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Entity Registrant Name Entity Registrant Name Dilutive effect of employee awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Estimated amortization expense, 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Year two Share-Based Payment Arrangement, Tranche Two [Member] Direct costs Cost of Sales [Member] Severance and Other Employee Costs Employee Severance [Member] Cash payments Payments for Restructuring Document Period End Date Document Period End Date Exercisable (in dollar per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Principal payments of long-term debt Repayments of Long-Term Debt Rollforward of Allowance for Credit Losses Accounts Receivable, Allowance for Credit Loss [Table Text Block] Entity Central Index Key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total stock compensation expense Share-Based Payment Arrangement, Expense Gross Carrying Amount Finite-Lived Intangible Assets, Gross Provision for (benefit from) income taxes Income Tax Expense (Benefit) Designated as hedging instrument Designated as Hedging Instrument [Member] Write-offs Accounts Receivable, Allowance for Credit Loss, Writeoff Vesting [Axis] Vesting [Axis] Estimated amortization expense, thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Number of operating segments Number of Operating Segments Revenue Revenue Benchmark [Member] Subcontract services Subcontract Services [Member] Subcontract Services Other comprehensive loss, net of tax Other comprehensive income, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Summary of Revenue by Segment and Geography Disaggregation of Revenue [Table Text Block] 7.5% senior notes due 2030 7.5% Senior Notes, Due 2030 [Member] 7.5% Senior Notes, Due 2030 Issuance of common stock Stock Issued During Period, Value, New Issues Equity [Abstract] Revenues Revenue from Contract with Customer, Excluding Assessed Tax Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Capitalized Contract Cost [Table] Capitalized Contract Cost [Table] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Number of countries with primary office locations Number Of Countries With Primary Office Locations Number Of Countries With Primary Office Locations Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Credit Facility [Domain] Credit Facility [Domain] Total net transfers (to) from Former Parent Net Transfers From (To) Parent Net Transfers From (To) Parent Long-term debt, less current portion Total long-term debt Long-Term Debt, Excluding Current Maturities Number of derivative instruments Derivative, Number of Instruments Held Outstanding shares, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Employee Stock Purchase Plan Fortrea's Employee Stock Purchase Plan [Member] Fortrea's Employee Stock Purchase Plan REVENUES Revenue from Contract with Customer [Text Block] Additional Paid-in Capital Additional Paid-in Capital [Member] Cancelled (in dollar per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Total assets Assets Cover [Abstract] Cover [Abstract] Stock compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Other liabilities Other Liabilities, Noncurrent Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Schedule of Supplemental Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Other comprehensive loss before tax Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent BUSINESS SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Secured debt Secured Debt [Member] Proceeds from sale of receivables Proceeds from Sale of Other Receivables Equity Component [Domain] Equity Component [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Outstanding shares, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Accounts receivable sold Accounts Receivable, Sale Operating income Segment operating income: Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Related Party Transaction [Axis] Related Party Transaction [Axis] Capitalized Contract Cost [Domain] Capitalized Contract Cost [Domain] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Transfer from Former Parent Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Stock Options Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Selling, general and administrative expenses Selling, General And Administrative Expenses, Related Party [Member] Selling, General And Administrative Expenses, Related Party Line of credit, outstanding balance Long-Term Line of Credit Customer relationships Customer Relationships [Member] Facility Costs Facility Cost [Member] Facility Cost Proceeds from revolving credit facilities Proceeds from Long-Term Lines of Credit Net transfers to Former Parent Proceeds From (Payments To) Former Parent Company Proceeds From (Payments To) Former Parent Company Type of Restructuring [Domain] Type of Restructuring [Domain] Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Year one Share-Based Payment Arrangement, Tranche One [Member] EX-101.PRE 10 ftre-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
COVER - shares
shares in Millions
 9 Months Ended
Sep. 30, 2023
Nov. 09, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-41704  
Entity Registrant Name FORTREA HOLDINGS INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 92-2796441  
Entity Address, Address Line One 8 Moore Drive  
Entity Address, City or Town Durham  
Entity Address, State or Province NC  
Entity Address, Postal Zip Code 27709  
City Area Code (480)  
Local Phone Number 295-7600  
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol FTRE  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   88.8
Amendment Flag false  
Entity Central Index Key 0001965040  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 107.5 $ 112.0
Accounts receivable and unbilled services, net 1,047.1 1,022.2
Prepaid expenses and other 103.2 112.7
Total current assets 1,257.8 1,246.9
Property, plant and equipment, net 219.2 164.9
Goodwill, net 1,994.7 1,997.3
Intangible assets, net 773.7 823.3
Deferred income taxes 1.6 1.2
Other assets, net 69.7 54.3
Total assets 4,316.7 4,287.9
Current liabilities:    
Accounts payable 128.3 81.5
Accrued expenses and other current liabilities 335.8 322.7
Unearned revenue 264.8 271.5
Current portion of long-term debt 26.1 0.0
Short-term operating lease liabilities 19.6 23.3
Total current liabilities 774.6 699.0
Long-term debt, less current portion 1,572.4 0.0
Operating lease liabilities 68.0 40.1
Deferred income taxes and other tax liabilities 171.7 184.5
Other liabilities 35.7 21.7
Total liabilities 2,622.4 945.3
Commitments and contingent liabilities (Note 8)
Equity    
Former parent investment 0.0 3,618.6
Common stock, 88.8 and 0.0 shares outstanding at September 30, 2023 and December 31, 2022, respectively 0.1 0.0
Additional paid-in capital 1,987.6 0.0
Accumulated deficit (13.1) 0.0
Accumulated other comprehensive loss (280.3) (276.0)
Total equity 1,694.3 3,342.6
Total liabilities and equity $ 4,316.7 $ 4,287.9
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS (Parenthetical) - shares
shares in Millions
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]      
Common stock, outstanding (in shares) 88.8 88.8 0.0
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenues $ 776.4 $ 762.3 $ 2,333.6 $ 2,334.4
Costs and expenses:        
Direct costs, exclusive of depreciation and amortization (including costs incurred from related parties of $0.0, $21.6, $48.8 and $65.7 during the three and nine months ended September 30, 2023 and 2022, respectively) 647.3 594.8 1,932.9 1,847.6
Selling, general and administrative expenses, exclusive of depreciation and amortization 78.9 70.7 237.7 216.5
Depreciation and amortization 24.6 22.7 72.5 69.7
Restructuring and other charges 11.6 5.2 16.7 27.8
Total costs and expenses 762.4 693.4 2,259.8 2,161.6
Operating income 14.0 68.9 73.8 172.8
Other income (expense):        
Interest expense (34.6) 0.0 (35.3) 0.0
Foreign exchange gain (loss) (0.9) 4.8 (1.0) 21.1
Other, net 3.6 0.5 4.6 1.4
Net income (loss) before income taxes (17.9) 74.2 42.1 195.3
Provision for (benefit from) income taxes (4.8) 13.6 9.5 35.8
Net income (loss) $ (13.1) $ 60.6 $ 32.6 $ 159.5
Earnings (loss) per common share        
Basic (in dollars per share) $ (0.15) $ 0.68 $ 0.37 $ 1.80
Diluted (in dollars per share) $ (0.15) $ 0.68 $ 0.37 $ 1.80
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Costs incurred from related parties $ 647.3 $ 594.8 $ 1,932.9 $ 1,847.6
Related party        
Costs incurred from related parties $ 0.0 $ 21.6 $ 48.8 $ 65.7
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ (13.1) $ 60.6 $ 32.6 $ 159.5
Foreign currency translation adjustments (56.0) (96.6) (7.6) (216.8)
Net benefit plan adjustments 0.0 0.0 2.1 0.0
Unrealized gain on derivative instruments 1.6 0.0 1.6 0.0
Other comprehensive loss before tax (54.4) (96.6) (3.9) (216.8)
Provision (benefit) for income tax related to items of comprehensive income (0.4) 0.0 (0.4) 0.0
Other comprehensive loss, net of tax (54.8) (96.6) (4.3) (216.8)
Comprehensive income (loss) $ (67.9) $ (36.0) $ 28.3 $ (57.3)
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Former Parent Investment
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   0.0        
Beginning balance at Dec. 31, 2021 $ 3,260.6 $ 0.0 $ 0.0 $ 3,409.0 $ 0.0 $ (148.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 32.5     32.5    
Other comprehensive income, net of tax (34.6)         (34.6)
Net transfers (to) from Former Parent 88.6     88.6    
Ending balance (in shares) at Mar. 31, 2022   0.0        
Ending balance at Mar. 31, 2022 3,347.1 $ 0.0 0.0 3,530.1 0.0 (183.0)
Beginning balance (in shares) at Dec. 31, 2021   0.0        
Beginning balance at Dec. 31, 2021 3,260.6 $ 0.0 0.0 3,409.0 0.0 (148.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 159.5          
Other comprehensive income, net of tax (216.8)          
Ending balance (in shares) at Sep. 30, 2022   0.0        
Ending balance at Sep. 30, 2022 3,222.5 $ 0.0 0.0 3,587.7 0.0 (365.2)
Beginning balance (in shares) at Mar. 31, 2022   0.0        
Beginning balance at Mar. 31, 2022 3,347.1 $ 0.0 0.0 3,530.1 0.0 (183.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 66.4     66.4    
Other comprehensive income, net of tax (85.6)         (85.6)
Net transfers (to) from Former Parent (29.3)     (29.3)    
Ending balance (in shares) at Jun. 30, 2022   0.0        
Ending balance at Jun. 30, 2022 3,298.6 $ 0.0 0.0 3,567.2 0.0 (268.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 60.6     60.6    
Other comprehensive income, net of tax (96.6)         (96.6)
Net transfers (to) from Former Parent (40.1)     (40.1)    
Ending balance (in shares) at Sep. 30, 2022   0.0        
Ending balance at Sep. 30, 2022 $ 3,222.5 $ 0.0 0.0 3,587.7 0.0 (365.2)
Beginning balance (in shares) at Dec. 31, 2022 0.0 0.0        
Beginning balance at Dec. 31, 2022 $ 3,342.6 $ 0.0 0.0 3,618.6 0.0 (276.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 17.4     17.4    
Other comprehensive income, net of tax 18.9         18.9
Net transfers (to) from Former Parent 26.6     26.6    
Ending balance (in shares) at Mar. 31, 2023   0.0        
Ending balance at Mar. 31, 2023 $ 3,405.5 $ 0.0 0.0 3,662.6 0.0 (257.1)
Beginning balance (in shares) at Dec. 31, 2022 0.0 0.0        
Beginning balance at Dec. 31, 2022 $ 3,342.6 $ 0.0 0.0 3,618.6 0.0 (276.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 32.6          
Other comprehensive income, net of tax $ (4.3)          
Ending balance (in shares) at Sep. 30, 2023 88.8 88.8        
Ending balance at Sep. 30, 2023 $ 1,694.3 $ 0.1 1,987.6 0.0 (13.1) (280.3)
Beginning balance (in shares) at Mar. 31, 2023   0.0        
Beginning balance at Mar. 31, 2023 3,405.5 $ 0.0 0.0 3,662.6 0.0 (257.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 28.3     28.3    
Other comprehensive income, net of tax 31.6         31.6
Special payment to Former Parent (1,595.0)     (1,595.0)    
Net transfers (to) from Former Parent (119.4)     (119.4)    
Reclassification of Former Parent investment to additional paid-in capital 0.0   1,976.5 (1,976.5)    
Issuance of common stock (in shares)   88.8        
Issuance of common stock $ 0.1 $ 0.1        
Ending balance (in shares) at Jun. 30, 2023 88.8 88.8        
Ending balance at Jun. 30, 2023 $ 1,751.1 $ 0.1 1,976.5 0.0 0.0 (225.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (13.1)       (13.1)  
Other comprehensive income, net of tax (54.8)         (54.8)
Stock compensation $ 11.1   11.1      
Ending balance (in shares) at Sep. 30, 2023 88.8 88.8        
Ending balance at Sep. 30, 2023 $ 1,694.3 $ 0.1 $ 1,987.6 $ 0.0 $ (13.1) $ (280.3)
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ 32.6 $ 159.5
Adjustments to reconcile net income to net cash provided by (used for) operating activities:    
Depreciation and amortization 72.5 69.7
Stock compensation 27.2 19.6
Operating lease right-of-use asset expense 20.9 19.0
Deferred income taxes (12.7) (6.8)
Other, net 3.5 3.4
Changes in assets and liabilities:    
Increase in accounts receivable and unbilled services, net (26.6) (72.7)
Increase in prepaid expenses and other (3.1) (15.0)
Increase in accounts payable 47.3 23.5
Decrease in unearned revenue (6.5) (38.3)
Decrease in accrued expenses and other (0.1) (102.7)
Net cash provided by operating activities 155.0 59.2
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (30.9) (36.0)
Proceeds from sale of assets 8.1 0.4
Net cash used for investing activities (22.8) (35.6)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from revolving credit facilities 24.0 0.0
Payments on revolving credit facilities (24.0) 0.0
Proceeds from term loans 1,061.4 0.0
Proceeds from issuance of senior notes 570.0 0.0
Debt issuance costs (26.4) 0.0
Principal payments of long-term debt (7.7) 0.0
Special payment to Former Parent (1,595.0) 0.0
Net transfers to Former Parent (136.7) (0.4)
Net cash used for financing activities (134.4) (0.4)
Effect of exchange rate changes on cash and cash equivalents (2.3) (10.3)
Net change in cash and cash equivalents (4.5) 12.9
Cash and cash equivalents at beginning of period 112.0 94.6
Cash and cash equivalents at end of period $ 107.5 $ 107.5
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF FINANCIAL STATEMENT PREPARATION
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF FINANCIAL STATEMENT PREPARATION BASIS OF FINANCIAL STATEMENT PRESENTATION
Description of Business
Fortrea Holdings Inc. ("Fortrea" or the “Company”), a Delaware corporation incorporated on January 31, 2023, is a leading global contract research organization (“CRO”) providing biopharmaceutical product and medical device development services, patient access solutions and other enabling services to pharmaceutical, biotechnology and medical device customers. The Company offers customers highly flexible delivery models that include Full Service, Functional Service Provider, and Hybrid Service structures. The Company has a rich history of providing clinical development services for over 30 years across more than 20 therapeutic areas, first as Covance and later as Labcorp Drug Development. On June 30, 2023, the Company completed a spin-off (the “Spin” or the “Separation”) from Laboratory Corporation of America Holdings (“Labcorp” or “Former Parent”). The Company leverages its global scale, clinical data insights, technology innovation, industry network and decades of experience as a standalone company and as a business unit prior to the Spin to deliver tailored solutions to its customers. With what the Company believes is a distinctive market offering, Fortrea meets growing global demand for clinical development services.
The team of approximately 19,000 employees conducts operations in more than 90 countries and delivers comprehensive phase I – IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services for our customers. The Company’s offering is scaled to deliver focused and agile solutions to customers globally, streamlining the biopharmaceutical product and medical device development process. Additionally, Fortrea successfully utilizes enabling technologies to optimize processes and evolve with a dynamic marketplace.
The Company manages its business in two reportable segments - Clinical Services and Enabling Services. The Clinical Services segment provides services across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. For further financial information about these segments, see Note 14, Business Segment Information to the condensed consolidated and combined financial statements.
The Company has established access to all key markets worldwide through a strategic footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Agreements with Labcorp
On June 30, 2023, the Company completed the Spin from Labcorp. The Company has entered into several agreements with Labcorp that govern the relationship of the parties following the Separation, including the Separation and Distribution Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and the Transition Services Agreement, which are described in the Company’s Registration Statement on Form 10, as amended (“Form 10”), as filed with the Securities and Exchange Commission (the “SEC”). Under the terms of the Transition Services Agreement, the Company and Labcorp agreed to provide each other certain transitional services. The services and assets to be provided to Fortrea by Labcorp support the Company’s enterprise functions, most notably IT applications, network and security support and hosting as well as finance, human resources, marketing and other administrative support.
Basis of Financial Statement Presentation
Prior to June 30, 2023, Fortrea existed and functioned as part of the consolidated business of Former Parent. The Company’s financial statements for periods through the Spin reflect the historical financial position, results of operations and cash flows of the Company, for the periods presented, prepared on a “carve-out” basis and have been derived from the condensed consolidated financial statements and accounting records of Labcorp using the historical results of operations and historical basis of assets and liabilities of the Company and reflect Labcorp’s net investment in the Company. The Company’s balance sheet as of September 30, 2023 is a consolidated balance sheet based on the financial position of Fortrea as a standalone company. The three months ended September 30, 2023
includes condensed consolidated financial statements, whereas all prior periods included combined financial statements. The Company’s unaudited condensed consolidated and combined financial statements for all periods presented are referred to throughout this document as “financial statements.”
The Company’s condensed consolidated and combined financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated and combined financial statements do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the prior periods presented.
The accompanying condensed consolidated and combined financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated and combined balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The condensed consolidated and combined financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company’s fiscal year 2022 reporting included within the Form 10. Therefore, these interim statements should be read in conjunction with the combined financial statements and notes thereto contained in the Form 10.
The condensed combined statements of operations include all revenues and costs directly attributable to our business. The condensed combined statements of operations for prior periods also include costs for certain centralized functions and programs provided and administered by Labcorp that were allocated to Fortrea. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation.
These expenses were allocated to Fortrea based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues or headcount or other reasonable driver, as applicable. Fortrea considers the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, Fortrea during the prior periods presented. However, the allocations may not reflect the expenses Fortrea would have incurred as an independent company for the prior periods presented. Actual costs that may have been incurred if Fortrea had been a standalone company would depend on a number of factors, including, but not limited to, the organizational structure, whether functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. For a period following the Spin some of these functions are provided by Labcorp as discussed within the Agreements with Labcorp section above.
Labcorp utilizes a centralized approach to cash management and financing of its operations. The cash and cash equivalents held by Labcorp at the corporate level were not specifically identifiable to Fortrea and therefore have not been reflected in the Company’s condensed combined balance sheet as of December 31, 2022. Cash and cash equivalents in the condensed consolidated and combined balance sheets represent cash and cash equivalents held by the Company.
As of December 31, 2022, the condensed combined financial statements include certain assets and liabilities that have historically been held at the Labcorp corporate level but are specifically identifiable or otherwise attributable to Fortrea. Labcorp’s third-party long-term debt and the related interest expense have not been allocated to Fortrea for any of the periods presented because Fortrea was not the legal obligor of such debt.
As of December 31, 2022, a Former Parent investment is shown in lieu of common stock and retained earnings accounts in the condensed combined financial statements. The total net effect of the settlement of the transactions between the Company and Labcorp, exclusive of those historically settled in cash, is reflected in the condensed combined statements of cash flows in cash flows from financing activities as net transfers (to) from Former Parent and in the condensed consolidated and combined balance sheets as Former Parent investment.
All intercompany transactions within the Company have been eliminated. All transactions between the Company and Former Parent have been included in these condensed consolidated and combined financial statements. For those transactions between the Company and Former Parent that were historically settled in cash, the Company has reflected such balances in the condensed consolidated and combined balance sheets as due from related parties or due to related parties. The Former Parent investment and all due from or due to Former Parent were settled at the time of the Spin. Refer to Note 12, Transactions with Former Parent for further information.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and unbilled services.
The Company maintains cash and cash equivalents with various major financial institutions. These financial institutions are generally highly rated and geographically dispersed. The Company evaluates the relative credit standing of these financial institutions and has not sustained credit losses from instruments held at financial institutions.
Substantially all the Company’s accounts receivable and unbilled services are with companies in the pharmaceutical, biotechnology and medical device industries. As of September 30, 2023, no customer accounted for more than 10% of the Company's combined gross accounts receivable and unbilled services. As of December 31, 2022, one pharmaceutical company accounted for approximately 10.5% of the Company's combined gross accounts receivable and unbilled services. Additionally, for the three months and nine months ended September 30, 2023, one customer accounted for approximately 13.5% and 10.2% of revenues, respectively. For the three and nine months ended September 30, 2022, no customer accounted for more than 10% of revenues. Concentrations of credit risk are mitigated due to the number of the Company’s customers as well as their dispersion across many different geographic regions. Additionally, the Company applies assumptions and judgments, including historical collection experience and reasonable and supportable forecasts, for assessing collectability and determining allowances for doubtful accounts.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUES
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
REVENUES REVENUES
The Company’s revenues by segment and geography for the three and nine months ended September 30, 2023 and 2022 are as follows:
Three Months Ended September 30, 2023Three Months Ended September 30, 2022
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Clinical Services$347.4 $204.3 $160.0 $711.7 $355.3 $196.0 $145.9 $697.2 
Enabling Services64.4 — 0.3 64.7 64.6 — 0.5 65.1 
Total$411.8 $204.3 $160.3 $776.4 $419.9 $196.0 $146.4 $762.3 
Nine Months Ended September 30, 2023Nine Months Ended September 30, 2022
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Clinical Services$1,070.6 $600.7 $458.5 $2,129.8 $1,047.0 $642.6 $438.0 $2,127.6 
Enabling Services202.9 — 0.9 203.8 205.2 — 1.6 206.8 
Total$1,273.5 $600.7 $459.4 $2,333.6 $1,252.2 $642.6 $439.6 $2,334.4 
Revenue from the United States comprises substantially all revenue in North America.
Contract Costs
The following table provides information about contract asset balances:
September 30, 2023December 31, 2022
Sales commission assets$16.5 $18.6 
Deferred contract costs13.2 14.8
Total$29.7 $33.4 
Amortization related to sales commission assets for the three months ended September 30, 2023 and 2022 was $2.3 and $3.7, respectively, and for the nine months ended September 30, 2023 and 2022 was $10.2 and $10.2, respectively. Amortization related to deferred contract costs for the three months ended September 30, 2023 and 2022 was $2.2 and $3.1, respectively, and for the nine months ended September 30, 2023 and 2022 was $6.9 and $9.1, respectively. The Company does not recognize the effect of financing in its contracts with customers when the difference in timing of payment and performance is one year or less.
Accounts Receivable, Unbilled Services and Unearned Revenue
The following table provides information about accounts receivable, unbilled services and unearned revenue from contracts with customers:
September 30, 2023December 31, 2022
Accounts receivable$468.7 $449.2 
Gross unbilled services606.7 585.7 
Less: Allowance for credit losses(28.3)(12.7)
Total$1,047.1 $1,022.2 
Unearned revenue$264.8 $271.5 
Revenue recognized during the period included in the unearned revenue balance at the beginning of the period was $187.6 and $212.0 for the nine months ended September 30, 2023 and 2022, respectively.
Credit Loss Rollforward
The Company estimates future expected losses on accounts receivable and unbilled services over the remaining collection period of the instrument.
The rollforward for the allowance for credit losses for the nine months ended September 30, 2023 is as follows:
Accounts Receivable
Allowance for credit losses as of December, 2022$12.7 
Credit loss expense21.9 
Write-offs(6.3)
Allowance for credit losses as of September 30, 2023$28.3 
Performance Obligations Under Long-Term Contracts
As of September 30, 2023, approximately $4,958.2 of revenues are expected to be recognized from remaining long-term performance obligations. The Company expects to recognize approximately 29% of the existing
performance obligations as of September 30, 2023 as revenue over the next 12 months and the remaining balance thereafter. The Company's long-term contracts generally range from one to eight years.
During the three and nine months ended September 30, 2023, there were reductions of approximately $15.6 and $48.5, respectively, in the Company’s revenues related to performance obligations partially satisfied in previous periods. These reductions primarily relate to changes in scope. The gross and net amounts of revenue recognized solely from changes in estimates were not material.
Accounts Receivable Purchase Program
On June 23, 2023, Fortrea entered into an accounts receivable purchase program (“ARPP”) with a financial institution (the "Financial Institution"). The ARPP establishes a receivables factoring facility whereby the Company may sell up to $80.0 in customer receivables based on the availability of certain eligible receivables and the satisfaction of certain conditions. Under the facility, the Company may sell eligible receivables and retains no interest in the transferred receivables other than collection and administrative functions for the Financial Institution.
The Company accounts for these receivable transfers as sales and derecognizes the sold receivables from its balance sheets. The fair value of the sold receivables approximated their book value due to their short-term nature. The Company continues to service, administer and collect the receivables on behalf of the Financial Institution and does not receive a servicing fee as part of the arrangement. During the three months ended September 30, 2023, no receivables were sold. During the nine months ended September 30, 2023, $17.5 of receivables were sold with net proceeds of $17.3.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
RESTRUCTURING AND OTHER CHARGES
 9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
RESTRUCTURING AND OTHER CHARGES RESTRUCTURING AND OTHER CHARGES
In the three months ended September 30, 2023, the Company took actions to reduce overcapacity, align resources, and restructure certain operations. These actions included eliminating redundant positions and aligning resources for cost improvement and to meet customer requirements. These restructuring actions are expected to continue throughout 2023 and 2024.
The following summarizes a component of the Company’s restructuring and other charges:
Severance and Other Employee CostsFacility CostsTotal
Balance as of December 31, 2022$1.9 $5.0 $6.9 
Expense12.0 1.0 13.0 
Cash payments(10.5)(1.5)(12.0)
Balance as of September 30, 2023$3.4 $4.5 $7.9 
The Company expects the restructuring and other charges accrued as of September 30, 2023 will be paid within the next twelve months and are included within accrued expenses and other current liabilities on the accompanying condensed consolidated and combined balance sheets. Restructuring costs are not allocated to the Company’s reportable segments as they are not part of the segment performance measures regularly reviewed by management.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
EARNINGS (LOSS) PER SHARE
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE EARNINGS (LOSS) PER SHAREOn June 30, 2023, the Separation from Labcorp was effected through a pro-rata distribution of one share of the Company's common stock for every share of Labcorp common stock held at the close of business on the record date of June 20, 2023. As a result, on June 30, 2023, the Company had 88.8 shares of common stock outstanding. This share amount is being utilized for the calculation of basic earnings per share for all periods presented through the Separation date. As of the Separation date, actual outstanding shares are used to calculate basic weighted average common shares outstanding. Basic earnings per share is computed by dividing net earnings attributable to the Company by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common
shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company’s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.
The following represents a reconciliation of basic earnings per share to diluted earnings per share.
Three Months Ended September 30,
20232022
Earnings
Shares
Per Share Amount
Earnings
Shares
Per Share Amount
Basic earnings (loss) per share:
Net earnings (loss)
$(13.1)88.8 $(0.15)$60.6 88.8 $0.68 
Dilutive effect of employee stock options and awards
— — — — — — 
Net earnings (loss) including impact of dilutive adjustments$(13.1)$88.8 $(0.15)$60.6 88.8$0.68 
Nine Months Ended September 30,
20232022
Earnings
Shares
Per Share Amount
Earnings
Shares
Per Share Amount
Basic earnings (loss) per share:
Net earnings (loss)
$32.6 88.8 $0.37 $159.5 88.8 $1.80 
Dilutive effect of employee stock options and awards
— 0.2 — — — — 
Net earnings (loss) including impact of dilutive adjustments$32.6 89.0 $0.37 $159.5 88.8 $1.80 
Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. Potential common shares are also considered antidilutive in the event of a net loss from operations.
The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Employee stock options and awards0.5 — 1.5 — 
Antidilutive employee stock options and awards excluded based on reporting a net loss for the period0.4 — — — 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS GOODWILL AND INTANGIBLE ASSETSThe Company's goodwill and intangible assets are the result of historical acquisitions; primarily the acquisition of Covance in 2015 by Labcorp. Subsequent acquisitions of businesses were allocated to the clinical development and commercialization services business of Fortrea based on the inclusion of the business activities using valuations at the time of acquisition.
The changes in the carrying amount of goodwill for the nine months ended September 30, 2023 and 2022 are as follows:
Clinical ServicesEnabling ServicesTotal
September 30, 2023September 30, 2022September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Balance as of December 31$1,707.4 $1,791.0 $289.9 $289.9 $1,997.3 $2,080.9 
Goodwill acquired during the period— — — — — — 
Foreign currency impact(2.6)(143.7)— — (2.6)(143.7)
Balance as of September 30$1,704.8 $1,647.3 $289.9 $289.9 $1,994.7 $1,937.2 
The Company assesses goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.
Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable and appropriate, the Company’s business could be impacted by unfavorable changes, including those that impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions; primarily a worsening economic environment and protracted economic downturn and related impacts, including delays in revenue from new customers, increases in customer termination activity, or increases in operating costs.
Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance.
The Company will continue to monitor the financial performance of and assumptions for its reporting units. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin or substantial reductions in end markets and volume assumptions could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations.
The components of identifiable intangible assets are as follows:
September 30, 2023December 31, 2022
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$1,188.2 $(420.3)$767.9 $1,191.1 $(376.7)$814.4 
Technology53.7 (49.8)3.9 53.7 (47.8)5.9 
Other13.3 (11.4)1.9 13.3 (10.3)3.0 
Total$1,255.2 $(481.5)$773.7 $1,258.1 $(434.8)$823.3 
Amortization of intangible assets for the three and nine months ended September 30, 2023 was $16.0 and $47.9, respectively. For the three and nine months ended September 30, 2022, amortization was $16.2 and $49.7, respectively. Amortization expense of intangible assets is estimated to be $15.8 for the remainder of 2023, $62.8 in 2024, $60.0 in 2025, $59.1 in 2026, $59.1 in 2027 and $516.9 thereafter.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
DEBT
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
DEBT DEBTIn connection with the Spin, Fortrea incurred indebtedness in an aggregate principal amount of approximately $1,640.0, which consisted of borrowings under senior secured term loan facilities and senior secured notes. Fortrea also entered into a $450.0 senior secured revolving credit facility. Fortrea used the proceeds from
these debt transactions to make a cash distribution to Labcorp as consideration for the assets that were contributed to the Company in connection with the Spin.
The current portion of long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:
September 30, 2023December 31, 2022
Current portion of senior secured term loan A facility due 2028$25.0 $— 
Current portion of senior secured term loan B facility due 20305.7 — 
Debt issuance discount and fees(4.6)— 
Total short-term borrowings and current portion of long-term debt$26.1 $— 
Long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:
September 30, 2023December 31, 2022
7.5% senior notes due 2030
$570.0 $— 
Senior secured term loan A due 2028468.8 — 
Senior secured term loan B due 2030562.9 — 
Debt issuance discount and fees(29.3)— 
Total long-term debt$1,572.4 $— 
Senior Notes
On June 27, 2023, the Company issued $570.0 aggregate principal amount of 7.50% senior notes due 2030 (the “Notes"). Interest on these notes is payable semi-annually on January 1 and July 1 of each year. Net proceeds from the offering of the Notes were $560.2 after deducting expenses of the offering.
Credit Facilities
On June 30, 2023, Fortrea entered into a credit agreement (the “Credit Agreement”) providing for (i) a senior secured revolving credit facility in the principal amount of up to $450.0; (ii) a five-year $500.0 first lien senior secured term A loan facility; and (iii) a seven-year $570.0 first lien senior secured term B loan facility. The initial revolving facility includes a $75.0 swingline sub-facility and a $75.0 letter of credit sub-facility.
The Company drew on the term A and term B loans on June 30, 2023. The net proceeds received for the term A and term B loans were $491.8 and $552.9, respectively after deducting underwriting discounts and other expenses. The term A and term B loans will mature on June 30, 2028 and June 30, 2030, respectively. The term loans accrue interest at a per annum rate equal to the sum of, at the option of the Company, a Base Rate or a Term SOFR Rate and the Applicable Margin as defined by the Credit Agreement. As of September 30, 2023, the effective interest rate on the term A loan and term B loan was 7.57% and 9.07%, respectively.
The revolving credit facility is permitted, subject to certain covenant restrictions, to be used for general corporate purposes, including working capital and capital expenditures. There were no balances outstanding on the Company's current revolving credit facility as of September 30, 2023 and December 31, 2022. As of September 30, 2023, the effective interest rate on the revolving credit facility, assuming one month borrowing, was 7.57%. There is a commitment fee associated with the revolving credit facility of 0.35% (per annum and paid quarterly) and an annual $0.1 agency fee (paid in quarterly installments). The credit facility matures on June 30, 2028.
Under the Credit Agreement, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for similarly rated borrowers, and the Company is required to maintain certain net leverage and interest coverage ratios. The Company is permitted to make adjustments, such as excluding certain costs, from the calculation of leverage and interest coverage ratios for compliance purposes. The Company was in compliance with all covenants in the Credit Agreement at September 30, 2023.
There were no outstanding letters of credit under the Credit Agreement as of September 30, 2023.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
DERIVATIVE INSTRUMENTS AND HEDGING
 9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS AND HEDGING DERIVATIVE INSTRUMENTS AND HEDGING
Summary of Derivative Instruments
The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and foreign currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative instruments such as foreign currency forward contracts (see “Foreign Currency Forward Contracts” section below) and interest rate swap agreements (see “Interest Rate Swaps” section below). The Company does not hold or issue derivative instruments for trading purposes. The derivative instrument contracts are with major investment grade financial institutions and the Company does not anticipate any material non-performance by any of the counterparties. The Company does not believe that its exposure to market risk is material to the Company’s financial position or results of operations.
Interest rate swap agreements, which are used by the Company from time to time in the management of interest rate exposure, are accounted for at fair value. These derivative instruments are accounted for as cash flow hedges and recognized as assets and liabilities, as applicable, and classified as current or noncurrent based on the swap’s settlement dates. The derivative instruments have been assessed and are considered to be perfectly effective hedges and accordingly, changes in the fair value of the interest rate swaps are initially recorded in the condensed consolidated and combined statements of comprehensive income. Cash flows from the interest rate swaps are included in financing activities.
Foreign currency forward contracts, which are used by the Company to hedge the Company’s foreign currency exposure, are accounted for at fair value. As these contracts are short-term in nature and are not designated hedging instruments, changes in the fair value of the Company’s foreign currency forward contracts are recognized directly in earnings.
The fair value of the Company's interest rate swaps and foreign currency forward contracts are determined based on observable market inputs (Level 2). The table below presents the fair value of the Company’s derivatives on a gross basis and the balance sheet classification of those instruments:
Fair Value of Derivatives At
September 30, 2023December 31, 2022
Balance Sheet ClassificationAssetLiabilityAssetLiability
Derivatives designated as hedging instruments:
Interest rate swapsPrepaid expenses and other$2.2 $(0.6)$— $— 
Derivatives not designated as hedging instruments:
Foreign currency forward contractsPrepaid expenses and other$2.2 $— $— $— 
Derivative Contracts Designated as Hedges
Interest Rate Swaps
In August 2023, the Company entered into two fixed-to-variable interest rate swap agreements for its senior secured term A loan facilities to hedge the cash flow variability associated with the Company’s floating interest rate exposure. The interest rate swaps, both of which mature on December 31, 2026, had an aggregate notional amount of $150.0 at September 30, 2023, each had a fixed interest rate of 4.20%, and each return variable interest rates based on one-month SOFR. Because these derivative instruments meet the criteria for hedge accounting, all related gains and losses are accumulated within other comprehensive loss and are being reclassified to earnings as interest payments are recognized in the condensed consolidated and combined statements of operations.
Refer to Note 9, Preferred Stock and Common Shareholders' Equity for the impact of the Company’s derivative instruments included in accumulated other comprehensive loss.
Derivative Contracts Not Designated as Hedges
Foreign Currency Forward Contracts
The Company utilizes foreign currency forward contracts with external counterparties to hedge the Company’s exposure to foreign currencies with exposure predominantly to the Euro and British Pound. These contracts do not qualify for hedge accounting and are recognized as assets or liabilities at their fair value with changes in fair value recorded directly to earnings. The contracts are short-term in nature and the fair value of these contracts is based on market prices for comparable contracts. The aggregate notional value of these contracts was $406.3 at September 30, 2023.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
COMMITMENTS AND CONTINGENT LIABILITIES
 9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES
The Company is involved from time to time in various claims and legal actions arising in the ordinary course of business. These matters may include commercial and contract disputes, employee-related matters, and professional liability claims. In accordance with FASB ASC 450, Contingencies, the Company establishes reserves for claims and legal actions when those matters present loss contingencies that are both probable and estimable. When loss contingencies are not both probable and estimable, the Company does not establish reserves. The Company does not believe that any liabilities related to such claims and legal actions will have a material effect on its financial condition, results of operations or cash flows.
The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its drug development support services. The drug development industry is, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, and/or additional liabilities from third-party claims.
Fortrea obtains insurance coverage for certain catastrophic exposures as well as those risks required to be insured by law or contract. The Company is covered by those policies but is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY
The Company is authorized to issue up to 265.0 shares of common stock, par value $0.001 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.001 per share. There were no preferred shares outstanding as of September 30, 2023 and December 31, 2022.
Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss) are as follows:
Three months ended September 30, 2023
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at June 30, 2023$(218.8)$(6.7)$— $(225.5)
Current quarter foreign exchange adjustments(56.0)— — (56.0)
Unrealized gain on derivative instrument— — 1.6 1.6
Tax effect of adjustments— — (0.4)(0.4)
Balance at September 30, 2023$(274.8)$(6.7)$1.2 $(280.3)
Three months ended September 30, 2022
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at June 30, 2022$(260.4)$(8.2)$— $(268.6)
Current quarter foreign exchange adjustments(96.6)— — (96.6)
Tax effect of adjustments— — — — 
Balance at September 30, 2022$(357.0)$(8.2)$— $(365.2)
Nine months ended September 30, 2023
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022$(267.2)$(8.8)$— $(276.0)
Current quarter foreign exchange adjustments(7.6)— — (7.6)
Unrealized gain on derivative instrument— — 1.6 1.6
Tax effect of adjustments— — (0.4)(0.4)
Transfer from Former Parent— 2.1 — 2.1 
Balance at September 30, 2023$(274.8)$(6.7)$1.2 $(280.3)
Nine months ended September 30, 2022
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at December 31, 2021$(140.2)$(8.2)$— $(148.4)
Current quarter foreign exchange adjustments(216.8)— — (216.8)
Tax effect of adjustments— — — — 
Balance at September 30, 2022$(357.0)$(8.2)$— $(365.2)
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES
 9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
Prior to the Separation, the Company’s operations were historically included in Labcorp’s U.S. combined federal, certain state and local, and foreign income tax returns. The income tax provision included in these combined financial statements has been calculated using the separate return basis as if the Company had filed separate tax returns. The Company believes the assumptions supporting its allocation and presentation of income taxes on a separate return basis are reasonable. The Company’s tax results, as presented in the combined financial statements, do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the periods presented. For the periods prior to the Separation, the income tax expense and deferred tax balances that are presented in these financial statements were calculated on a carve-out basis, which applied the accounting guidance as if the Company filed its own tax returns in each jurisdiction and included tax losses and tax credits that may not reflect tax positions taken by the Former Parent.
Applicable accounting standards provide that the Company may estimate an annual effective tax rate (“AETR method”) and apply that forecasted tax rate to year-to-date income for each interim period. However, the AETR method resulted in an unreliable estimate of the Company’s annual effective tax rate due to changes in the Company’s post spin-off operational forecast as well as the impact of certain components of the forecast which are not inherent in the Company’s results of operations for the nine months ended September 30, 2023. Therefore, the Company recorded its interim income tax provision through September 30, 2023 using the discrete method, as allowed under ASC 740-270, Income Taxes – Interim Reporting. Using the discrete method, the Company determined income tax expense as if the nine months ended September 30, 2023 were an annual period.
For the three months ended September 30, 2023, the Company’s effective tax rate was 26.8% compared to 18.3% for the three months ended September 30, 2022. The effective tax rate for the three months ended September 30, 2023 was higher than the Company’s statutory tax rate primarily due to earnings mix partially offset by U.S. taxes on foreign earnings. The effective tax rate for the three months ended September 30, 2022 was lower than the Company’s statutory tax rate primarily due to U.S. taxes on foreign earnings and domestic tax credits, partially offset by state taxes and additional tax deductions.
The effective income tax rate for the nine months ended September 30, 2023 was 22.6% compared to 18.3% for the nine months ended September 30, 2022. The effective tax rate for the nine months ended September 30, 2023 was higher than the statutory tax rate primarily due to earnings mix and foreign withholding taxes partially offset by U.S. taxes on foreign earnings. The effective tax rate for the nine months ended September 30, 2022 was lower than the statutory tax rate primarily due to U.S. taxes on foreign earnings and domestic tax credits, partially offset by state taxes and additional tax deductions.
The Company will file a consolidated U.S. federal income tax return, as well as separate and combined income tax returns in numerous state and international jurisdictions. The Company has not filed its initial consolidated U.S. federal income tax return and therefore there are no open IRS examinations. However, the Company is currently subject to examination by various U.S. state and international tax authorities where existing legal entities were transferred to the Company as part of the Separation. Management regularly assesses the potential outcomes of both ongoing and future examinations for the current and prior years and has concluded that the Company’s provision for income taxes is adequate. Management does not anticipate that ongoing audits or negotiations will conclude during the next 12 months.
During the nine months ended September 30, 2023, the amount of net unrecognized tax positions decreased by $0.3. Management believes that it is reasonably possible that the amount of unrecognized income tax benefits and interest may decrease during the next 12 months by approximately $1.0.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK COMPENSATION PLANS
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK COMPENSATION PLANS STOCK COMPENSATION PLANS
Stock Incentive Plans
Prior to the Separation, certain Company employees were covered by the Former Parent-sponsored stock compensation arrangements. The stock compensation expense for the period prior to the Separation has been derived from the equity awards granted by Labcorp to the Company’s employees who are specifically identified in the plans, as well as an allocation of expense related to corporate employees of Labcorp. The Former Parent-sponsored stock compensation arrangements are approved under the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan (the “Labcorp Plan”).
In June of 2023, Fortrea’s Board of Directors approved Fortrea’s Omnibus Incentive Plan and Employee Stock Purchase Plan (the “Plans”) and the current Board of Directors of Fortrea ratified the Plans by a unanimous written consent dated July 3, 2023. Under the Plans, the Company may grant incentive stock options, restricted stock units, and performance shares, as well as other forms of stock-based compensation to the Company’s employees, officers, and non-employee directors.
On July 18, 2023, all Labcorp equity incentive awards held by Fortrea employees that were outstanding on the distribution date were converted to 2.5 shares of Fortrea restricted stock units and 0.1 shares of Fortrea performance shares. Additionally, during the three months ended September 30, 2023, the Company granted awards under the Plans, including restricted stock units, performance stock units, and stock options, as indicated below.
As of September 30, 2023, 11.0 and 1.8 shares were authorized for future grants under Fortrea’s Omnibus Incentive Plan and Employee Stock Purchase Plan, respectively.
The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock units (“RSUs”) is determined based on the number of shares granted and the quoted price of Fortrea’s common stock on the grant date. The grant date fair value of performance awards is based on a Monte Carlo simulated fair value for the relative (as compared to the peer companies) total shareholder return component of the performance awards. Such value is recognized as an expense over the service period, net of estimated forfeitures and Fortrea’s determination of whether it is probable that the performance targets will be achieved. At the end of each reporting period, the Company reassesses the probability of achieving performance targets. The estimation of equity awards that will ultimately vest requires judgment and Fortrea considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience.
Stock Options
The following table summarizes grants of non-qualified options made by the Company to officers, key employees, or non-employee directors under all plans. Stock options are generally granted at an exercise price equal to or greater than the fair market price per share on the date of grant. Options vest ratably over a period of 3 years on the anniversaries of the grant date and have a contractual exercise period of 10 years subject to their earlier expiration or termination.
Changes in options outstanding under the plans for the three months ended September 30, 2023, were as follows:
Number of OptionsWeighted-Average Exercise Price per OptionWeighted-Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at June 30, 2023—$— 
Granted0.8$26.52 
Exercised
—$— 
Cancelled—$— 
Outstanding at September 30, 20230.8$26.52 9.9 years$1.7 
Exercisable at September 30, 2023—$— 0.0 years$— 
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2023.
The Company uses the Black-Scholes model to calculate the fair value of stock options. The following table shows the weighted average grant-date fair values of options issued during the period and the weighted average assumptions that the Company used to develop the fair value estimates:
Three Months Ended September 30, 2023
Weighted-average grant date fair value per option$12.51 
Weighted-average expected life (in years)6.3
Risk free interest rate4.4 %
Expected volatility40.4 %
Expected dividend yield— %
The volatility used in the determination of the fair value of the stock options was based on analysis of the historical volatility of guideline public companies and factors specific to the Company.
Restricted Stock Units and Performance Shares
The Company grants RSUs to officers, key employees, and non-employee directors. RSUs typically vest annually in equal one-third increments beginning on the first anniversary of the grant (e.g., a share grant in 2023 represents a three-year award opportunity for the period of 2023-2025 and, if earned, vests fully (to the extent earned) in the first quarter of 2026).
The Company grants performance shares (non-vested shares) to officers and key employees. Performance share awards are subject to a 3 year cliff vesting period in addition to certain revenue and adjusted EBITDA targets, the achievement of which may increase or decrease the number of shares which the grantee earns and therefore receives upon vesting. Unearned RSU and performance share compensation is amortized to expense, when probable, over the applicable vesting periods.
The following table shows a summary of non-vested shares for the three months ended September 30, 2023:
Number of Shares
Weighted-Average Grant Date Fair Value
Restricted Stock UnitsPerformance SharesRestricted Stock UnitsPerformance Shares
Non-vested at June 30, 2023——$— $— 
Converted2.50.134.243.8
Granted0.6—27.3—
Vested————
Cancelled(0.1)—34.9—
Non-vested at September 30, 20233.00.1$32.9 $43.8 
All Plans
Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated and combined statements of operations were as follows:
Three Months Ended September 30, 2023Nine Months Ended September 30, 2023
Direct costs$7.0 $16.4 
Selling, general and administrative expenses4.110.8
Total stock compensation expense$11.1 $27.2 
Income tax benefits$0.2 $1.7 
Unrecognized Compensation Cost
As of September 30, 2023, there was $83.4 of total unrecognized compensation cost related to non-vested stock options, restricted stock units and performance share-based compensation arrangements granted under the Plans. That cost is expected to be recognized over a weighted average period of 2.0 years and will be included in cost of revenues and selling, general and administrative expenses.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
TRANSACTIONS WITH FORMER PARENT
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
TRANSACTIONS WITH FORMER PARENT TRANSACTIONS WITH FORMER PARENT
Prior to the Separation on June 30, 2023, the condensed consolidated and combined financial statements were prepared on a standalone basis and were derived from the condensed consolidated financial statements and accounting records of Labcorp. The following discussion summarizes activity between the Company and Labcorp.
Allocation of General Corporate and Other Expenses
Prior to the Separation, the Company’s condensed consolidated and combined statements of operations included expenses for certain centralized functions and other programs provided and administered by Labcorp that are charged directly to the Company. In addition, for purposes of preparing these condensed consolidated and combined financial statements on a carve-out basis, a portion of Labcorp’s total corporate expenses were allocated to the Company. See Note 1, Basis of Financial Statement Presentation for a discussion of the methodology used to allocate corporate-related costs for purposes of preparing these financial statements on a carve-out basis.
The following table is a summary of corporate and other allocations for the three and nine months ended September 30, 2023 and 2022:
Three Months Ended September 30,Nine Months Ended September 30,
20232022
2023 1
2022
Direct costs$— $39.4 $86.6 $120.9 
Selling, general and administrative expenses— 55.7 105.0 160.9 
Restructuring and other charges— 0.1 0.2 0.7 
Foreign exchange gain (loss)— 5.2 2.2 13.2 
Corporate and other allocations$— $100.4 $194.0 $295.7 
1 Activity reflected through the Separation date
Included in the aforementioned amounts are $0.0 and $72.0 related to costs for certain centralized functions and programs provided and administered by Labcorp that are charged directly to the Company for the three months ended September 30, 2023 and 2022, respectively, and $147.6 and $214.8 for the nine months ended September 30, 2023 and 2022, respectively. In addition, a portion of Labcorp’s total corporate expenses has been allocated to the Company for services from Labcorp. These costs were $0.0 and $28.4 for the three months ended September 30, 2023 and 2022, respectively, and $46.4 and $80.9 for the nine months ended September 30, 2023 and 2022, respectively. The allocations of foreign exchange gain (loss) represent the allocation of the results of hedging activities performed by Labcorp on behalf of the Company.
The Company has arrangements with third parties where the services are subcontracted to Labcorp (and its affiliates that were not part of the transaction). The Company’s direct costs include services purchased from Labcorp for commercial contracts totaling $0.0 and $21.6 for the three months ended September 30, 2023 and 2022, respectively, and $48.8 and $65.7 for the nine months ended September 30, 2023 and 2022, respectively.
Hedging Activities
Prior to the Separation, the Company did not enter into any derivative contracts with external counterparties. However, foreign currency forward contracts with external counterparties were utilized to hedge certain foreign currency transactions with exposure predominantly to the Euro and British Pound. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. Earnings related to these contracts
were included in the condensed consolidated and combined statements of operations as part of corporate allocations. Refer to Note 7, Derivative Instruments and Hedging, for information regarding derivative contracts entered into after Separation.
Net Transfers To and From Labcorp
Net transfers to and from Labcorp are included within Former Parent company investment on the condensed consolidated and combined statements of changes in equity. The components of the transfers to and from Labcorp during the three and nine months ended September 30, 2023 and 2022 were as follows:
Three Months Ended September 30,
20232022
General financing activities$— $(140.5)
Corporate allocations— 94.0 
Stock compensation expense— 6.4 
Total net transfers (to) from Former Parent$— $(40.1)
Nine Months Ended September 30,
2023 1
2022
Special Payment to Former Parent$(1,595.0)$— 
General financing activities(286.8)(276.5)
Corporate allocations183.8 276.1 
Stock compensation expense10.2 19.6 
Total net transfers (to) from Former Parent$(1,687.8)$19.2 
1 Activity reflected through the Separation date.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLEMENTAL CASH FLOW INFORMATION
 9 Months Ended
Sep. 30, 2023
Supplemental Cash Flow Elements [Abstract]  
SUPPLEMENTAL CASH FLOW INFORMATION SUPPLEMENTAL CASH FLOW INFORMATION
Nine Months Ended September 30,
20232022
Supplemental schedule of cash flow information:
Cash paid during period for:
Interest$22.9 $0.2 
Income taxes, net of refunds21.9 20.0 
Disclosure of non-cash investing activities:
Change in accrued property, plant and equipment(1.5)2.3 
Disclosure of non-cash transfers to (from) Parent:
Change in right-of-use lease assets13.9 — 
Change in property, plant and equipment, net(27.7)— 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
BUSINESS SEGMENT INFORMATION
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
BUSINESS SEGMENT INFORMATION BUSINESS SEGMENT INFORMATIONThe following tables are a summary of segment information for the three and nine months ended September 30, 2023 and 2022. The segment information is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (“CODM”) for evaluating segment performance and deciding how to allocate resources to segments. The Fortrea chief executive officer has been identified as the CODM.
The CODM allocates resources and assesses performance based on the underlying businesses which determines the Company's operating segments. The Company reports its business in two reportable segments: Clinical Services, which provides phase I-IV clinical trials, including clinical pharmacology and comprehensive clinical development capabilities, and Enabling Services, which provides post-approval patient access services and technology enabled solutions to support clinical trials. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. The CODM evaluates performance using revenue and segment operating income. Segment asset information is not presented because it is not used by the CODM at the segment level.
Revenues from external customers by reportable segment were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Revenues from external customers:
Clinical Services$711.7 $697.2 $2,129.8 $2,127.6 
Enabling Services64.7 65.1 203.8 206.8 
Total revenues$776.4 $762.3 $2,333.6 $2,334.4 
Intersegment revenues, which are eliminated in consolidation, were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Intersegment revenues:
Clinical Services$0.3 $0.3 $0.9 $0.8 
Enabling Services2.5 1.8 6.9 7.1 
Total revenues$2.8 $2.1 $7.8 $7.9 
Through the Spin, the condensed combined statements of operations include costs for certain centralized functions and programs provided and administered by Labcorp that are charged directly to the Company. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation. These additional allocations were reported as “corporate costs not allocated to segments” in the table below. After the Separation, as a standalone public company, the Company has allocated costs for certain centralized functions and programs to the Clinical Services and Enabling Services segments based on appropriate metrics such as revenues or headcount. The Corporate costs not allocated to segments include the costs of centralized functions including corporate governance, executive management and related human resources, finance, legal, risk management, and information technology functions. Operating income of each segment represents revenues less directly identifiable expenses to arrive at operating income for the segment.
Operating income by reportable segment was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Operating Income:
Clinical Services$59.9 $108.5 $192.4 $299.8 
Enabling Services2.3 5.7 6.0 21.3 
Segment operating income:62.2 114.2 198.4 321.1 
Corporate costs not allocated to segments(20.6)(23.9)(60.0)(70.8)
Amortization(16.0)(16.2)(47.9)(49.7)
Restructuring and other(11.6)(5.2)(16.7)(27.8)
Total operating income$14.0 $68.9 $73.8 $172.8 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF FINANCIAL STATEMENT PREPARATION (Policies)
 9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Financial Statement Presentation
Basis of Financial Statement Presentation
Prior to June 30, 2023, Fortrea existed and functioned as part of the consolidated business of Former Parent. The Company’s financial statements for periods through the Spin reflect the historical financial position, results of operations and cash flows of the Company, for the periods presented, prepared on a “carve-out” basis and have been derived from the condensed consolidated financial statements and accounting records of Labcorp using the historical results of operations and historical basis of assets and liabilities of the Company and reflect Labcorp’s net investment in the Company. The Company’s balance sheet as of September 30, 2023 is a consolidated balance sheet based on the financial position of Fortrea as a standalone company. The three months ended September 30, 2023
includes condensed consolidated financial statements, whereas all prior periods included combined financial statements. The Company’s unaudited condensed consolidated and combined financial statements for all periods presented are referred to throughout this document as “financial statements.”
The Company’s condensed consolidated and combined financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated and combined financial statements do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the prior periods presented.
The accompanying condensed consolidated and combined financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated and combined balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The condensed consolidated and combined financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company’s fiscal year 2022 reporting included within the Form 10. Therefore, these interim statements should be read in conjunction with the combined financial statements and notes thereto contained in the Form 10.
The condensed combined statements of operations include all revenues and costs directly attributable to our business. The condensed combined statements of operations for prior periods also include costs for certain centralized functions and programs provided and administered by Labcorp that were allocated to Fortrea. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation.
These expenses were allocated to Fortrea based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues or headcount or other reasonable driver, as applicable. Fortrea considers the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, Fortrea during the prior periods presented. However, the allocations may not reflect the expenses Fortrea would have incurred as an independent company for the prior periods presented. Actual costs that may have been incurred if Fortrea had been a standalone company would depend on a number of factors, including, but not limited to, the organizational structure, whether functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. For a period following the Spin some of these functions are provided by Labcorp as discussed within the Agreements with Labcorp section above.
Labcorp utilizes a centralized approach to cash management and financing of its operations. The cash and cash equivalents held by Labcorp at the corporate level were not specifically identifiable to Fortrea and therefore have not been reflected in the Company’s condensed combined balance sheet as of December 31, 2022. Cash and cash equivalents in the condensed consolidated and combined balance sheets represent cash and cash equivalents held by the Company.
As of December 31, 2022, the condensed combined financial statements include certain assets and liabilities that have historically been held at the Labcorp corporate level but are specifically identifiable or otherwise attributable to Fortrea. Labcorp’s third-party long-term debt and the related interest expense have not been allocated to Fortrea for any of the periods presented because Fortrea was not the legal obligor of such debt.
As of December 31, 2022, a Former Parent investment is shown in lieu of common stock and retained earnings accounts in the condensed combined financial statements. The total net effect of the settlement of the transactions between the Company and Labcorp, exclusive of those historically settled in cash, is reflected in the condensed combined statements of cash flows in cash flows from financing activities as net transfers (to) from Former Parent and in the condensed consolidated and combined balance sheets as Former Parent investment.
All intercompany transactions within the Company have been eliminated. All transactions between the Company and Former Parent have been included in these condensed consolidated and combined financial statements. For those transactions between the Company and Former Parent that were historically settled in cash, the Company has reflected such balances in the condensed consolidated and combined balance sheets as due from related parties or due to related parties. The Former Parent investment and all due from or due to Former Parent were settled at the time of the Spin.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and unbilled services.
The Company maintains cash and cash equivalents with various major financial institutions. These financial institutions are generally highly rated and geographically dispersed. The Company evaluates the relative credit standing of these financial institutions and has not sustained credit losses from instruments held at financial institutions.
Substantially all the Company’s accounts receivable and unbilled services are with companies in the pharmaceutical, biotechnology and medical device industries. As of September 30, 2023, no customer accounted for more than 10% of the Company's combined gross accounts receivable and unbilled services. As of December 31, 2022, one pharmaceutical company accounted for approximately 10.5% of the Company's combined gross accounts receivable and unbilled services. Additionally, for the three months and nine months ended September 30, 2023, one customer accounted for approximately 13.5% and 10.2% of revenues, respectively. For the three and nine months ended September 30, 2022, no customer accounted for more than 10% of revenues. Concentrations of credit risk are mitigated due to the number of the Company’s customers as well as their dispersion across many different geographic regions. Additionally, the Company applies assumptions and judgments, including historical collection experience and reasonable and supportable forecasts, for assessing collectability and determining allowances for doubtful accounts.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUES (Tables)
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Summary of Revenue by Segment and Geography
The Company’s revenues by segment and geography for the three and nine months ended September 30, 2023 and 2022 are as follows:
Three Months Ended September 30, 2023Three Months Ended September 30, 2022
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Clinical Services$347.4 $204.3 $160.0 $711.7 $355.3 $196.0 $145.9 $697.2 
Enabling Services64.4 — 0.3 64.7 64.6 — 0.5 65.1 
Total$411.8 $204.3 $160.3 $776.4 $419.9 $196.0 $146.4 $762.3 
Nine Months Ended September 30, 2023Nine Months Ended September 30, 2022
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Clinical Services$1,070.6 $600.7 $458.5 $2,129.8 $1,047.0 $642.6 $438.0 $2,127.6 
Enabling Services202.9 — 0.9 203.8 205.2 — 1.6 206.8 
Total$1,273.5 $600.7 $459.4 $2,333.6 $1,252.2 $642.6 $439.6 $2,334.4 
Summary of Capitalized Contract Cost
The following table provides information about contract asset balances:
September 30, 2023December 31, 2022
Sales commission assets$16.5 $18.6 
Deferred contract costs13.2 14.8
Total$29.7 $33.4 
Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue
The following table provides information about accounts receivable, unbilled services and unearned revenue from contracts with customers:
September 30, 2023December 31, 2022
Accounts receivable$468.7 $449.2 
Gross unbilled services606.7 585.7 
Less: Allowance for credit losses(28.3)(12.7)
Total$1,047.1 $1,022.2 
Unearned revenue$264.8 $271.5 
Rollforward of Allowance for Credit Losses
The rollforward for the allowance for credit losses for the nine months ended September 30, 2023 is as follows:
Accounts Receivable
Allowance for credit losses as of December, 2022$12.7 
Credit loss expense21.9 
Write-offs(6.3)
Allowance for credit losses as of September 30, 2023$28.3 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
RESTRUCTURING AND OTHER CHARGES (Tables)
 9 Months Ended
Sep. 30, 2023
Restructuring and Related Activities [Abstract]  
Schedule Of Restructuring and Other Charges
The following summarizes a component of the Company’s restructuring and other charges:
Severance and Other Employee CostsFacility CostsTotal
Balance as of December 31, 2022$1.9 $5.0 $6.9 
Expense12.0 1.0 13.0 
Cash payments(10.5)(1.5)(12.0)
Balance as of September 30, 2023$3.4 $4.5 $7.9 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
EARNINGS (LOSS) PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Reconciliation of Basic Earnings per Share to Diluted Earnings per Share
The following represents a reconciliation of basic earnings per share to diluted earnings per share.
Three Months Ended September 30,
20232022
Earnings
Shares
Per Share Amount
Earnings
Shares
Per Share Amount
Basic earnings (loss) per share:
Net earnings (loss)
$(13.1)88.8 $(0.15)$60.6 88.8 $0.68 
Dilutive effect of employee stock options and awards
— — — — — — 
Net earnings (loss) including impact of dilutive adjustments$(13.1)$88.8 $(0.15)$60.6 88.8$0.68 
Nine Months Ended September 30,
20232022
Earnings
Shares
Per Share Amount
Earnings
Shares
Per Share Amount
Basic earnings (loss) per share:
Net earnings (loss)
$32.6 88.8 $0.37 $159.5 88.8 $1.80 
Dilutive effect of employee stock options and awards
— 0.2 — — — — 
Net earnings (loss) including impact of dilutive adjustments$32.6 89.0 $0.37 $159.5 88.8 $1.80 
Schedule of Antidilutive Securities Excluded from Computation
The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Employee stock options and awards0.5 — 1.5 — 
Antidilutive employee stock options and awards excluded based on reporting a net loss for the period0.4 — — — 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS (Tables)
 9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in Carrying Amount of Goodwill
The changes in the carrying amount of goodwill for the nine months ended September 30, 2023 and 2022 are as follows:
Clinical ServicesEnabling ServicesTotal
September 30, 2023September 30, 2022September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Balance as of December 31$1,707.4 $1,791.0 $289.9 $289.9 $1,997.3 $2,080.9 
Goodwill acquired during the period— — — — — — 
Foreign currency impact(2.6)(143.7)— — (2.6)(143.7)
Balance as of September 30$1,704.8 $1,647.3 $289.9 $289.9 $1,994.7 $1,937.2 
Components of Intangible Assets
The components of identifiable intangible assets are as follows:
September 30, 2023December 31, 2022
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$1,188.2 $(420.3)$767.9 $1,191.1 $(376.7)$814.4 
Technology53.7 (49.8)3.9 53.7 (47.8)5.9 
Other13.3 (11.4)1.9 13.3 (10.3)3.0 
Total$1,255.2 $(481.5)$773.7 $1,258.1 $(434.8)$823.3 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
DEBT (Tables)
 9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Debt
The current portion of long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:
September 30, 2023December 31, 2022
Current portion of senior secured term loan A facility due 2028$25.0 $— 
Current portion of senior secured term loan B facility due 20305.7 — 
Debt issuance discount and fees(4.6)— 
Total short-term borrowings and current portion of long-term debt$26.1 $— 
Long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:
September 30, 2023December 31, 2022
7.5% senior notes due 2030
$570.0 $— 
Senior secured term loan A due 2028468.8 — 
Senior secured term loan B due 2030562.9 — 
Debt issuance discount and fees(29.3)— 
Total long-term debt$1,572.4 $— 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
DERIVATIVE INSTRUMENTS AND HEDGING (Tables)
 9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments The table below presents the fair value of the Company’s derivatives on a gross basis and the balance sheet classification of those instruments:
Fair Value of Derivatives At
September 30, 2023December 31, 2022
Balance Sheet ClassificationAssetLiabilityAssetLiability
Derivatives designated as hedging instruments:
Interest rate swapsPrepaid expenses and other$2.2 $(0.6)$— $— 
Derivatives not designated as hedging instruments:
Foreign currency forward contractsPrepaid expenses and other$2.2 $— $— $— 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY (Tables)
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss) are as follows:
Three months ended September 30, 2023
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at June 30, 2023$(218.8)$(6.7)$— $(225.5)
Current quarter foreign exchange adjustments(56.0)— — (56.0)
Unrealized gain on derivative instrument— — 1.6 1.6
Tax effect of adjustments— — (0.4)(0.4)
Balance at September 30, 2023$(274.8)$(6.7)$1.2 $(280.3)
Three months ended September 30, 2022
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at June 30, 2022$(260.4)$(8.2)$— $(268.6)
Current quarter foreign exchange adjustments(96.6)— — (96.6)
Tax effect of adjustments— — — — 
Balance at September 30, 2022$(357.0)$(8.2)$— $(365.2)
Nine months ended September 30, 2023
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022$(267.2)$(8.8)$— $(276.0)
Current quarter foreign exchange adjustments(7.6)— — (7.6)
Unrealized gain on derivative instrument— — 1.6 1.6
Tax effect of adjustments— — (0.4)(0.4)
Transfer from Former Parent— 2.1 — 2.1 
Balance at September 30, 2023$(274.8)$(6.7)$1.2 $(280.3)
Nine months ended September 30, 2022
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at December 31, 2021$(140.2)$(8.2)$— $(148.4)
Current quarter foreign exchange adjustments(216.8)— — (216.8)
Tax effect of adjustments— — — — 
Balance at September 30, 2022$(357.0)$(8.2)$— $(365.2)
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK COMPENSATION PLANS (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
Changes in options outstanding under the plans for the three months ended September 30, 2023, were as follows:
Number of OptionsWeighted-Average Exercise Price per OptionWeighted-Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at June 30, 2023—$— 
Granted0.8$26.52 
Exercised
—$— 
Cancelled—$— 
Outstanding at September 30, 20230.8$26.52 9.9 years$1.7 
Exercisable at September 30, 2023—$— 0.0 years$— 
Schedule of Fair Value Estimates
The Company uses the Black-Scholes model to calculate the fair value of stock options. The following table shows the weighted average grant-date fair values of options issued during the period and the weighted average assumptions that the Company used to develop the fair value estimates:
Three Months Ended September 30, 2023
Weighted-average grant date fair value per option$12.51 
Weighted-average expected life (in years)6.3
Risk free interest rate4.4 %
Expected volatility40.4 %
Expected dividend yield— %
Schedule of Restricted Stock Units and Performance Shares
The following table shows a summary of non-vested shares for the three months ended September 30, 2023:
Number of Shares
Weighted-Average Grant Date Fair Value
Restricted Stock UnitsPerformance SharesRestricted Stock UnitsPerformance Shares
Non-vested at June 30, 2023——$— $— 
Converted2.50.134.243.8
Granted0.6—27.3—
Vested————
Cancelled(0.1)—34.9—
Non-vested at September 30, 20233.00.1$32.9 $43.8 
Schedule of Share-Based Compensation Expense
Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated and combined statements of operations were as follows:
Three Months Ended September 30, 2023Nine Months Ended September 30, 2023
Direct costs$7.0 $16.4 
Selling, general and administrative expenses4.110.8
Total stock compensation expense$11.1 $27.2 
Income tax benefits$0.2 $1.7 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
TRANSACTIONS WITH FORMER PARENT (Tables)
 9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions
The following table is a summary of corporate and other allocations for the three and nine months ended September 30, 2023 and 2022:
Three Months Ended September 30,Nine Months Ended September 30,
20232022
2023 1
2022
Direct costs$— $39.4 $86.6 $120.9 
Selling, general and administrative expenses— 55.7 105.0 160.9 
Restructuring and other charges— 0.1 0.2 0.7 
Foreign exchange gain (loss)— 5.2 2.2 13.2 
Corporate and other allocations$— $100.4 $194.0 $295.7 
1 Activity reflected through the Separation date
The components of the transfers to and from Labcorp during the three and nine months ended September 30, 2023 and 2022 were as follows:
Three Months Ended September 30,
20232022
General financing activities$— $(140.5)
Corporate allocations— 94.0 
Stock compensation expense— 6.4 
Total net transfers (to) from Former Parent$— $(40.1)
Nine Months Ended September 30,
2023 1
2022
Special Payment to Former Parent$(1,595.0)$— 
General financing activities(286.8)(276.5)
Corporate allocations183.8 276.1 
Stock compensation expense10.2 19.6 
Total net transfers (to) from Former Parent$(1,687.8)$19.2 
1 Activity reflected through the Separation date.
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLEMENTAL CASH FLOW INFORMATION (Tables)
 9 Months Ended
Sep. 30, 2023
Supplemental Cash Flow Elements [Abstract]  
Schedule of Supplemental Cash Flow Information
Nine Months Ended September 30,
20232022
Supplemental schedule of cash flow information:
Cash paid during period for:
Interest$22.9 $0.2 
Income taxes, net of refunds21.9 20.0 
Disclosure of non-cash investing activities:
Change in accrued property, plant and equipment(1.5)2.3 
Disclosure of non-cash transfers to (from) Parent:
Change in right-of-use lease assets13.9 — 
Change in property, plant and equipment, net(27.7)— 
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
BUSINESS SEGMENT INFORMATION (Tables)
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
Revenues from external customers by reportable segment were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Revenues from external customers:
Clinical Services$711.7 $697.2 $2,129.8 $2,127.6 
Enabling Services64.7 65.1 203.8 206.8 
Total revenues$776.4 $762.3 $2,333.6 $2,334.4 
Intersegment revenues, which are eliminated in consolidation, were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Intersegment revenues:
Clinical Services$0.3 $0.3 $0.9 $0.8 
Enabling Services2.5 1.8 6.9 7.1 
Total revenues$2.8 $2.1 $7.8 $7.9 
Operating income of each segment represents revenues less directly identifiable expenses to arrive at operating income for the segment.
Operating income by reportable segment was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Operating Income:
Clinical Services$59.9 $108.5 $192.4 $299.8 
Enabling Services2.3 5.7 6.0 21.3 
Segment operating income:62.2 114.2 198.4 321.1 
Corporate costs not allocated to segments(20.6)(23.9)(60.0)(70.8)
Amortization(16.0)(16.2)(47.9)(49.7)
Restructuring and other(11.6)(5.2)(16.7)(27.8)
Total operating income$14.0 $68.9 $73.8 $172.8 
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
BASIS OF FINANCIAL STATEMENT PREPARATION (Details)
employee in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
employee
country
Sep. 30, 2023
employee
segment
country
Dec. 31, 2022
Concentration Risk [Line Items]      
Number of employees (more than) | employee 19 19  
Number of countries in which entity operates (more than) | country 90 90  
Number of reportable segments | segment   2  
Number of operating segments | segment   2  
Number of countries with primary office locations | country   5  
One pharmaceutical company | Accounts receivable and unbilled services | Customer concentration risk      
Concentration Risk [Line Items]      
Concentration risk, percentage     10.50%
One customer | Revenue | Customer concentration risk      
Concentration Risk [Line Items]      
Concentration risk, percentage 13.50% 10.20%  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUES - Summary of Revenue by Segment and Geography (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 776.4 $ 762.3 $ 2,333.6 $ 2,334.4
North America        
Disaggregation of Revenue [Line Items]        
Revenues 411.8 419.9 1,273.5 1,252.2
Europe        
Disaggregation of Revenue [Line Items]        
Revenues 204.3 196.0 600.7 642.6
Other        
Disaggregation of Revenue [Line Items]        
Revenues 160.3 146.4 459.4 439.6
Clinical Services        
Disaggregation of Revenue [Line Items]        
Revenues 711.7 697.2 2,129.8 2,127.6
Clinical Services | North America        
Disaggregation of Revenue [Line Items]        
Revenues 347.4 355.3 1,070.6 1,047.0
Clinical Services | Europe        
Disaggregation of Revenue [Line Items]        
Revenues 204.3 196.0 600.7 642.6
Clinical Services | Other        
Disaggregation of Revenue [Line Items]        
Revenues 160.0 145.9 458.5 438.0
Enabling Services        
Disaggregation of Revenue [Line Items]        
Revenues 64.7 65.1 203.8 206.8
Enabling Services | North America        
Disaggregation of Revenue [Line Items]        
Revenues 64.4 64.6 202.9 205.2
Enabling Services | Europe        
Disaggregation of Revenue [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Enabling Services | Other        
Disaggregation of Revenue [Line Items]        
Revenues $ 0.3 $ 0.5 $ 0.9 $ 1.6
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUES - Summary of Capitalized Contract Cost (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Capitalized Contract Cost [Line Items]    
Total contract assets $ 29.7 $ 33.4
Sales commission assets    
Capitalized Contract Cost [Line Items]    
Total contract assets 16.5 18.6
Deferred contract costs    
Capitalized Contract Cost [Line Items]    
Total contract assets $ 13.2 $ 14.8
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUES - Narrative (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Jun. 23, 2023
Capitalized Contract Cost [Line Items]          
Unearned revenue, revenue recognized     $ 187,600,000 $ 212,000,000.0  
Remaining performance obligation $ 4,958,200,000   4,958,200,000    
Performance obligation partially satisfied in previous period, revenue recognized 15,600,000   48,500,000    
ARPP, maximum facility amount         $ 80,000,000.0
Accounts receivable sold $ 0   17,500,000    
Proceeds from sale of receivables     $ 17,300,000    
Minimum          
Capitalized Contract Cost [Line Items]          
Remaining performance obligation, period 1 year   1 year    
Maximum          
Capitalized Contract Cost [Line Items]          
Remaining performance obligation, period 8 years   8 years    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01          
Capitalized Contract Cost [Line Items]          
Remaining performance obligation, percentage 29.00%   29.00%    
Remaining performance obligation, period 12 months   12 months    
Sales commission assets          
Capitalized Contract Cost [Line Items]          
Capitalized assets, amortization $ 2,300,000 $ 3,700,000 $ 10,200,000 10,200,000  
Deferred contract costs          
Capitalized Contract Cost [Line Items]          
Capitalized assets, amortization $ 2,200,000 $ 3,100,000 $ 6,900,000 $ 9,100,000  
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUES - Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]    
Accounts receivable $ 468.7 $ 449.2
Gross unbilled services 606.7 585.7
Less: Allowance for credit losses (28.3) (12.7)
Total 1,047.1 1,022.2
Unearned revenue $ 264.8 $ 271.5
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUES - Rollforward of Allowance for Credit Losses (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Allowance for credit losses as of December, 2022 $ 12.7
Credit loss expense 21.9
Write-offs (6.3)
Allowance for credit losses as of September 30, 2023 $ 28.3
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.3
RESTRUCTURING AND OTHER CHARGES (Details)
$ in Millions
 9 Months Ended
Sep. 30, 2023
USD ($)
Restructuring Reserve [Roll Forward]  
Beginning balance $ 6.9
Expense 13.0
Cash payments (12.0)
Ending balance 7.9
Severance and Other Employee Costs  
Restructuring Reserve [Roll Forward]  
Beginning balance 1.9
Expense 12.0
Cash payments (10.5)
Ending balance 3.4
Facility Costs  
Restructuring Reserve [Roll Forward]  
Beginning balance 5.0
Expense 1.0
Cash payments (1.5)
Ending balance $ 4.5
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
EARNINGS (LOSS) PER SHARE - Narrative (Details) - shares
shares in Millions
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]      
Common stock, outstanding (in shares) 88.8 88.8 0.0
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.3
EARNINGS (LOSS) PER SHARE - Reconciliation of Basic Earnings per Share to Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]                
Net earnings (loss) $ (13.1) $ 28.3 $ 17.4 $ 60.6 $ 66.4 $ 32.5 $ 32.6 $ 159.5
Net earnings (loss) including impact of dilutive adjustments $ (13.1)     $ 60.6     $ 32.6 $ 159.5
Outstanding shares, basic (in shares) 88.8     88.8     88.8 88.8
Dilutive effect of employee awards (in shares) 0.0     0.0     0.2 0.0
Outstanding shares, diluted (in shares) 88.8     88.8     89.0 88.8
Per share amount, basic (in dollars per share) $ (0.15)     $ 0.68     $ 0.37 $ 1.80
Per share amount, diluted (in dollars per share) $ (0.15)     $ 0.68     $ 0.37 $ 1.80
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.3
EARNINGS (LOSS) PER SHARE - Antidilutive Securities Excluded from Computation (Details) - shares
shares in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Outstanding shares, diluted (in shares) 88.8 88.8 89.0 88.8
Stock Options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Outstanding shares, diluted (in shares) 0.5 0.0 1.5 0.0
Stock Options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 0.4 0.0 0.0 0.0
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Goodwill [Roll Forward]    
Balance as of December 31 $ 1,997.3 $ 2,080.9
Goodwill acquired during the period 0.0 0.0
Foreign currency impact (2.6) (143.7)
Balance as of September 30 1,994.7 1,937.2
Clinical Services    
Goodwill [Roll Forward]    
Balance as of December 31 1,707.4 1,791.0
Goodwill acquired during the period 0.0 0.0
Foreign currency impact (2.6) (143.7)
Balance as of September 30 1,704.8 1,647.3
Enabling Services    
Goodwill [Roll Forward]    
Balance as of December 31 289.9 289.9
Goodwill acquired during the period 0.0 0.0
Foreign currency impact 0.0 0.0
Balance as of September 30 $ 289.9 $ 289.9
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS - Components of Intangible Assets (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 1,255.2 $ 1,258.1
Accumulated Amortization (481.5) (434.8)
Net Carrying Amount 773.7 823.3
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 1,188.2 1,191.1
Accumulated Amortization (420.3) (376.7)
Net Carrying Amount 767.9 814.4
Technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 53.7 53.7
Accumulated Amortization (49.8) (47.8)
Net Carrying Amount 3.9 5.9
Other    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 13.3 13.3
Accumulated Amortization (11.4) (10.3)
Net Carrying Amount $ 1.9 $ 3.0
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization of intangible assets $ 16.0 $ 16.2 $ 47.9 $ 49.7
Estimated amortization expense, remainder of year 15.8   15.8  
Estimated amortization expense, 2024 62.8   62.8  
Estimated amortization expense, 2025 60.0   60.0  
Estimated amortization expense, 2026 59.1   59.1  
Estimated amortization expense, 2027 59.1   59.1  
Estimated amortization expense, thereafter $ 516.9   $ 516.9  
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.3
DEBT - Narrative (Details) - USD ($)
 9 Months Ended
Jun. 30, 2023
Jun. 27, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Debt Instrument [Line Items]          
Aggregate principal amount issued     $ 1,640,000,000    
Maximum borrowing capacity     450,000,000.0    
Proceeds from issuance of senior notes     570,000,000.0 $ 0  
Proceeds from term loans     1,061,400,000 $ 0  
Letters of credit outstanding     $ 0    
7.5% senior notes due 2030 | Senior notes          
Debt Instrument [Line Items]          
Aggregate principal amount issued   $ 570,000,000.0      
Stated interest rate   7.50% 7.50%    
Proceeds from issuance of senior notes   $ 560,200,000      
Senior secured revolving credit facility | Line of credit | Revolving credit facility          
Debt Instrument [Line Items]          
Maximum borrowing capacity $ 450,000,000.0        
Effective interest rate     7.57%    
Line of credit, outstanding balance     $ 0   $ 0
Commitment fee 0.35%        
Annual agency fee $ 100,000        
Senior secured revolving credit facility | Line of credit | Swingline sub-facility          
Debt Instrument [Line Items]          
Maximum borrowing capacity 75,000,000.0        
Senior secured revolving credit facility | Line of credit | Letter of credit          
Debt Instrument [Line Items]          
Maximum borrowing capacity 75,000,000.0        
Senior secured term loan A due 2028 | Line of credit | Secured debt          
Debt Instrument [Line Items]          
Aggregate principal amount issued $ 500,000,000.0        
Debt term 5 years        
Proceeds from term loans $ 491,800,000        
Effective interest rate     7.57%    
Senior secured term loan B due 2030 | Line of credit | Secured debt          
Debt Instrument [Line Items]          
Aggregate principal amount issued $ 570,000,000.0        
Debt term 7 years        
Proceeds from term loans $ 552,900,000        
Effective interest rate     9.07%    
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.3
DEBT - Schedule of Debt (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 27, 2023
Dec. 31, 2022
Current Portion of Long-Term Debt      
Debt issuance discount and fees $ (4.6)   $ 0.0
Total short-term borrowings and current portion of long-term debt 26.1   0.0
Long-Term Debt      
Debt issuance discount and fees (29.3)   0.0
Total long-term debt 1,572.4   0.0
Line of credit | Secured debt | Senior secured term loan A due 2028      
Current Portion of Long-Term Debt      
Current portion of debt, gross 25.0   0.0
Long-Term Debt      
Debt, gross 468.8   0.0
Line of credit | Secured debt | Senior secured term loan B due 2030      
Current Portion of Long-Term Debt      
Current portion of debt, gross 5.7   0.0
Long-Term Debt      
Debt, gross 562.9   0.0
Senior notes | 7.5% senior notes due 2030      
Long-Term Debt      
Debt, gross $ 570.0   $ 0.0
Stated interest rate 7.50% 7.50%  
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.3
DERIVATIVE INSTRUMENTS AND HEDGING - Schedule of Derivative Instruments (Details) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Interest rate swaps | Designated as hedging instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Asset $ 2.2 $ 0.0
Liability (0.6) 0.0
Foreign currency forward contracts | Not designated as hedging instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Asset 2.2 0.0
Liability $ 0.0 $ 0.0
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.3
DERIVATIVE INSTRUMENTS AND HEDGING - Narrative (Details)
$ in Millions
Sep. 30, 2023
USD ($)
Aug. 31, 2023
derivative
Interest rate swaps | Designated as hedging instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Number of derivative instruments | derivative   2
Derivative, notional amount $ 150.0  
Derivative, fixed interest rate 4.20%  
Foreign currency forward contracts | Not designated as hedging instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative, notional amount $ 406.3  
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.3
PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY - Narrative (Details) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Equity [Abstract]    
Common stock, shares authorized (in shares) 265,000,000.0  
Common stock, par value per share (in dollars per share) $ 0.001  
Preferred stock, shares authorized (in shares) 30,000,000.0  
Preferred stock, par value per share (in dollars per share) $ 0.001  
Preferred stock, shares outstanding (in shares) 0 0
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.3
PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance $ 1,751.1 $ 3,298.6 $ 3,342.6 $ 3,260.6
Current quarter foreign exchange adjustments (56.0) (96.6) (7.6) (216.8)
Unrealized gain on derivative instrument 1.6 0.0 1.6 0.0
Tax effect of adjustments (0.4) 0.0 (0.4) 0.0
Transfer from Former Parent     2.1  
Ending balance 1,694.3 3,222.5 1,694.3 3,222.5
Accumulated Other Comprehensive Loss        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (225.5) (268.6) (276.0) (148.4)
Ending balance (280.3) (365.2) (280.3) (365.2)
Foreign Currency Translation Adjustments        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (218.8) (260.4) (267.2) (140.2)
Current quarter foreign exchange adjustments (56.0) (96.6) (7.6) (216.8)
Unrealized gain on derivative instrument 0.0   0.0  
Tax effect of adjustments 0.0 0.0 0.0 0.0
Transfer from Former Parent     0.0  
Ending balance (274.8) (357.0) (274.8) (357.0)
Net Benefit Plan Adjustments        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance (6.7) (8.2) (8.8) (8.2)
Current quarter foreign exchange adjustments 0.0 0.0 0.0 0.0
Unrealized gain on derivative instrument 0.0   0.0  
Tax effect of adjustments 0.0 0.0 0.0 0.0
Transfer from Former Parent     2.1  
Ending balance (6.7) (8.2) (6.7) (8.2)
Unrealized Gain (Loss) on Derivative Instruments        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Beginning balance 0.0 0.0 0.0 0.0
Current quarter foreign exchange adjustments 0.0 0.0 0.0 0.0
Unrealized gain on derivative instrument 1.6   1.6  
Tax effect of adjustments (0.4) 0.0 (0.4) 0.0
Transfer from Former Parent     0.0  
Ending balance $ 1.2 $ 0.0 $ 1.2 $ 0.0
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.3
INCOME TAXES (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]        
Effective income tax rate 26.80% 18.30% 22.60% 18.30%
Unrecognized tax benefits, decrease     $ 0.3  
Decrease in unrecognized tax benefits, reasonably possible $ 1.0   $ 1.0  
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK COMPENSATION PLANS - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
 9 Months Ended
Jul. 18, 2023
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Cliff vesting period   3 years
Unrecognized compensation cost   $ 83.4
Unrecognized compensation cost, recognition period   2 years
Fortrea’s Omnibus Incentive Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares authorized for future issuance (in shares)   11.0
Employee Stock Purchase Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares authorized for future issuance (in shares)   1.8
Restricted Stock Units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares converted (in shares) 2.5  
Award vesting period   3 years
Restricted Stock Units | Year one    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting percentage   33.00%
Restricted Stock Units | Year two    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting percentage   33.00%
Restricted Stock Units | Year three    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting percentage   33.00%
Performance Shares    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares converted (in shares) 0.1  
Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting period   3 years
Exercise period   10 years
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK COMPENSATION PLANS - Schedule of Stock Option Activity (Details)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Number of Options  
Outstanding, beginning (in shares) | shares 0.0
Granted (in shares) | shares 0.8
Exercised (in shares) | shares 0.0
Cancelled (in share) | shares 0.0
Outstanding, ending (in shares) | shares 0.8
Exercisable (in shares) | shares 0.0
Weighted-Average Exercise Price per Option  
Options, beginning (in dollar per share) | $ / shares $ 0
Granted (in dollar per share) | $ / shares 26.52
Exercised (in dollar per share) | $ / shares 0
Cancelled (in dollar per share) | $ / shares 0
Options, ending (in dollar per share) | $ / shares 26.52
Exercisable (in dollar per share) | $ / shares $ 0
Stock Options Additional Disclosures  
Outstanding, weighted average remaining contractual term 9 years 10 months 24 days
Exercisable, weighted average remaining contractual term 0 years
Outstanding, aggregate intrinsic value (in dollar per share) | $ $ 1.7
Exercisable, aggregate intrinsic value (in dollar per share) | $ $ 0.0
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK COMPENSATION PLANS - Fair Value Estimates (Details) - Stock Options
 3 Months Ended
Sep. 30, 2023
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average grant date fair value per option (in dollars per share) $ 12.51
Weighted-average expected life (in years) 6 years 3 months 18 days
Risk free interest rate 4.40%
Expected volatility 40.40%
Expected dividend yield 0.00%
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK COMPENSATION PLANS - Restricted Stock Units and Performance Shares (Details)
shares in Millions
 3 Months Ended
Sep. 30, 2023
$ / shares
shares
Restricted Stock Units  
Number of Shares  
Non-vested, beginning balance (in shares) | shares 0.0
Converted (in shares) | shares 2.5
Granted (in share) | shares 0.6
Vested (in shares) | shares 0.0
Cancelled (in share) | shares (0.1)
Non-vested, ending balance (in shares) | shares 3.0
Weighted-Average Grant Date Fair Value  
Non-vested, beginning balance (in dollars per share) | $ / shares $ 0
Converted (in dollars per share) | $ / shares 34.2
Granted (in dollars per share) | $ / shares 27.3
Vested (in dollars per share) | $ / shares 0
Cancelled (in dollars per share) | $ / shares 34.9
Non-vested, ending balance (in dollars per share) | $ / shares $ 32.9
Performance Shares  
Number of Shares  
Non-vested, beginning balance (in shares) | shares 0.0
Converted (in shares) | shares 0.1
Granted (in share) | shares 0.0
Vested (in shares) | shares 0.0
Cancelled (in share) | shares 0.0
Non-vested, ending balance (in shares) | shares 0.1
Weighted-Average Grant Date Fair Value  
Non-vested, beginning balance (in dollars per share) | $ / shares $ 0
Converted (in dollars per share) | $ / shares 43.8
Granted (in dollars per share) | $ / shares 0
Vested (in dollars per share) | $ / shares 0
Cancelled (in dollars per share) | $ / shares 0
Non-vested, ending balance (in dollars per share) | $ / shares $ 43.8
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK COMPENSATION PLANS - Share-Based Compensation Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total stock compensation expense $ 11.1 $ 27.2
Income tax benefits 0.2 1.7
Direct costs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total stock compensation expense 7.0 16.4
Selling, general and administrative expenses    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total stock compensation expense $ 4.1 $ 10.8
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.3
TRANSACTIONS WITH FORMER PARENT - Allocation of General Corporate and Other Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Related Party Transaction [Line Items]        
Corporate and other allocations $ 0.0 $ 100.4 $ 194.0 $ 295.7
Direct costs        
Related Party Transaction [Line Items]        
Corporate and other allocations 0.0 39.4 86.6 120.9
Selling, general and administrative expenses        
Related Party Transaction [Line Items]        
Corporate and other allocations 0.0 55.7 105.0 160.9
Restructuring and other charges        
Related Party Transaction [Line Items]        
Corporate and other allocations 0.0 0.1 0.2 0.7
Foreign exchange gain (loss)        
Related Party Transaction [Line Items]        
Corporate and other allocations $ 0.0 $ 5.2 $ 2.2 $ 13.2
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.3
TRANSACTIONS WITH FORMER PARENT - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Related Party Transaction [Line Items]        
Direct costs $ 0.0 $ 100.4 $ 194.0 $ 295.7
General financing activities        
Related Party Transaction [Line Items]        
Direct costs 0.0 72.0 147.6 214.8
Corporate allocations        
Related Party Transaction [Line Items]        
Direct costs 0.0 28.4 46.4 80.9
Subcontract services        
Related Party Transaction [Line Items]        
Direct costs $ 0.0 $ 21.6 $ 48.8 $ 65.7
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.3
TRANSACTIONS WITH FORMER PARENT - Net Transfers To and From Labcorp (Details) - Related party - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Related Party Transaction [Line Items]        
Total net transfers (to) from Former Parent $ 0.0 $ (40.1) $ (1,687.8) $ 19.2
Special Payment to Former Parent        
Related Party Transaction [Line Items]        
Total net transfers (to) from Former Parent     (1,595.0) 0.0
General financing activities        
Related Party Transaction [Line Items]        
Total net transfers (to) from Former Parent 0.0 (140.5) (286.8) (276.5)
Corporate allocations        
Related Party Transaction [Line Items]        
Total net transfers (to) from Former Parent 0.0 94.0 183.8 276.1
Stock compensation expense        
Related Party Transaction [Line Items]        
Total net transfers (to) from Former Parent $ 0.0 $ 6.4 $ 10.2 $ 19.6
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.3
SUPPLEMENTAL CASH FLOW INFORMATION (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash paid during period for:    
Interest $ 22.9 $ 0.2
Income taxes, net of refunds 21.9 20.0
Disclosure of non-cash investing activities:    
Change in accrued property, plant and equipment (1.5) 2.3
Disclosure of non-cash transfers to (from) Parent:    
Change in right-of-use lease assets 13.9 0.0
Change in property, plant and equipment, net $ (27.7) $ 0.0
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.3
BUSINESS SEGMENT INFORMATION - Narrative (Details)
 9 Months Ended
Sep. 30, 2023
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
Number of operating segments 2
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.3
BUSINESS SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Segment Reporting Information [Line Items]        
Revenues $ 776.4 $ 762.3 $ 2,333.6 $ 2,334.4
Segment operating income: 14.0 68.9 73.8 172.8
Restructuring and other     (13.0)  
Operating income 14.0 68.9 73.8 172.8
Operating segments        
Segment Reporting Information [Line Items]        
Segment operating income: 62.2 114.2 198.4 321.1
Operating income 62.2 114.2 198.4 321.1
Intersegment eliminations        
Segment Reporting Information [Line Items]        
Revenues (2.8) (2.1) (7.8) (7.9)
Corporate, non-segment        
Segment Reporting Information [Line Items]        
Corporate costs not allocated to segments (20.6) (23.9) (60.0) (70.8)
Amortization (16.0) (16.2) (47.9) (49.7)
Restructuring and other (11.6) (5.2) (16.7) (27.8)
Clinical Services        
Segment Reporting Information [Line Items]        
Revenues 711.7 697.2 2,129.8 2,127.6
Clinical Services | Operating segments        
Segment Reporting Information [Line Items]        
Revenues 711.7 697.2 2,129.8 2,127.6
Segment operating income: 59.9 108.5 192.4 299.8
Operating income 59.9 108.5 192.4 299.8
Clinical Services | Intersegment eliminations        
Segment Reporting Information [Line Items]        
Revenues (0.3) (0.3) (0.9) (0.8)
Enabling Services        
Segment Reporting Information [Line Items]        
Revenues 64.7 65.1 203.8 206.8
Enabling Services | Operating segments        
Segment Reporting Information [Line Items]        
Revenues 64.7 65.1 203.8 206.8
Segment operating income: 2.3 5.7 6.0 21.3
Operating income 2.3 5.7 6.0 21.3
Enabling Services | Intersegment eliminations        
Segment Reporting Information [Line Items]        
Revenues $ (2.5) $ (1.8) $ (6.9) $ (7.1)
XML 76 ftre-20230930_htm.xml IDEA: XBRL DOCUMENT 0001965040 2023-01-01 2023-09-30 0001965040 2023-11-09 0001965040 2023-09-30 0001965040 2022-12-31 0001965040 2023-07-01 2023-09-30 0001965040 2022-07-01 2022-09-30 0001965040 2022-01-01 2022-09-30 0001965040 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001965040 us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001965040 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001965040 us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001965040 us-gaap:CommonStockMember 2022-12-31 0001965040 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001965040 ftre:ParentCompanyInvestmentMember 2022-12-31 0001965040 us-gaap:RetainedEarningsMember 2022-12-31 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001965040 ftre:ParentCompanyInvestmentMember 2023-01-01 2023-03-31 0001965040 2023-01-01 2023-03-31 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001965040 us-gaap:CommonStockMember 2023-03-31 0001965040 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001965040 ftre:ParentCompanyInvestmentMember 2023-03-31 0001965040 us-gaap:RetainedEarningsMember 2023-03-31 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001965040 2023-03-31 0001965040 ftre:ParentCompanyInvestmentMember 2023-04-01 2023-06-30 0001965040 2023-04-01 2023-06-30 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001965040 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001965040 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001965040 us-gaap:CommonStockMember 2023-06-30 0001965040 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001965040 ftre:ParentCompanyInvestmentMember 2023-06-30 0001965040 us-gaap:RetainedEarningsMember 2023-06-30 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001965040 2023-06-30 0001965040 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001965040 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001965040 us-gaap:CommonStockMember 2023-09-30 0001965040 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001965040 ftre:ParentCompanyInvestmentMember 2023-09-30 0001965040 us-gaap:RetainedEarningsMember 2023-09-30 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001965040 us-gaap:CommonStockMember 2021-12-31 0001965040 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001965040 ftre:ParentCompanyInvestmentMember 2021-12-31 0001965040 us-gaap:RetainedEarningsMember 2021-12-31 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001965040 2021-12-31 0001965040 ftre:ParentCompanyInvestmentMember 2022-01-01 2022-03-31 0001965040 2022-01-01 2022-03-31 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001965040 us-gaap:CommonStockMember 2022-03-31 0001965040 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001965040 ftre:ParentCompanyInvestmentMember 2022-03-31 0001965040 us-gaap:RetainedEarningsMember 2022-03-31 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001965040 2022-03-31 0001965040 ftre:ParentCompanyInvestmentMember 2022-04-01 2022-06-30 0001965040 2022-04-01 2022-06-30 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001965040 us-gaap:CommonStockMember 2022-06-30 0001965040 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001965040 ftre:ParentCompanyInvestmentMember 2022-06-30 0001965040 us-gaap:RetainedEarningsMember 2022-06-30 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001965040 2022-06-30 0001965040 ftre:ParentCompanyInvestmentMember 2022-07-01 2022-09-30 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001965040 us-gaap:CommonStockMember 2022-09-30 0001965040 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001965040 ftre:ParentCompanyInvestmentMember 2022-09-30 0001965040 us-gaap:RetainedEarningsMember 2022-09-30 0001965040 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001965040 2022-09-30 0001965040 ftre:OnePharmaceuticalCompanyMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001965040 ftre:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001965040 ftre:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001965040 srt:NorthAmericaMember ftre:ClinicalServicesSegmentMember 2023-07-01 2023-09-30 0001965040 srt:EuropeMember ftre:ClinicalServicesSegmentMember 2023-07-01 2023-09-30 0001965040 ftre:OtherGeographicalAreasMember ftre:ClinicalServicesSegmentMember 2023-07-01 2023-09-30 0001965040 ftre:ClinicalServicesSegmentMember 2023-07-01 2023-09-30 0001965040 srt:NorthAmericaMember ftre:ClinicalServicesSegmentMember 2022-07-01 2022-09-30 0001965040 srt:EuropeMember ftre:ClinicalServicesSegmentMember 2022-07-01 2022-09-30 0001965040 ftre:OtherGeographicalAreasMember ftre:ClinicalServicesSegmentMember 2022-07-01 2022-09-30 0001965040 ftre:ClinicalServicesSegmentMember 2022-07-01 2022-09-30 0001965040 srt:NorthAmericaMember ftre:EnablingServicesSegmentMember 2023-07-01 2023-09-30 0001965040 srt:EuropeMember ftre:EnablingServicesSegmentMember 2023-07-01 2023-09-30 0001965040 ftre:OtherGeographicalAreasMember ftre:EnablingServicesSegmentMember 2023-07-01 2023-09-30 0001965040 ftre:EnablingServicesSegmentMember 2023-07-01 2023-09-30 0001965040 srt:NorthAmericaMember ftre:EnablingServicesSegmentMember 2022-07-01 2022-09-30 0001965040 srt:EuropeMember ftre:EnablingServicesSegmentMember 2022-07-01 2022-09-30 0001965040 ftre:OtherGeographicalAreasMember ftre:EnablingServicesSegmentMember 2022-07-01 2022-09-30 0001965040 ftre:EnablingServicesSegmentMember 2022-07-01 2022-09-30 0001965040 srt:NorthAmericaMember 2023-07-01 2023-09-30 0001965040 srt:EuropeMember 2023-07-01 2023-09-30 0001965040 ftre:OtherGeographicalAreasMember 2023-07-01 2023-09-30 0001965040 srt:NorthAmericaMember 2022-07-01 2022-09-30 0001965040 srt:EuropeMember 2022-07-01 2022-09-30 0001965040 ftre:OtherGeographicalAreasMember 2022-07-01 2022-09-30 0001965040 srt:NorthAmericaMember ftre:ClinicalServicesSegmentMember 2023-01-01 2023-09-30 0001965040 srt:EuropeMember ftre:ClinicalServicesSegmentMember 2023-01-01 2023-09-30 0001965040 ftre:OtherGeographicalAreasMember ftre:ClinicalServicesSegmentMember 2023-01-01 2023-09-30 0001965040 ftre:ClinicalServicesSegmentMember 2023-01-01 2023-09-30 0001965040 srt:NorthAmericaMember ftre:ClinicalServicesSegmentMember 2022-01-01 2022-09-30 0001965040 srt:EuropeMember ftre:ClinicalServicesSegmentMember 2022-01-01 2022-09-30 0001965040 ftre:OtherGeographicalAreasMember ftre:ClinicalServicesSegmentMember 2022-01-01 2022-09-30 0001965040 ftre:ClinicalServicesSegmentMember 2022-01-01 2022-09-30 0001965040 srt:NorthAmericaMember ftre:EnablingServicesSegmentMember 2023-01-01 2023-09-30 0001965040 srt:EuropeMember ftre:EnablingServicesSegmentMember 2023-01-01 2023-09-30 0001965040 ftre:OtherGeographicalAreasMember ftre:EnablingServicesSegmentMember 2023-01-01 2023-09-30 0001965040 ftre:EnablingServicesSegmentMember 2023-01-01 2023-09-30 0001965040 srt:NorthAmericaMember ftre:EnablingServicesSegmentMember 2022-01-01 2022-09-30 0001965040 srt:EuropeMember ftre:EnablingServicesSegmentMember 2022-01-01 2022-09-30 0001965040 ftre:OtherGeographicalAreasMember ftre:EnablingServicesSegmentMember 2022-01-01 2022-09-30 0001965040 ftre:EnablingServicesSegmentMember 2022-01-01 2022-09-30 0001965040 srt:NorthAmericaMember 2023-01-01 2023-09-30 0001965040 srt:EuropeMember 2023-01-01 2023-09-30 0001965040 ftre:OtherGeographicalAreasMember 2023-01-01 2023-09-30 0001965040 srt:NorthAmericaMember 2022-01-01 2022-09-30 0001965040 srt:EuropeMember 2022-01-01 2022-09-30 0001965040 ftre:OtherGeographicalAreasMember 2022-01-01 2022-09-30 0001965040 ftre:SalesCommissionAssetsMember 2023-09-30 0001965040 ftre:SalesCommissionAssetsMember 2022-12-31 0001965040 ftre:DeferredContractCostsMember 2023-09-30 0001965040 ftre:DeferredContractCostsMember 2022-12-31 0001965040 ftre:SalesCommissionAssetsMember 2023-07-01 2023-09-30 0001965040 ftre:SalesCommissionAssetsMember 2022-07-01 2022-09-30 0001965040 ftre:SalesCommissionAssetsMember 2023-01-01 2023-09-30 0001965040 ftre:SalesCommissionAssetsMember 2022-01-01 2022-09-30 0001965040 ftre:DeferredContractCostsMember 2023-07-01 2023-09-30 0001965040 ftre:DeferredContractCostsMember 2022-07-01 2022-09-30 0001965040 ftre:DeferredContractCostsMember 2023-01-01 2023-09-30 0001965040 ftre:DeferredContractCostsMember 2022-01-01 2022-09-30 0001965040 2023-10-01 2023-09-30 0001965040 srt:MinimumMember 2023-09-30 0001965040 srt:MaximumMember 2023-09-30 0001965040 2023-06-23 0001965040 us-gaap:EmployeeSeveranceMember 2022-12-31 0001965040 ftre:FacilityCostMember 2022-12-31 0001965040 us-gaap:EmployeeSeveranceMember 2023-01-01 2023-09-30 0001965040 ftre:FacilityCostMember 2023-01-01 2023-09-30 0001965040 us-gaap:EmployeeSeveranceMember 2023-09-30 0001965040 ftre:FacilityCostMember 2023-09-30 0001965040 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001965040 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0001965040 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001965040 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001965040 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001965040 us-gaap:EmployeeStockOptionMember 2022-07-01 2022-09-30 0001965040 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001965040 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001965040 ftre:ClinicalServicesSegmentMember 2022-12-31 0001965040 ftre:ClinicalServicesSegmentMember 2021-12-31 0001965040 ftre:EnablingServicesSegmentMember 2022-12-31 0001965040 ftre:EnablingServicesSegmentMember 2021-12-31 0001965040 ftre:ClinicalServicesSegmentMember 2023-09-30 0001965040 ftre:ClinicalServicesSegmentMember 2022-09-30 0001965040 ftre:EnablingServicesSegmentMember 2023-09-30 0001965040 ftre:EnablingServicesSegmentMember 2022-09-30 0001965040 us-gaap:CustomerRelationshipsMember 2023-09-30 0001965040 us-gaap:CustomerRelationshipsMember 2022-12-31 0001965040 us-gaap:TechnologyBasedIntangibleAssetsMember 2023-09-30 0001965040 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001965040 us-gaap:OtherIntangibleAssetsMember 2023-09-30 0001965040 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0001965040 us-gaap:SecuredDebtMember ftre:SeniorSecuredTermLoanAFacilityDue2028Member us-gaap:LineOfCreditMember 2023-09-30 0001965040 us-gaap:SecuredDebtMember ftre:SeniorSecuredTermLoanAFacilityDue2028Member us-gaap:LineOfCreditMember 2022-12-31 0001965040 us-gaap:SecuredDebtMember ftre:SeniorSecuredTermLoanBFacilityDue2028Member us-gaap:LineOfCreditMember 2023-09-30 0001965040 us-gaap:SecuredDebtMember ftre:SeniorSecuredTermLoanBFacilityDue2028Member us-gaap:LineOfCreditMember 2022-12-31 0001965040 ftre:A75SeniorNotesDue2030Member us-gaap:SeniorNotesMember 2023-09-30 0001965040 ftre:A75SeniorNotesDue2030Member us-gaap:SeniorNotesMember 2022-12-31 0001965040 ftre:A75SeniorNotesDue2030Member us-gaap:SeniorNotesMember 2023-06-27 0001965040 ftre:A75SeniorNotesDue2030Member us-gaap:SeniorNotesMember 2023-06-27 2023-06-27 0001965040 us-gaap:RevolvingCreditFacilityMember ftre:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2023-06-30 0001965040 us-gaap:SecuredDebtMember ftre:SeniorSecuredTermLoanAFacilityDue2028Member us-gaap:LineOfCreditMember 2023-06-30 2023-06-30 0001965040 us-gaap:SecuredDebtMember ftre:SeniorSecuredTermLoanAFacilityDue2028Member us-gaap:LineOfCreditMember 2023-06-30 0001965040 us-gaap:SecuredDebtMember ftre:SeniorSecuredTermLoanBFacilityDue2028Member us-gaap:LineOfCreditMember 2023-06-30 2023-06-30 0001965040 us-gaap:SecuredDebtMember ftre:SeniorSecuredTermLoanBFacilityDue2028Member us-gaap:LineOfCreditMember 2023-06-30 0001965040 us-gaap:BridgeLoanMember ftre:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2023-06-30 0001965040 us-gaap:LetterOfCreditMember ftre:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2023-06-30 0001965040 us-gaap:RevolvingCreditFacilityMember ftre:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-12-31 0001965040 us-gaap:RevolvingCreditFacilityMember ftre:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2023-09-30 0001965040 us-gaap:RevolvingCreditFacilityMember ftre:SeniorSecuredRevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2023-06-30 2023-06-30 0001965040 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-09-30 0001965040 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001965040 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2023-09-30 0001965040 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-12-31 0001965040 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-08-31 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2023-09-30 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-07-01 2023-09-30 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2023-09-30 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2023-09-30 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-09-30 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-09-30 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-06-30 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-07-01 2022-09-30 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2022-09-30 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-09-30 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-09-30 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-09-30 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-09-30 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001965040 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0001965040 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-09-30 0001965040 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0001965040 us-gaap:RestrictedStockUnitsRSUMember 2023-07-18 2023-07-18 0001965040 us-gaap:PerformanceSharesMember 2023-07-18 2023-07-18 0001965040 ftre:FortreasOmnibusIncentivePlanMember 2023-09-30 0001965040 ftre:FortreasEmployeeStockPurchasePlanMember 2023-09-30 0001965040 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001965040 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001965040 us-gaap:PerformanceSharesMember 2023-06-30 0001965040 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001965040 us-gaap:PerformanceSharesMember 2023-07-01 2023-09-30 0001965040 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001965040 us-gaap:PerformanceSharesMember 2023-09-30 0001965040 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001965040 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001965040 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001965040 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001965040 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-09-30 0001965040 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-09-30 0001965040 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-01-01 2023-09-30 0001965040 ftre:DirectCostsRelatedPartyMember 2023-07-01 2023-09-30 0001965040 ftre:DirectCostsRelatedPartyMember 2022-07-01 2022-09-30 0001965040 ftre:DirectCostsRelatedPartyMember 2023-01-01 2023-09-30 0001965040 ftre:DirectCostsRelatedPartyMember 2022-01-01 2022-09-30 0001965040 ftre:SellingGeneralAndAdministrativeExpensesRelatedPartyMember 2023-07-01 2023-09-30 0001965040 ftre:SellingGeneralAndAdministrativeExpensesRelatedPartyMember 2022-07-01 2022-09-30 0001965040 ftre:SellingGeneralAndAdministrativeExpensesRelatedPartyMember 2023-01-01 2023-09-30 0001965040 ftre:SellingGeneralAndAdministrativeExpensesRelatedPartyMember 2022-01-01 2022-09-30 0001965040 ftre:RestructuringAndOtherChargesRelatedPartyMember 2023-07-01 2023-09-30 0001965040 ftre:RestructuringAndOtherChargesRelatedPartyMember 2022-07-01 2022-09-30 0001965040 ftre:RestructuringAndOtherChargesRelatedPartyMember 2023-01-01 2023-09-30 0001965040 ftre:RestructuringAndOtherChargesRelatedPartyMember 2022-01-01 2022-09-30 0001965040 ftre:ForeignExchangeGainLossRelatedPartyMember 2023-07-01 2023-09-30 0001965040 ftre:ForeignExchangeGainLossRelatedPartyMember 2022-07-01 2022-09-30 0001965040 ftre:ForeignExchangeGainLossRelatedPartyMember 2023-01-01 2023-09-30 0001965040 ftre:ForeignExchangeGainLossRelatedPartyMember 2022-01-01 2022-09-30 0001965040 ftre:GeneralFinancingActivitiesMember 2023-07-01 2023-09-30 0001965040 ftre:GeneralFinancingActivitiesMember 2022-07-01 2022-09-30 0001965040 ftre:GeneralFinancingActivitiesMember 2023-01-01 2023-09-30 0001965040 ftre:GeneralFinancingActivitiesMember 2022-01-01 2022-09-30 0001965040 ftre:CorporateAllocationsMember 2023-07-01 2023-09-30 0001965040 ftre:CorporateAllocationsMember 2022-07-01 2022-09-30 0001965040 ftre:CorporateAllocationsMember 2023-01-01 2023-09-30 0001965040 ftre:CorporateAllocationsMember 2022-01-01 2022-09-30 0001965040 ftre:SubcontractServicesMember 2023-07-01 2023-09-30 0001965040 ftre:SubcontractServicesMember 2022-07-01 2022-09-30 0001965040 ftre:SubcontractServicesMember 2023-01-01 2023-09-30 0001965040 ftre:SubcontractServicesMember 2022-01-01 2022-09-30 0001965040 ftre:GeneralFinancingActivitiesMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001965040 ftre:GeneralFinancingActivitiesMember us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001965040 ftre:CorporateAllocationsMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001965040 ftre:CorporateAllocationsMember us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001965040 ftre:StockCompensationExpenseMember us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001965040 ftre:StockCompensationExpenseMember us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001965040 ftre:SpecialPaymentToFormerParentMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001965040 ftre:SpecialPaymentToFormerParentMember us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001965040 ftre:GeneralFinancingActivitiesMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001965040 ftre:GeneralFinancingActivitiesMember us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001965040 ftre:CorporateAllocationsMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001965040 ftre:CorporateAllocationsMember us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001965040 ftre:StockCompensationExpenseMember us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001965040 ftre:StockCompensationExpenseMember us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001965040 us-gaap:OperatingSegmentsMember ftre:ClinicalServicesSegmentMember 2023-07-01 2023-09-30 0001965040 us-gaap:OperatingSegmentsMember ftre:ClinicalServicesSegmentMember 2022-07-01 2022-09-30 0001965040 us-gaap:OperatingSegmentsMember ftre:ClinicalServicesSegmentMember 2023-01-01 2023-09-30 0001965040 us-gaap:OperatingSegmentsMember ftre:ClinicalServicesSegmentMember 2022-01-01 2022-09-30 0001965040 us-gaap:OperatingSegmentsMember ftre:EnablingServicesSegmentMember 2023-07-01 2023-09-30 0001965040 us-gaap:OperatingSegmentsMember ftre:EnablingServicesSegmentMember 2022-07-01 2022-09-30 0001965040 us-gaap:OperatingSegmentsMember ftre:EnablingServicesSegmentMember 2023-01-01 2023-09-30 0001965040 us-gaap:OperatingSegmentsMember ftre:EnablingServicesSegmentMember 2022-01-01 2022-09-30 0001965040 us-gaap:IntersegmentEliminationMember ftre:ClinicalServicesSegmentMember 2023-07-01 2023-09-30 0001965040 us-gaap:IntersegmentEliminationMember ftre:ClinicalServicesSegmentMember 2022-07-01 2022-09-30 0001965040 us-gaap:IntersegmentEliminationMember ftre:ClinicalServicesSegmentMember 2023-01-01 2023-09-30 0001965040 us-gaap:IntersegmentEliminationMember ftre:ClinicalServicesSegmentMember 2022-01-01 2022-09-30 0001965040 us-gaap:IntersegmentEliminationMember ftre:EnablingServicesSegmentMember 2023-07-01 2023-09-30 0001965040 us-gaap:IntersegmentEliminationMember ftre:EnablingServicesSegmentMember 2022-07-01 2022-09-30 0001965040 us-gaap:IntersegmentEliminationMember ftre:EnablingServicesSegmentMember 2023-01-01 2023-09-30 0001965040 us-gaap:IntersegmentEliminationMember ftre:EnablingServicesSegmentMember 2022-01-01 2022-09-30 0001965040 us-gaap:IntersegmentEliminationMember 2023-07-01 2023-09-30 0001965040 us-gaap:IntersegmentEliminationMember 2022-07-01 2022-09-30 0001965040 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-09-30 0001965040 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-09-30 0001965040 us-gaap:OperatingSegmentsMember 2023-07-01 2023-09-30 0001965040 us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001965040 us-gaap:OperatingSegmentsMember 2023-01-01 2023-09-30 0001965040 us-gaap:OperatingSegmentsMember 2022-01-01 2022-09-30 0001965040 us-gaap:CorporateNonSegmentMember 2023-07-01 2023-09-30 0001965040 us-gaap:CorporateNonSegmentMember 2022-07-01 2022-09-30 0001965040 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-09-30 0001965040 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-09-30 shares iso4217:USD iso4217:USD shares ftre:employee ftre:country ftre:segment pure ftre:derivative false 0001965040 Q3 2023 --12-31 P1Y 0.33 0.33 0.33 10-Q true 2023-09-30 false 001-41704 FORTREA HOLDINGS INC. DE 92-2796441 8 Moore Drive Durham NC 27709 (480) 295-7600 Common Stock, $0.001 par value FTRE NASDAQ Yes Yes Non-accelerated Filer false false false 88800000 107500000 112000000.0 1047100000 1022200000 103200000 112700000 1257800000 1246900000 219200000 164900000 1994700000 1997300000 773700000 823300000 1600000 1200000 69700000 54300000 4316700000 4287900000 128300000 81500000 335800000 322700000 264800000 271500000 26100000 0 19600000 23300000 774600000 699000000.0 1572400000 0 68000000.0 40100000 171700000 184500000 35700000 21700000 2622400000 945300000 0 3618600000 88800000 0.0 100000 0 1987600000 0 -13100000 0 -280300000 -276000000.0 1694300000 3342600000 4316700000 4287900000 776400000 762300000 2333600000 2334400000 0.0 21600000 48800000 65700000 647300000 594800000 1932900000 1847600000 78900000 70700000 237700000 216500000 24600000 22700000 72500000 69700000 11600000 5200000 16700000 27800000 762400000 693400000 2259800000 2161600000 14000000.0 68900000 73800000 172800000 34600000 0 35300000 0 -900000 4800000 -1000000.0 21100000 3600000 500000 4600000 1400000 -17900000 74200000 42100000 195300000 -4800000 13600000 9500000 35800000 -13100000 60600000 32600000 159500000 -0.15 0.68 0.37 1.80 -0.15 0.68 0.37 1.80 -13100000 60600000 32600000 159500000 -56000000.0 -96600000 -7600000 -216800000 0 0 -2100000 0 1600000 0 1600000 0 -54400000 -96600000 -3900000 -216800000 400000 0 400000 0 -54800000 -96600000 -4300000 -216800000 -67900000 -36000000.0 28300000 -57300000 0 0 0 3618600000 0 -276000000.0 3342600000 17400000 17400000 18900000 18900000 26600000 26600000 0 0 0 3662600000 0 -257100000 3405500000 28300000 28300000 31600000 31600000 1595000000 1595000000 -119400000 -119400000 1976500000 -1976500000 0 88800000 100000 100000 88800000 100000 1976500000 0 0 -225500000 1751100000 -13100000 -13100000 -54800000 -54800000 11100000 11100000 88800000 100000 1987600000 0 -13100000 -280300000 1694300000 0 0 0 3409000000 0 -148400000 3260600000 32500000 32500000 -34600000 -34600000 88600000 88600000 0 0 0 3530100000 0 -183000000.0 3347100000 66400000 66400000 -85600000 -85600000 -29300000 -29300000 0 0 0 3567200000 0 -268600000 3298600000 60600000 60600000 -96600000 -96600000 -40100000 -40100000 0 0 0 3587700000 0 -365200000 3222500000 32600000 159500000 72500000 69700000 27200000 19600000 20900000 19000000.0 -12700000 -6800000 -3500000 -3400000 26600000 72700000 3100000 15000000.0 47300000 23500000 -6500000 -38300000 -100000 -102700000 155000000.0 59200000 30900000 36000000.0 8100000 400000 -22800000 -35600000 24000000.0 0 24000000.0 0 1061400000 0 570000000.0 0 26400000 0 7700000 0 1595000000 0 -136700000 -400000 -134400000 -400000 -2300000 -10300000 -4500000 12900000 112000000.0 94600000 107500000 107500000 BASIS OF FINANCIAL STATEMENT PRESENTATION<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fortrea Holdings Inc. ("Fortrea" or the “Company”), a Delaware corporation incorporated on January 31, 2023, is a leading global contract research organization (“CRO”) providing biopharmaceutical product and medical device development services, patient access solutions and other enabling services to pharmaceutical, biotechnology and medical device customers. The Company offers customers highly flexible delivery models that include Full Service, Functional Service Provider, and Hybrid Service structures. The Company has a rich history of providing clinical development services for over 30 years across more than 20 therapeutic areas, first as Covance and later as Labcorp Drug Development. On June 30, 2023, the Company completed a spin-off (the “Spin” or the “Separation”) from Laboratory Corporation of America Holdings (“Labcorp” or “Former Parent”). The Company leverages its global scale, clinical data insights, technology innovation, industry network and decades of experience as a standalone company and as a business unit prior to the Spin to deliver tailored solutions to its customers. With what the Company believes is a distinctive market offering, Fortrea meets growing global demand for clinical development services. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The team of approximately 19,000 employees conducts operations in more than 90 countries and delivers comprehensive phase I – IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services for our customers. The Company’s offering is scaled to deliver focused and agile solutions to customers globally, streamlining the biopharmaceutical product and medical device development process. Additionally, Fortrea successfully utilizes enabling technologies to optimize processes and evolve with a dynamic marketplace.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its business in two reportable segments - Clinical Services and Enabling Services. The Clinical Services segment provides services across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. For further financial information about these segments, see Note 14, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the condensed consolidated and combined financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has established access to all key markets worldwide through a strategic footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreements with Labcorp</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2023, the Company completed the Spin from Labcorp. The Company has entered into several agreements with Labcorp that govern the relationship of the parties following the Separation, including the Separation and Distribution Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and the Transition Services Agreement, which are described in the Company’s Registration Statement on Form 10, as amended (“Form 10”), as filed with the Securities and Exchange Commission (the “SEC”). Under the terms of the Transition Services Agreement, the Company and Labcorp agreed to provide each other certain transitional services. The services and assets to be provided to Fortrea by Labcorp support the Company’s enterprise functions, most notably IT applications, network and security support and hosting as well as finance, human resources, marketing and other administrative support. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Financial Statement Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2023, Fortrea existed and functioned as part of the consolidated business of Former Parent. The Company’s financial statements for periods through the Spin reflect the historical financial position, results of operations and cash flows of the Company, for the periods presented, prepared on a “carve-out” basis and have been derived from the condensed consolidated financial statements and accounting records of Labcorp using the historical results of operations and historical basis of assets and liabilities of the Company and reflect Labcorp’s net investment in the Company. The Company’s balance sheet as of September 30, 2023 is a consolidated balance sheet based on the financial position of Fortrea as a standalone company. The three months ended September 30, 2023 </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes condensed consolidated financial statements, whereas all prior periods included combined financial statements. The Company’s unaudited condensed consolidated and combined financial statements for all periods presented are referred to throughout this document as “financial statements.”</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company’s condensed consolidated and combined financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated and combined financial statements do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the prior periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated and combined financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated and combined balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The condensed consolidated and combined financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company’s fiscal year 2022 reporting included within the Form 10. Therefore, these interim statements should be read in conjunction with the combined financial statements and notes thereto contained in the Form 10.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed combined statements of operations include all revenues and costs directly attributable to our business. The condensed combined statements of operations for prior periods also include costs for certain centralized functions and programs provided and administered by Labcorp that were allocated to Fortrea. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These expenses were allocated to Fortrea based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues or headcount or other reasonable driver, as applicable. Fortrea considers the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, Fortrea during the prior periods presented. However, the allocations may not reflect the expenses Fortrea would have incurred as an independent company for the prior periods presented. Actual costs that may have been incurred if Fortrea had been a standalone company would depend on a number of factors, including, but not limited to, the organizational structure, whether functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. For a period following the Spin some of these functions are provided by Labcorp as discussed within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Agreements with Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp utilizes a centralized approach to cash management and financing of its operations. The cash and cash equivalents held by Labcorp at the corporate level were not specifically identifiable to Fortrea and therefore have not been reflected in the Company’s condensed combined balance sheet as of December 31, 2022. Cash and cash equivalents in the condensed consolidated and combined balance sheets represent cash and cash equivalents held by the Company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the condensed combined financial statements include certain assets and liabilities that have historically been held at the Labcorp corporate level but are specifically identifiable or otherwise attributable to Fortrea. Labcorp’s third-party long-term debt and the related interest expense have not been allocated to Fortrea for any of the periods presented because Fortrea was not the legal obligor of such debt.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, a Former Parent investment is shown in lieu of common stock and retained earnings accounts in the condensed combined financial statements. The total net effect of the settlement of the transactions between the Company and Labcorp, exclusive of those historically settled in cash, is reflected in the condensed combined statements of cash flows in cash flows from financing activities as net transfers (to) from Former Parent and in the condensed consolidated and combined balance sheets as Former Parent investment. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany transactions within the Company have been eliminated. All transactions between the Company and Former Parent have been included in these condensed consolidated and combined financial statements. For those transactions between the Company and Former Parent that were historically settled in cash, the Company has reflected such balances in the condensed consolidated and combined balance sheets as due from related parties or due to related parties. The Former Parent investment and all due from or due to Former Parent were settled at the time of the Spin. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transactions with Former Parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and unbilled services.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalents with various major financial institutions. These financial institutions are generally highly rated and geographically dispersed. The Company evaluates the relative credit standing of these financial institutions and has not sustained credit losses from instruments held at financial institutions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all the Company’s accounts receivable and unbilled services are with companies in the pharmaceutical, biotechnology and medical device industries. As of September 30, 2023, no customer accounted for more than 10% of the Company's combined gross accounts receivable and unbilled services. As of December 31, 2022, one pharmaceutical company accounted for approximately 10.5% of the Company's combined gross accounts receivable and unbilled services. Additionally, for the three months and nine months ended September 30, 2023, one customer accounted for approximately 13.5% and 10.2% of revenues, respectively. For the three and nine months ended September 30, 2022, no customer accounted for more than 10% of revenues. Concentrations of credit risk are mitigated due to the number of the Company’s customers as well as their dispersion across many different geographic regions. Additionally, the Company applies assumptions and judgments, including historical collection experience and reasonable and supportable forecasts, for assessing collectability and determining allowances for doubtful accounts.</span></div> 19000 90 2 2 5 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Financial Statement Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to June 30, 2023, Fortrea existed and functioned as part of the consolidated business of Former Parent. The Company’s financial statements for periods through the Spin reflect the historical financial position, results of operations and cash flows of the Company, for the periods presented, prepared on a “carve-out” basis and have been derived from the condensed consolidated financial statements and accounting records of Labcorp using the historical results of operations and historical basis of assets and liabilities of the Company and reflect Labcorp’s net investment in the Company. The Company’s balance sheet as of September 30, 2023 is a consolidated balance sheet based on the financial position of Fortrea as a standalone company. The three months ended September 30, 2023 </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes condensed consolidated financial statements, whereas all prior periods included combined financial statements. The Company’s unaudited condensed consolidated and combined financial statements for all periods presented are referred to throughout this document as “financial statements.”</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company’s condensed consolidated and combined financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated and combined financial statements do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the prior periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated and combined financial statements of the Company are unaudited. In the opinion of management, all adjustments necessary for a fair statement of results of operations, cash flows, and financial position have been made. Except as otherwise disclosed, all such adjustments are of a normal recurring nature. Interim results are not necessarily indicative of results for a full year. The year-end condensed consolidated and combined balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. The condensed consolidated and combined financial statements and notes are presented in accordance with the rules and regulations of the SEC and do not contain certain information included in the Company’s fiscal year 2022 reporting included within the Form 10. Therefore, these interim statements should be read in conjunction with the combined financial statements and notes thereto contained in the Form 10.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed combined statements of operations include all revenues and costs directly attributable to our business. The condensed combined statements of operations for prior periods also include costs for certain centralized functions and programs provided and administered by Labcorp that were allocated to Fortrea. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These expenses were allocated to Fortrea based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues or headcount or other reasonable driver, as applicable. Fortrea considers the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, Fortrea during the prior periods presented. However, the allocations may not reflect the expenses Fortrea would have incurred as an independent company for the prior periods presented. Actual costs that may have been incurred if Fortrea had been a standalone company would depend on a number of factors, including, but not limited to, the organizational structure, whether functions were outsourced or performed by employees, and strategic decisions made in areas such as information technology and infrastructure. For a period following the Spin some of these functions are provided by Labcorp as discussed within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Agreements with Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp utilizes a centralized approach to cash management and financing of its operations. The cash and cash equivalents held by Labcorp at the corporate level were not specifically identifiable to Fortrea and therefore have not been reflected in the Company’s condensed combined balance sheet as of December 31, 2022. Cash and cash equivalents in the condensed consolidated and combined balance sheets represent cash and cash equivalents held by the Company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the condensed combined financial statements include certain assets and liabilities that have historically been held at the Labcorp corporate level but are specifically identifiable or otherwise attributable to Fortrea. Labcorp’s third-party long-term debt and the related interest expense have not been allocated to Fortrea for any of the periods presented because Fortrea was not the legal obligor of such debt.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, a Former Parent investment is shown in lieu of common stock and retained earnings accounts in the condensed combined financial statements. The total net effect of the settlement of the transactions between the Company and Labcorp, exclusive of those historically settled in cash, is reflected in the condensed combined statements of cash flows in cash flows from financing activities as net transfers (to) from Former Parent and in the condensed consolidated and combined balance sheets as Former Parent investment. </span></div>All intercompany transactions within the Company have been eliminated. All transactions between the Company and Former Parent have been included in these condensed consolidated and combined financial statements. For those transactions between the Company and Former Parent that were historically settled in cash, the Company has reflected such balances in the condensed consolidated and combined balance sheets as due from related parties or due to related parties. The Former Parent investment and all due from or due to Former Parent were settled at the time of the Spin. <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and unbilled services.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalents with various major financial institutions. These financial institutions are generally highly rated and geographically dispersed. The Company evaluates the relative credit standing of these financial institutions and has not sustained credit losses from instruments held at financial institutions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all the Company’s accounts receivable and unbilled services are with companies in the pharmaceutical, biotechnology and medical device industries. As of September 30, 2023, no customer accounted for more than 10% of the Company's combined gross accounts receivable and unbilled services. As of December 31, 2022, one pharmaceutical company accounted for approximately 10.5% of the Company's combined gross accounts receivable and unbilled services. Additionally, for the three months and nine months ended September 30, 2023, one customer accounted for approximately 13.5% and 10.2% of revenues, respectively. For the three and nine months ended September 30, 2022, no customer accounted for more than 10% of revenues. Concentrations of credit risk are mitigated due to the number of the Company’s customers as well as their dispersion across many different geographic regions. Additionally, the Company applies assumptions and judgments, including historical collection experience and reasonable and supportable forecasts, for assessing collectability and determining allowances for doubtful accounts.</span></div> 0.105 0.135 0.102 REVENUES<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenues by segment and geography for the three and nine months ended September 30, 2023 and 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,127.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from the United States comprises substantially all revenue in North America. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract asset balances:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization related to sales commission assets for the three months ended September 30, 2023 and 2022 was $2.3 and $3.7</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023 and 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. Amortization related to deferred contract costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended September 30, 2023 and 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023 and 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. The Company does not recognize the effect of financing in its contracts with customers when the difference in timing of payment and performance is one year or less.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable, Unbilled Services and Unearned Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about accounts receivable, unbilled services and unearned revenue from contracts with customers:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the period included in the unearned revenue balance at the beginning of the peri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">od was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$187.6 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212.0</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the nine months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Loss Rollforward</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates future expected losses on accounts receivable and unbilled services over the remaining collection period of the instrument. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward for the allowance for credit losses for the nine months ended September 30, 2023 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of September 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Obligations Under Long-Term Contracts</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of September 30, 2023, approximately $4,958.2 of revenues are expected to be recognized from remaining long-term performance obligations. The Company expects to recognize approximately 29% of the existing </span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance obligations as of September 30, 2023 as revenue over the next 12 months and the remaining balance thereafter. The Company's long-term contracts generally range from <span style="-sec-ix-hidden:f-439">one</span> to eight years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2023, there were reductions of approximately $15.6 and $48.5, respectively, in the Company’s revenues related to performance obligations partially satisfied in previous periods. These reductions primarily relate to changes in scope. The gross and net amounts of revenue recognized solely from changes in estimates were not material.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable Purchase Program</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 23, 2023, Fortrea entered into an accounts receivable purchase program (“ARPP”) with a financial institution (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the "Financial Institution")</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The ARPP establishes a receivables factoring facility whereby the Company may sell up to $80.0 in customer receivables based on the availability of certain eligible receivables and the satisfaction of certain conditions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the facility, the Company may sell eligible receivables and retains no interest in the transferred receivables other than collection and administrative functions for the Financial Institution.</span></div>The Company accounts for these receivable transfers as sales and derecognizes the sold receivables from its balance sheets. The fair value of the sold receivables approximated their book value due to their short-term nature. The Company continues to service, administer and collect the receivables on behalf of the Financial Institution and does not receive a servicing fee as part of the arrangement. During the three months ended September 30, 2023, no receivables were sold. During the nine months ended September 30, 2023, $17.5 of receivables were sold with net proceeds of $17.3. <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s revenues by segment and geography for the three and nine months ended September 30, 2023 and 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,127.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,252.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 347400000 204300000 160000000.0 711700000 355300000 196000000.0 145900000 697200000 64400000 0 300000 64700000 64600000 0 500000 65100000 411800000 204300000 160300000 776400000 419900000 196000000.0 146400000 762300000 1070600000 600700000 458500000 2129800000 1047000000 642600000 438000000.0 2127600000 202900000 0 900000 203800000 205200000 0 1600000 206800000 1273500000 600700000 459400000 2333600000 1252200000 642600000 439600000 2334400000 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about contract asset balances:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 16500000 18600000 13200000 14800000 29700000 33400000 2300000 3700000 10200000 10200000 2200000 3100000 6900000 9100000 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about accounts receivable, unbilled services and unearned revenue from contracts with customers:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Allowance for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 468700000 449200000 606700000 585700000 28300000 12700000 1047100000 1022200000 264800000 271500000 187600000 212000000.0 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward for the allowance for credit losses for the nine months ended September 30, 2023 is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of September 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 12700000 21900000 6300000 28300000 4958200000 0.29 P12M P8Y 15600000 48500000 80000000.0 0 17500000 17300000 RESTRUCTURING AND OTHER CHARGES<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended September 30, 2023, the Company took actions to reduce overcapacity, align resources, and restructure certain operations. These actions included eliminating redundant positions and aligning resources for cost improvement and to meet customer requirements. These restructuring actions are expected to continue throughout 2023 and 2024.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes a component of the Company’s restructuring and other charges:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:43.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Severance and Other Employee Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facility Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The Company expects the restructuring and other charges accrued as of September 30, 2023 will be paid within the next twelve months and are included within accrued expenses and other current liabilities on the accompanying condensed consolidated and combined balance sheets. Restructuring costs are not allocated to the Company’s reportable segments as they are not part of the segment performance measures regularly reviewed by management. <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes a component of the Company’s restructuring and other charges:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:43.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Severance and Other Employee Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facility Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1900000 5000000.0 6900000 12000000.0 1000000.0 13000000.0 10500000 1500000 12000000.0 3400000 4500000 7900000 EARNINGS (LOSS) PER SHAREOn June 30, 2023, the Separation from Labcorp was effected through a pro-rata distribution of one share of the Company's common stock for every share of Labcorp common stock held at the close of business on the record date of June 20, 2023. As a result, on June 30, 2023, the Company had 88.8 shares of common stock outstanding. This share amount is being utilized for the calculation of basic earnings per share for all periods presented through the Separation date. As of the Separation date, actual outstanding shares are used to calculate basic weighted average common shares outstanding. Basic earnings per share is computed by dividing net earnings attributable to the Company by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company’s outstanding stock options, restricted stock awards, restricted stock units, and performance share awards.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:39.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="33" style="border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Earnings</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Shares</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Per Share Amount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Earnings</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Shares</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Per Share Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic earnings (loss) per share:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net earnings (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dilutive effect of employee stock options and awards</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net earnings (loss) including impact of dilutive adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:39.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Earnings</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Shares</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Per Share Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Earnings</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Shares</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Per Share Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic earnings (loss) per share:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net earnings (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dilutive effect of employee stock options and awards</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net earnings (loss) including impact of dilutive adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.80 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share represent the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. These potential shares include dilutive stock options and unissued restricted stock awards. Potential common shares are also considered antidilutive in the event of a net loss from operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:49.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.736%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive employee stock options and awards excluded based on reporting a net loss for the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div> 88800000 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:39.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="33" style="border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Earnings</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Shares</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Per Share Amount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Earnings</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Shares</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Per Share Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic earnings (loss) per share:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net earnings (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dilutive effect of employee stock options and awards</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net earnings (loss) including impact of dilutive adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.68 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:39.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Earnings</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Shares</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Per Share Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Earnings</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Shares</span></div></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Per Share Amount</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic earnings (loss) per share:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net earnings (loss)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dilutive effect of employee stock options and awards</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net earnings (loss) including impact of dilutive adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.80 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -13100000 88800000 -0.15 60600000 88800000 0.68 0 0 -13100000 88800000 -0.15 60600000 88800000 0.68 32600000 88800000 0.37 159500000 88800000 1.80 200000 0 32600000 89000000.0 0.37 159500000 88800000 1.80 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:49.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.736%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options and awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Antidilutive employee stock options and awards excluded based on reporting a net loss for the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div> 500000 0 1500000 0 400000 0 0 0 GOODWILL AND INTANGIBLE ASSETSThe Company's goodwill and intangible assets are the result of historical acquisitions; primarily the acquisition of Covance in 2015 by Labcorp. Subsequent acquisitions of businesses were allocated to the clinical development and commercialization services business of Fortrea based on the inclusion of the business activities using valuations at the time of acquisition.<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the nine months ended September 30, 2023 and 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Enabling Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,997.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,080.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable and appropriate, the Company’s business could be impacted by unfavorable changes, including those that impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions; primarily a worsening economic environment and protracted economic downturn and related impacts, including delays in revenue from new customers, increases in customer termination activity, or increases in operating costs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to monitor the financial performance of and assumptions for its reporting units. A significant increase in the discount rate, decrease in the revenue and terminal growth rates, decreased operating margin or substantial reductions in end markets and volume assumptions could have a negative impact on the estimated fair value of the reporting units. A future impairment charge for goodwill or intangible assets could have a material effect on the Company's consolidated financial position and results of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three and nine months ended September 30, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$16.0 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$47.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. For </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the three and nine months ended September 30, 2022, amortization was $16.2 and $49.7, respectively. Amortization expense of intangible assets is estimated to be $15.8 for the remainder of 2023, $62.8 in 2024, $60.0 in 2025, $59.1 in 2026, $59.1 in 2027 and $516.9 thereafter.</span></div> <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the nine months ended September 30, 2023 and 2022 are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Clinical Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Enabling Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,997.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,080.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,937.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1707400000 1791000000 289900000 289900000 1997300000 2080900000 0 0 0 0 0 0 -2600000 -143700000 0 0 -2600000 -143700000 1704800000 1647300000 289900000 289900000 1994700000 1937200000 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(481.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(434.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1188200000 420300000 767900000 1191100000 376700000 814400000 53700000 49800000 3900000 53700000 47800000 5900000 13300000 11400000 1900000 13300000 10300000 3000000.0 1255200000 481500000 773700000 1258100000 434800000 823300000 16000000.0 47900000 16200000 49700000 15800000 62800000 60000000.0 59100000 59100000 516900000 DEBTIn connection with the Spin, Fortrea incurred indebtedness in an aggregate principal amount of approximately $1,640.0, which consisted of borrowings under senior secured term loan facilities and senior secured notes. Fortrea also entered into a $450.0 senior secured revolving credit facility. Fortrea used the proceeds from <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these debt transactions to make a cash distribution to Labcorp as consideration for the assets that were contributed to the Company in connection with the Spin. </span></div><div style="margin-bottom:9pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current portion of long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:56.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Current portion of senior secured term loan A facility due 2028</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Current portion of senior secured term loan B facility due 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Debt issuance discount and fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:55.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.5% senior notes due 2030</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Senior secured term loan A due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Senior secured term loan B due 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Debt issuance discount and fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 27, 2023, the Company issued $570.0 aggregate principal amount of 7.50% senior notes due 2030 (the “Notes"). Interest on these notes is payable semi-annually on January 1 and July 1 of each year. Net proceeds from the offering of the Notes were $560.2 after deducting expenses of the offering. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2023, Fortrea entered into a credit agreement (the “Credit Agreement”) providing for (i) a senior secured revolving credit facility in the principal amount of up to $450.0; (ii) a five-year $500.0 first lien senior secured term A loan facility; and (iii) a seven-year $570.0 first lien senior secured term B loan facility. The initial revolving facility includes a $75.0 swingline sub-facility and a $75.0 letter of credit sub-facility. </span></div><div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company drew on the term A and term B loans on June 30, 2023. The net proceeds received for the term A and term B loans were $491.8 and $552.9, respectively after deducting underwriting discounts and other expenses. The term A and term B loans will mature on June 30, 2028 and June 30, 2030, respectively. The term loans accrue interest at a per annum rate equal to the sum of, at the option of the Company, a Base Rate or a Term SOFR Rate and the Applicable Margin as defined by the Credit Agreement. As of September 30, 2023, the effective interest rate on the term A loan and term B loan was 7.57% and 9.07%, respectively. </span></div><div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revolving credit facility is permitted, subject to certain covenant restrictions, to be used for general corporate purposes, including working capital and capital expenditures. There were no balances outstanding on the Company's current revolving credit facility as of September 30, 2023 and December 31, 2022. As of September 30, 2023, the effective interest rate on the revolving credit facility, assuming one month borrowing, was 7.57%. There is a commitment fee associated with the revolving credit facility of 0.35% (per annum and paid quarterly) and an annual $0.1 agency fee (paid in quarterly installments). The credit facility matures on June 30, 2028. </span></div><div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Credit Agreement, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for similarly rated borrowers, and the Company is required to maintain certain net leverage and interest coverage ratios. The Company is permitted to make adjustments, such as excluding certain costs, from the calculation of leverage and interest coverage ratios for compliance purposes. The Company was in compliance with all covenants in the Credit Agreement at September 30, 2023. </span></div><div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no outstanding letters of credit under the Credit Agreement as of September 30, 2023.</span></div> 1640000000 450000000.0 <div style="margin-bottom:9pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current portion of long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:56.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.633%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.735%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Current portion of senior secured term loan A facility due 2028</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Current portion of senior secured term loan B facility due 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Debt issuance discount and fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Long-term debt at September 30, 2023 and December 31, 2022 consisted of the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:55.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.5% senior notes due 2030</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Senior secured term loan A due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Senior secured term loan B due 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Debt issuance discount and fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 25000000.0 0 5700000 0 4600000 0 26100000 0 0.075 570000000.0 0 468800000 0 562900000 0 29300000 0 1572400000 0 570000000.0 0.0750 560200000 450000000.0 P5Y 500000000.0 P7Y 570000000.0 75000000.0 75000000.0 491800000 552900000 0.0757 0.0907 0 0 0.0757 0.0035 100000 0 DERIVATIVE INSTRUMENTS AND HEDGING<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Derivative Instruments</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and foreign currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative instruments such as foreign currency forward contracts (see “Foreign Currency Forward Contracts” section below) and interest rate swap agreements (see “Interest Rate Swaps” section below). The Company does not hold or issue derivative instruments for trading purposes. The derivative instrument contracts are with major investment grade financial institutions and the Company does not anticipate any material non-performance by any of the counterparties. The Company does not believe that its exposure to market risk is material to the Company’s financial position or results of operations.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Interest rate swap agreements, which are used by the Company from time to time in the management of interest rate exposure, are accounted for at fair value. These derivative instruments are accounted for as cash flow hedges and recognized as assets and liabilities, as applicable, and classified as current or noncurrent based on the swap’s settlement dates. The derivative instruments have been assessed and are considered to be perfectly effective hedges and accordingly, changes in the fair value of the interest rate swaps are initially recorded in the condensed consolidated and combined statements of comprehensive income. Cash flows from the interest rate swaps are included in financing activities.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Foreign currency forward contracts, which are used by the Company to hedge the Company’s foreign currency exposure, are accounted for at fair value. As these contracts are short-term in nature and are not designated hedging instruments, changes in the fair value of the Company’s foreign currency forward contracts are recognized directly in earnings. </span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The fair value of the Company's interest rate swaps and foreign currency forward contracts are determined based on observable market inputs (Level 2). The table below presents the fair value of the Company’s derivatives on a gross basis and the balance sheet classification of those instruments:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:26.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.365%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value of Derivatives At</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Contracts Designated as Hedges</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swaps</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In August 2023, the Company entered into two fixed-to-variable interest rate swap agreements for its senior secured term A loan facilities to hedge the cash flow variability associated with the Company’s floating interest rate exposure. The interest rate swaps, both of which mature on December 31, 2026, had an aggregate notional amount of $150.0 at September 30, 2023, each had a fixed interest rate of 4.20%, and each return variable interest rates based on one-month SOFR. Because these derivative instruments meet the criteria for hedge accounting, all related gains and losses are accumulated within other comprehensive loss and are being reclassified to earnings as interest payments are recognized in the condensed consolidated and combined statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Note 9, Preferred Stock and Common Shareholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> for the impact of the Company’s derivative instruments included in accumulated other comprehensive loss.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Derivative Contracts Not Designated as Hedges</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Forward Contracts</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company utilizes foreign currency forward contracts with external counterparties to hedge the Company’s exposure to foreign currencies with exposure predominantly to the Euro and British Pound. These contracts do not qualify for hedge accounting and are recognized as assets or liabilities at their fair value with changes in fair value recorded directly to earnings. The contracts are short-term in nature and the fair value of these contracts is based on market prices for comparable contracts. The aggregate notional value of these contracts was $406.3 at September 30, 2023.</span></div> The table below presents the fair value of the Company’s derivatives on a gross basis and the balance sheet classification of those instruments:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:26.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.365%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value of Derivatives At</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table> 2200000 600000 0 0 2200000 0 0 0 2 150000000.0 0.0420 406300000 COMMITMENTS AND CONTINGENT LIABILITIES <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in various claims and legal actions arising in the ordinary course of business. These matters may include commercial and contract disputes, employee-related matters, and professional liability claims. In accordance with FASB ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company establishes reserves for claims and legal actions when those matters present loss contingencies that are both probable and estimable. When loss contingencies are not both probable and estimable, the Company does not establish reserves. The Company does not believe that any liabilities related to such claims and legal actions will have a material effect on its financial condition, results of operations or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its drug development support services. The drug development industry is, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, and/or additional liabilities from third-party claims.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fortrea obtains insurance coverage for certain catastrophic exposures as well as those risks required to be insured by law or contract. The Company is covered by those policies but is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.</span></div> PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 265.0 shares of common stock, par value $0.001 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.001 per share. There were no preferred shares outstanding as of September 30, 2023 and December 31, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income (loss) are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:28.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.079%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Derivative Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(225.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current quarter foreign exchange adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on derivative instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(274.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(280.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Derivative Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(260.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(268.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current quarter foreign exchange adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(96.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(96.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(357.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(365.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Derivative Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(267.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(276.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current quarter foreign exchange adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on derivative instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(274.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(280.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Derivative Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(140.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(148.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current quarter foreign exchange adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(216.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(216.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(357.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(365.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div> 265000000.0 0.001 30000000.0 0.001 0 0 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income (loss) are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:28.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.079%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Derivative Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(218.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(225.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current quarter foreign exchange adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(56.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on derivative instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(274.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(280.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Derivative Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(260.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(268.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current quarter foreign exchange adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(96.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(96.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(357.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(365.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Derivative Instruments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(267.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(276.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current quarter foreign exchange adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on derivative instrument</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Transfer from Former Parent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(274.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(280.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Benefit Plan Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Derivative Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(140.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(148.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current quarter foreign exchange adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(216.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(216.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(357.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(365.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div> -218800000 -6700000 0 -225500000 -56000000.0 0 0 -56000000.0 0 0 1600000 1600000 0 0 400000 400000 -274800000 -6700000 1200000 -280300000 -260400000 -8200000 0 -268600000 -96600000 0 0 -96600000 0 0 0 0 -357000000.0 -8200000 0 -365200000 -267200000 -8800000 0 -276000000.0 -7600000 0 0 -7600000 0 0 1600000 1600000 0 0 400000 400000 0 -2100000 0 -2100000 -274800000 -6700000 1200000 -280300000 -140200000 -8200000 0 -148400000 -216800000 0 0 -216800000 0 0 0 0 -357000000.0 -8200000 0 -365200000 INCOME TAXES<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Prior to the Separation, the Company’s operations were historically included in Labcorp’s U.S. combined federal, certain state and local, and foreign income tax returns. The income tax provision included in these combined financial statements has been calculated using the separate return basis as if the Company had filed separate tax returns. The Company believes the assumptions supporting its allocation and presentation of income taxes on a separate return basis are reasonable. The Company’s tax results, as presented in the combined financial statements, do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the periods presented. For the periods prior to the Separation, the income tax expense and deferred tax balances that are presented in these financial statements were calculated on a carve-out basis, which applied the accounting guidance as if the Company filed its own tax returns in each jurisdiction and included tax losses and tax credits that may not reflect tax positions taken by the Former Parent. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Applicable accounting standards provide that the Company may estimate an annual effective tax rate (“AETR method”) and apply that forecasted tax rate to year-to-date income for each interim period. However, the AETR method resulted in an unreliable estimate of the Company’s annual effective tax rate due to changes in the Company’s post spin-off operational forecast as well as the impact of certain components of the forecast which are not inherent in the Company’s results of operations for the nine months ended September 30, 2023. Therefore, the Company recorded its interim income tax provision through September 30, 2023 using the discrete method, as allowed under ASC 740-270, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Income Taxes – Interim Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. Using the discrete method, the Company determined income tax expense as if the nine months ended September 30, 2023 were an annual period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For the three months ended September 30, 2023, the Company’s effective tax rate was 26.8% compared to 18.3% for the three months ended September 30, 2022. The effective tax rate for the three months ended September 30, 2023 was higher than the Company’s statutory tax rate primarily due to earnings mix partially offset by U.S. taxes on foreign earnings. The effective tax rate for the three months ended September 30, 2022 was lower than the Company’s statutory tax rate primarily due to U.S. taxes on foreign earnings and domestic tax credits, partially offset by state taxes and additional tax deductions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The effective income tax rate for the nine months ended September 30, 2023 was 22.6% compared to 18.3% for the nine months ended September 30, 2022. The effective tax rate for the nine months ended September 30, 2023 was higher than the statutory tax rate primarily due to earnings mix and foreign withholding taxes partially offset by U.S. taxes on foreign earnings. The effective tax rate for the nine months ended September 30, 2022 was lower than the statutory tax rate primarily due to U.S. taxes on foreign earnings and domestic tax credits, partially offset by state taxes and additional tax deductions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company will file a consolidated U.S. federal income tax return, as well as separate and combined income tax returns in numerous state and international jurisdictions. The Company has not filed its initial consolidated U.S. federal income tax return and therefore there are no open IRS examinations. However, the Company is currently subject to examination by various U.S. state and international tax authorities where existing legal entities were transferred to the Company as part of the Separation. Management regularly assesses the potential outcomes of both ongoing and future examinations for the current and prior years and has concluded that the Company’s provision for income taxes is adequate. Management does not anticipate that ongoing audits or negotiations will conclude during the next 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During the nine months ended September 30, 2023, the amount of net unrecognized tax positions decreased by $0.3. Management believes that it is reasonably possible that the amount of unrecognized income tax benefits and interest may decrease during the next 12 months by approximately $1.0.</span></div> 0.268 0.183 0.226 0.183 -300000 1000000.0 STOCK COMPENSATION PLANS<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Stock Incentive Plans</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Prior to the Separation, certain Company employees were covered by the Former Parent-sponsored stock compensation arrangements. The stock compensation expense for the period prior to the Separation has been derived from the equity awards granted by Labcorp to the Company’s employees who are specifically identified in the plans, as well as an allocation of expense related to corporate employees of Labcorp. The Former Parent-sponsored stock compensation arrangements are approved under the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan (the “Labcorp Plan”). </span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In June of 2023, Fortrea’s Board of Directors approved Fortrea’s Omnibus Incentive Plan and Employee Stock Purchase Plan (the “Plans”) and the current Board of Directors of Fortrea ratified the Plans by a unanimous written consent dated July 3, 2023. Under the Plans, the Company may grant incentive stock options, restricted stock units, and performance shares, as well as other forms of stock-based compensation to the Company’s employees, officers, and non-employee directors. </span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On July 18, 2023, all Labcorp equity incentive awards held by Fortrea employees that were outstanding on the distribution date were converted to 2.5 shares of Fortrea restricted stock units and 0.1 shares of Fortrea performance shares. Additionally, during the three months ended September 30, 2023, the Company granted awards under the Plans, including restricted stock units, performance stock units, and stock options, as indicated below. </span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of September 30, 2023, 11.0 and 1.8 shares were authorized for future grants under Fortrea’s Omnibus Incentive Plan and Employee Stock Purchase Plan, respectively.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock units (“RSUs”) is determined based on the number of shares granted and the quoted price of Fortrea’s common stock on the grant date. The grant date fair value of performance awards is based on a Monte Carlo simulated fair value for the relative (as compared to the peer companies) total shareholder return component of the performance awards. Such value is recognized as an expense over the service period, net of estimated forfeitures and Fortrea’s determination of whether it is probable that the performance targets will be achieved. At the end of each reporting period, the Company reassesses the probability of achieving performance targets. The estimation of equity awards that will ultimately vest requires judgment and Fortrea considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Stock Options</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes grants of non-qualified options made by the Company to officers, key employees, or non-employee directors under all plans. Stock options are generally granted at an exercise price equal to or greater than the fair market price per share on the date of grant. Options vest ratably over a period of 3 years on the anniversaries of the grant date and have a contractual exercise period of 10 years subject to their earlier expiration or termination.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Changes in options outstanding under the plans for the three months ended September 30, 2023, were as follows:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:30.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price per Option</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2023.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company uses the Black-Scholes model to calculate the fair value of stock options. The following table shows the weighted average grant-date fair values of options issued during the period and the weighted average assumptions that the Company used to develop the fair value estimates:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:78.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.51 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The volatility used in the determination of the fair value of the stock options was based on analysis of the historical volatility of guideline public companies and factors specific to the Company.</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Restricted Stock Units and Performance Shares</span></div><div style="margin-bottom:9pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company grants RSUs to officers, key employees, and non-employee directors. RSUs typically vest annually in equal one-third increments beginning on the first anniversary of the grant (e.g., a share grant in 2023 represents a three-year award opportunity for the period of 2023-2025 and, if earned, vests fully (to the extent earned) in the first quarter of 2026). </span></div><div style="margin-bottom:9pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company grants performance shares (non-vested shares) to officers and key employees. Performance share awards are subject to a 3 year cliff vesting period in addition to certain revenue and adjusted EBITDA targets, the achievement of which may increase or decrease the number of shares which the grantee earns and therefore receives upon vesting. Unearned RSU and performance share compensation is amortized to expense, when probable, over the applicable vesting periods. </span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table shows a summary of non-vested shares for the three months ended September 30, 2023:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:30.953%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">All Plans</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated and combined statements of operations were as follows:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.192%"><tr><td style="width:1.0%"></td><td style="width:56.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Unrecognized Compensation Cost</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of September 30, 2023, there was $83.4 of total unrecognized compensation cost related to non-vested stock options, restricted stock units and performance share-based compensation arrangements granted under the Plans. That cost is expected to be recognized over a weighted average period of 2.0 years and will be included in cost of revenues and selling, general and administrative expenses.</span></div> 2500000 100000 11000000.0 1800000 P3Y P10Y <div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Changes in options outstanding under the plans for the three months ended September 30, 2023, were as follows:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:30.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price per Option</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.52 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 800000 26.52 0 0 0 0 800000 26.52 P9Y10M24D 1700000 0 0 P0Y 0 <div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company uses the Black-Scholes model to calculate the fair value of stock options. The following table shows the weighted average grant-date fair values of options issued during the period and the weighted average assumptions that the Company used to develop the fair value estimates:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:78.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.51 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 12.51 P6Y3M18D 0.044 0.404 0 P3Y P3Y <div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table shows a summary of non-vested shares for the three months ended September 30, 2023:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:30.953%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Converted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 0 0 2500000 100000 34.2 43.8 600000 0 27.3 0 0 0 0 0 100000 0 34.9 0 3000000.0 100000 32.9 43.8 <div style="margin-bottom:9pt;text-indent:15.85pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Total stock-based compensation expense and the associated income tax benefits recognized by the Company in the condensed consolidated and combined statements of operations were as follows:</span></div><div style="margin-bottom:9pt;text-indent:15.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.192%"><tr><td style="width:1.0%"></td><td style="width:56.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.103%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 7000000.0 16400000 4100000 10800000 11100000 27200000 200000 1700000 83400000 P2Y TRANSACTIONS WITH FORMER PARENT<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation on June 30, 2023, the condensed consolidated and combined financial statements were prepared on a standalone basis and were derived from the condensed consolidated financial statements and accounting records of Labcorp. The following discussion summarizes activity between the Company and Labcorp.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allocation of General Corporate and Other Expenses </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation, the Company’s condensed consolidated and combined statements of operations included expenses for certain centralized functions and other programs provided and administered by Labcorp that are charged directly to the Company. In addition, for purposes of preparing these condensed consolidated and combined financial statements on a carve-out basis, a portion of Labcorp’s total corporate expenses were allocated to the Company. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Financial Statement Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a discussion of the methodology used to allocate corporate-related costs for purposes of preparing these financial statements on a carve-out basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of corporate and other allocations for the three and nine months ended September 30, 2023 and 2022:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other allocations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Activity reflected through the Separation date</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the aforementioned amou</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nts are </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.0</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.0</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to costs for certain centralized functions and programs provided and administered by Labcorp that are charged directly to the Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended September 30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$147.6</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">214.8</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. In addition, a portion of Labcorp’s total corporate expenses has been allocated to the Company for services from Labcorp. These costs were $0.0 and $28.4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended September 30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$46.4</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80.9</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. The allocations of foreign exchange gain (loss) represent the allocation of the results of hedging activities performed by Labcorp on behalf of the Company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has arrangements with third parties where the services are subcontracted to Labcorp (and its affiliates that were not part of the transaction). The Company’s direct costs include services purchased from Labcorp for commercial contracts totaling $0.0 and $21.6 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended September 30, 2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$48.8</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.7</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nine months ended September 30, 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hedging Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Separation, the Company did not enter into any derivative contracts with external counterparties. However, foreign currency forward contracts with external counterparties were utilized to hedge certain foreign currency transactions with exposure predominantly to the Euro and British Pound. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. Earnings related to these contracts </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were included in the condensed consolidated and combined statements of operations as part of corporate allocations. Refer to Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Instruments and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information regarding derivative contracts entered into after Separation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Transfers To and From Labcorp</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net transfers to and from Labcorp are included within Former Parent company investment on the condensed consolidated and combined statements of changes in equity. The components of the transfers to and from Labcorp during the three and nine months ended September 30, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General financing activities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140.5)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate allocations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net transfers (to) from Former Parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special Payment to Former Parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,595.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate allocations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net transfers (to) from Former Parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,687.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Activity reflected through the Separation date.</span></div> <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of corporate and other allocations for the three and nine months ended September 30, 2023 and 2022:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other allocations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Activity reflected through the Separation date</span></div>The components of the transfers to and from Labcorp during the three and nine months ended September 30, 2023 and 2022 were as follows:<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General financing activities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140.5)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate allocations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net transfers (to) from Former Parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Special Payment to Former Parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,595.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate allocations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net transfers (to) from Former Parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,687.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Activity reflected through the Separation date.</span></div> 0 39400000 86600000 120900000 0 55700000 105000000.0 160900000 0 100000 200000 700000 0 5200000 2200000 13200000 0 100400000 194000000.0 295700000 0.0 72000000.0 147600000 214800000 0.0 28400000 46400000 80900000 0.0 21600000 48800000 65700000 0 -140500000 0 94000000.0 0 6400000 0 -40100000 -1595000000 0 -286800000 -276500000 183800000 276100000 10200000 19600000 -1687800000 19200000 SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash transfers to (from) Parent:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in right-of-use lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash transfers to (from) Parent:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in right-of-use lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 22900000 200000 21900000 20000000.0 -1500000 2300000 13900000 0 -27700000 0 BUSINESS SEGMENT INFORMATIONThe following tables are a summary of segment information for the three and nine months ended September 30, 2023 and 2022. The segment information is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (“CODM”) for evaluating segment performance and deciding how to allocate resources to segments. The Fortrea chief executive officer has been identified as the CODM.<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM allocates resources and assesses performance based on the underlying businesses which determines the Company's operating segments. The Company reports its business in two reportable segments: Clinical Services, which provides phase I-IV clinical trials, including clinical pharmacology and comprehensive clinical development capabilities, and Enabling Services, which provides post-approval patient access services and technology enabled solutions to support clinical trials. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. The CODM evaluates performance using revenue and segment operating income. Segment asset information is not presented because it is not used by the CODM at the segment level.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from external customers by reportable segment were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from external customers:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,127.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Intersegment revenues, which are eliminated in consolidation, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intersegment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the Spin, the condensed combined statements of operations include costs for certain centralized functions and programs provided and administered by Labcorp that are charged directly to the Company. These centralized functions and programs include, but are not limited to legal, tax, treasury, risk management, sales expenses, information technology, human resources, finance, supply chain, executive leadership and stock-based compensation. These additional allocations were reported as “corporate costs not allocated to segments” in the table below. After the Separation, as a standalone public company, the Company has allocated costs for certain centralized functions and programs to the Clinical Services and Enabling Services segments based on appropriate metrics such as revenues or headcount. The Corporate costs not allocated to segments include the costs of centralized functions including corporate governance, executive management and related human resources, finance, legal, risk management, and information technology functions. Operating income of each segment represents revenues less directly identifiable expenses to arrive at operating income for the segment. </span></div><div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating income by reportable segment was as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income:</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate costs not allocated to segments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2 2 <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from external customers by reportable segment were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from external customers:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,129.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,127.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Intersegment revenues, which are eliminated in consolidation, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intersegment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>Operating income of each segment represents revenues less directly identifiable expenses to arrive at operating income for the segment. <div style="margin-bottom:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating income by reportable segment was as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enabling Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income:</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate costs not allocated to segments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 711700000 697200000 2129800000 2127600000 64700000 65100000 203800000 206800000 776400000 762300000 2333600000 2334400000 -300000 -300000 -900000 -800000 -2500000 -1800000 -6900000 -7100000 -2800000 -2100000 -7800000 -7900000 59900000 108500000 192400000 299800000 2300000 5700000 6000000.0 21300000 62200000 114200000 198400000 321100000 20600000 23900000 60000000.0 70800000 16000000.0 16200000 47900000 49700000 11600000 5200000 16700000 27800000 14000000.0 68900000 73800000 172800000 EXCEL 77 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 78 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 79 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 80 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 308 264 1 false 66 0 false 8 false false R1.htm 0000001 - Document - COVER Sheet http://www.fortrea.com/role/COVER COVER Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS Sheet http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS (Parenthetical) Sheet http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS Sheet http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONSParenthetical CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 6 false false R7.htm 0000007 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY Sheet http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY Statements 7 false false R8.htm 0000008 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS Sheet http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 0000009 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION Sheet http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATION BASIS OF FINANCIAL STATEMENT PREPARATION Notes 9 false false R10.htm 0000010 - Disclosure - REVENUES Sheet http://www.fortrea.com/role/REVENUES REVENUES Notes 10 false false R11.htm 0000011 - Disclosure - RESTRUCTURING AND OTHER CHARGES Sheet http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGES RESTRUCTURING AND OTHER CHARGES Notes 11 false false R12.htm 0000012 - Disclosure - EARNINGS (LOSS) PER SHARE Sheet http://www.fortrea.com/role/EARNINGSLOSSPERSHARE EARNINGS (LOSS) PER SHARE Notes 12 false false R13.htm 0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETS GOODWILL AND INTANGIBLE ASSETS Notes 13 false false R14.htm 0000014 - Disclosure - DEBT Sheet http://www.fortrea.com/role/DEBT DEBT Notes 14 false false R15.htm 0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING Sheet http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGING DERIVATIVE INSTRUMENTS AND HEDGING Notes 15 false false R16.htm 0000016 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES Sheet http://www.fortrea.com/role/COMMITMENTSANDCONTINGENTLIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES Notes 16 false false R17.htm 0000017 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS??? EQUITY Sheet http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS??? EQUITY Notes 17 false false R18.htm 0000018 - Disclosure - INCOME TAXES Sheet http://www.fortrea.com/role/INCOMETAXES INCOME TAXES Notes 18 false false R19.htm 0000019 - Disclosure - STOCK COMPENSATION PLANS Sheet http://www.fortrea.com/role/STOCKCOMPENSATIONPLANS STOCK COMPENSATION PLANS Notes 19 false false R20.htm 0000020 - Disclosure - TRANSACTIONS WITH FORMER PARENT Sheet http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENT TRANSACTIONS WITH FORMER PARENT Notes 20 false false R21.htm 0000021 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION Sheet http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATION SUPPLEMENTAL CASH FLOW INFORMATION Notes 21 false false R22.htm 0000022 - Disclosure - BUSINESS SEGMENT INFORMATION Sheet http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATION BUSINESS SEGMENT INFORMATION Notes 22 false false R23.htm 9954471 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION (Policies) Sheet http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONPolicies BASIS OF FINANCIAL STATEMENT PREPARATION (Policies) Policies 23 false false R24.htm 9954472 - Disclosure - REVENUES (Tables) Sheet http://www.fortrea.com/role/REVENUESTables REVENUES (Tables) Tables http://www.fortrea.com/role/REVENUES 24 false false R25.htm 9954473 - Disclosure - RESTRUCTURING AND OTHER CHARGES (Tables) Sheet http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESTables RESTRUCTURING AND OTHER CHARGES (Tables) Tables http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGES 25 false false R26.htm 9954474 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) Sheet http://www.fortrea.com/role/EARNINGSLOSSPERSHARETables EARNINGS (LOSS) PER SHARE (Tables) Tables http://www.fortrea.com/role/EARNINGSLOSSPERSHARE 26 false false R27.htm 9954475 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETS 27 false false R28.htm 9954476 - Disclosure - DEBT (Tables) Sheet http://www.fortrea.com/role/DEBTTables DEBT (Tables) Tables http://www.fortrea.com/role/DEBT 28 false false R29.htm 9954477 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING (Tables) Sheet http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGTables DERIVATIVE INSTRUMENTS AND HEDGING (Tables) Tables http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGING 29 false false R30.htm 9954478 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS??? EQUITY (Tables) Sheet http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables PREFERRED STOCK AND COMMON SHAREHOLDERS??? EQUITY (Tables) Tables http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY 30 false false R31.htm 9954479 - Disclosure - STOCK COMPENSATION PLANS (Tables) Sheet http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSTables STOCK COMPENSATION PLANS (Tables) Tables http://www.fortrea.com/role/STOCKCOMPENSATIONPLANS 31 false false R32.htm 9954480 - Disclosure - TRANSACTIONS WITH FORMER PARENT (Tables) Sheet http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTTables TRANSACTIONS WITH FORMER PARENT (Tables) Tables http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENT 32 false false R33.htm 9954481 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables) Sheet http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables SUPPLEMENTAL CASH FLOW INFORMATION (Tables) Tables http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATION 33 false false R34.htm 9954482 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables) Sheet http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONTables BUSINESS SEGMENT INFORMATION (Tables) Tables http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATION 34 false false R35.htm 9954483 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION (Details) Sheet http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails BASIS OF FINANCIAL STATEMENT PREPARATION (Details) Details http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONPolicies 35 false false R36.htm 9954484 - Disclosure - REVENUES - Summary of Revenue by Segment and Geography (Details) Sheet http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails REVENUES - Summary of Revenue by Segment and Geography (Details) Details 36 false false R37.htm 9954485 - Disclosure - REVENUES - Summary of Capitalized Contract Cost (Details) Sheet http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails REVENUES - Summary of Capitalized Contract Cost (Details) Details 37 false false R38.htm 9954486 - Disclosure - REVENUES - Narrative (Details) Sheet http://www.fortrea.com/role/REVENUESNarrativeDetails REVENUES - Narrative (Details) Details 38 false false R39.htm 9954487 - Disclosure - REVENUES - Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue (Details) Sheet http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails REVENUES - Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue (Details) Details 39 false false R40.htm 9954488 - Disclosure - REVENUES - Rollforward of Allowance for Credit Losses (Details) Sheet http://www.fortrea.com/role/REVENUESRollforwardofAllowanceforCreditLossesDetails REVENUES - Rollforward of Allowance for Credit Losses (Details) Details 40 false false R41.htm 9954489 - Disclosure - RESTRUCTURING AND OTHER CHARGES (Details) Sheet http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails RESTRUCTURING AND OTHER CHARGES (Details) Details http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESTables 41 false false R42.htm 9954490 - Disclosure - EARNINGS (LOSS) PER SHARE - Narrative (Details) Sheet http://www.fortrea.com/role/EARNINGSLOSSPERSHARENarrativeDetails EARNINGS (LOSS) PER SHARE - Narrative (Details) Details http://www.fortrea.com/role/EARNINGSLOSSPERSHARETables 42 false false R43.htm 9954491 - Disclosure - EARNINGS (LOSS) PER SHARE - Reconciliation of Basic Earnings per Share to Diluted Earnings per Share (Details) Sheet http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails EARNINGS (LOSS) PER SHARE - Reconciliation of Basic Earnings per Share to Diluted Earnings per Share (Details) Details http://www.fortrea.com/role/EARNINGSLOSSPERSHARETables 43 false false R44.htm 9954492 - Disclosure - EARNINGS (LOSS) PER SHARE - Antidilutive Securities Excluded from Computation (Details) Sheet http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails EARNINGS (LOSS) PER SHARE - Antidilutive Securities Excluded from Computation (Details) Details http://www.fortrea.com/role/EARNINGSLOSSPERSHARETables 44 false false R45.htm 9954493 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill (Details) Sheet http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails GOODWILL AND INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill (Details) Details 45 false false R46.htm 9954494 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Components of Intangible Assets (Details) Sheet http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails GOODWILL AND INTANGIBLE ASSETS - Components of Intangible Assets (Details) Details 46 false false R47.htm 9954495 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) Sheet http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) Details 47 false false R48.htm 9954496 - Disclosure - DEBT - Narrative (Details) Sheet http://www.fortrea.com/role/DEBTNarrativeDetails DEBT - Narrative (Details) Details 48 false false R49.htm 9954497 - Disclosure - DEBT - Schedule of Debt (Details) Sheet http://www.fortrea.com/role/DEBTScheduleofDebtDetails DEBT - Schedule of Debt (Details) Details 49 false false R50.htm 9954498 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING - Schedule of Derivative Instruments (Details) Sheet http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails DERIVATIVE INSTRUMENTS AND HEDGING - Schedule of Derivative Instruments (Details) Details 50 false false R51.htm 9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING - Narrative (Details) Sheet http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails DERIVATIVE INSTRUMENTS AND HEDGING - Narrative (Details) Details 51 false false R52.htm 9954500 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS??? EQUITY - Narrative (Details) Sheet http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYNarrativeDetails PREFERRED STOCK AND COMMON SHAREHOLDERS??? EQUITY - Narrative (Details) Details 52 false false R53.htm 9954501 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS??? EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails PREFERRED STOCK AND COMMON SHAREHOLDERS??? EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) Details 53 false false R54.htm 9954502 - Disclosure - INCOME TAXES (Details) Sheet http://www.fortrea.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://www.fortrea.com/role/INCOMETAXES 54 false false R55.htm 9954503 - Disclosure - STOCK COMPENSATION PLANS - Narrative (Details) Sheet http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails STOCK COMPENSATION PLANS - Narrative (Details) Details 55 false false R56.htm 9954504 - Disclosure - STOCK COMPENSATION PLANS - Schedule of Stock Option Activity (Details) Sheet http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails STOCK COMPENSATION PLANS - Schedule of Stock Option Activity (Details) Details 56 false false R57.htm 9954505 - Disclosure - STOCK COMPENSATION PLANS - Fair Value Estimates (Details) Sheet http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails STOCK COMPENSATION PLANS - Fair Value Estimates (Details) Details 57 false false R58.htm 9954506 - Disclosure - STOCK COMPENSATION PLANS - Restricted Stock Units and Performance Shares (Details) Sheet http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails STOCK COMPENSATION PLANS - Restricted Stock Units and Performance Shares (Details) Details 58 false false R59.htm 9954507 - Disclosure - STOCK COMPENSATION PLANS - Share-Based Compensation Expense (Details) Sheet http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails STOCK COMPENSATION PLANS - Share-Based Compensation Expense (Details) Details 59 false false R60.htm 9954508 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Allocation of General Corporate and Other Expenses (Details) Sheet http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails TRANSACTIONS WITH FORMER PARENT - Allocation of General Corporate and Other Expenses (Details) Details 60 false false R61.htm 9954509 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Narrative (Details) Sheet http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails TRANSACTIONS WITH FORMER PARENT - Narrative (Details) Details 61 false false R62.htm 9954510 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Net Transfers To and From Labcorp (Details) Sheet http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails TRANSACTIONS WITH FORMER PARENT - Net Transfers To and From Labcorp (Details) Details 62 false false R63.htm 9954511 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details) Sheet http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails SUPPLEMENTAL CASH FLOW INFORMATION (Details) Details http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables 63 false false R64.htm 9954512 - Disclosure - BUSINESS SEGMENT INFORMATION - Narrative (Details) Sheet http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails BUSINESS SEGMENT INFORMATION - Narrative (Details) Details 64 false false R65.htm 9954513 - Disclosure - BUSINESS SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details) Sheet http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails BUSINESS SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details) Details 65 false false All Reports Book All Reports ftre-20230930.htm ftre-20230930.xsd ftre-20230930_cal.xml ftre-20230930_def.xml ftre-20230930_lab.xml ftre-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 83 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ftre-20230930.htm": { "nsprefix": "ftre", "nsuri": "http://www.fortrea.com/20230930", "dts": { "inline": { "local": [ "ftre-20230930.htm" ] }, "schema": { "local": [ "ftre-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "ftre-20230930_cal.xml" ] }, "definitionLink": { "local": [ "ftre-20230930_def.xml" ] }, "labelLink": { "local": [ "ftre-20230930_lab.xml" ] }, "presentationLink": { "local": [ "ftre-20230930_pre.xml" ] } }, "keyStandard": 242, "keyCustom": 22, "axisStandard": 24, "axisCustom": 0, "memberStandard": 41, "memberCustom": 24, "hidden": { "total": 9, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 4 }, "contextCount": 308, "entityCount": 1, "segmentCount": 66, "elementCount": 452, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 799, "http://xbrl.sec.gov/dei/2023": 30 }, "report": { "R1": { "role": "http://www.fortrea.com/role/COVER", "longName": "0000001 - Document - COVER", "shortName": "COVER", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS", "shortName": "CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED AND COMBINED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": null }, "R4": { "role": "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS", "shortName": "CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R5": { "role": "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONSParenthetical", "longName": "0000005 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R6": { "role": "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "shortName": "CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R7": { "role": "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "longName": "0000007 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY", "shortName": "CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CHANGES IN EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-45", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-51", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R8": { "role": "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "longName": "0000008 - Statement - CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS", "shortName": "CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R9": { "role": "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATION", "longName": "0000009 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION", "shortName": "BASIS OF FINANCIAL STATEMENT PREPARATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.fortrea.com/role/REVENUES", "longName": "0000010 - Disclosure - REVENUES", "shortName": "REVENUES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGES", "longName": "0000011 - Disclosure - RESTRUCTURING AND OTHER CHARGES", "shortName": "RESTRUCTURING AND OTHER CHARGES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.fortrea.com/role/EARNINGSLOSSPERSHARE", "longName": "0000012 - Disclosure - EARNINGS (LOSS) PER SHARE", "shortName": "EARNINGS (LOSS) PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETS", "longName": "0000013 - Disclosure - GOODWILL AND INTANGIBLE ASSETS", "shortName": "GOODWILL AND INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.fortrea.com/role/DEBT", "longName": "0000014 - Disclosure - DEBT", "shortName": "DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGING", "longName": "0000015 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.fortrea.com/role/COMMITMENTSANDCONTINGENTLIABILITIES", "longName": "0000016 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY", "longName": "0000017 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS\u2019 EQUITY", "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.fortrea.com/role/INCOMETAXES", "longName": "0000018 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANS", "longName": "0000019 - Disclosure - STOCK COMPENSATION PLANS", "shortName": "STOCK COMPENSATION PLANS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENT", "longName": "0000020 - Disclosure - TRANSACTIONS WITH FORMER PARENT", "shortName": "TRANSACTIONS WITH FORMER PARENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATION", "longName": "0000021 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION", "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATION", "longName": "0000022 - Disclosure - BUSINESS SEGMENT INFORMATION", "shortName": "BUSINESS SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONPolicies", "longName": "9954471 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION (Policies)", "shortName": "BASIS OF FINANCIAL STATEMENT PREPARATION (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.fortrea.com/role/REVENUESTables", "longName": "9954472 - Disclosure - REVENUES (Tables)", "shortName": "REVENUES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESTables", "longName": "9954473 - Disclosure - RESTRUCTURING AND OTHER CHARGES (Tables)", "shortName": "RESTRUCTURING AND OTHER CHARGES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.fortrea.com/role/EARNINGSLOSSPERSHARETables", "longName": "9954474 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)", "shortName": "EARNINGS (LOSS) PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSTables", "longName": "9954475 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.fortrea.com/role/DEBTTables", "longName": "9954476 - Disclosure - DEBT (Tables)", "shortName": "DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGTables", "longName": "9954477 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING (Tables)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables", "longName": "9954478 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS\u2019 EQUITY (Tables)", "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS\u2019 EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSTables", "longName": "9954479 - Disclosure - STOCK COMPENSATION PLANS (Tables)", "shortName": "STOCK COMPENSATION PLANS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTTables", "longName": "9954480 - Disclosure - TRANSACTIONS WITH FORMER PARENT (Tables)", "shortName": "TRANSACTIONS WITH FORMER PARENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables", "longName": "9954481 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)", "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONTables", "longName": "9954482 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)", "shortName": "BUSINESS SEGMENT INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails", "longName": "9954483 - Disclosure - BASIS OF FINANCIAL STATEMENT PREPARATION (Details)", "shortName": "BASIS OF FINANCIAL STATEMENT PREPARATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-3", "name": "dei:EntityNumberOfEmployees", "unitRef": "employee", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ftre:NumberOfCountriesWithPrimaryOfficeLocations", "unitRef": "country", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R36": { "role": "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails", "longName": "9954484 - Disclosure - REVENUES - Summary of Revenue by Segment and Geography (Details)", "shortName": "REVENUES - Summary of Revenue by Segment and Geography (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-96", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R37": { "role": "http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails", "longName": "9954485 - Disclosure - REVENUES - Summary of Capitalized Contract Cost (Details)", "shortName": "REVENUES - Summary of Capitalized Contract Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CapitalizedContractCostNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:CapitalizedContractCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CapitalizedContractCostNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:CapitalizedContractCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.fortrea.com/role/REVENUESNarrativeDetails", "longName": "9954486 - Disclosure - REVENUES - Narrative (Details)", "shortName": "REVENUES - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails", "longName": "9954487 - Disclosure - REVENUES - Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue (Details)", "shortName": "REVENUES - Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.fortrea.com/role/REVENUESRollforwardofAllowanceforCreditLossesDetails", "longName": "9954488 - Disclosure - REVENUES - Rollforward of Allowance for Credit Losses (Details)", "shortName": "REVENUES - Rollforward of Allowance for Credit Losses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ProvisionForDoubtfulAccounts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R41": { "role": "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails", "longName": "9954489 - Disclosure - RESTRUCTURING AND OTHER CHARGES (Details)", "shortName": "RESTRUCTURING AND OTHER CHARGES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.fortrea.com/role/EARNINGSLOSSPERSHARENarrativeDetails", "longName": "9954490 - Disclosure - EARNINGS (LOSS) PER SHARE - Narrative (Details)", "shortName": "EARNINGS (LOSS) PER SHARE - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": null }, "R43": { "role": "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails", "longName": "9954491 - Disclosure - EARNINGS (LOSS) PER SHARE - Reconciliation of Basic Earnings per Share to Diluted Earnings per Share (Details)", "shortName": "EARNINGS (LOSS) PER SHARE - Reconciliation of Basic Earnings per Share to Diluted Earnings per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R44": { "role": "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails", "longName": "9954492 - Disclosure - EARNINGS (LOSS) PER SHARE - Antidilutive Securities Excluded from Computation (Details)", "shortName": "EARNINGS (LOSS) PER SHARE - Antidilutive Securities Excluded from Computation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-146", "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R45": { "role": "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails", "longName": "9954493 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-50", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R46": { "role": "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails", "longName": "9954494 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Components of Intangible Assets (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Components of Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails", "longName": "9954495 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.fortrea.com/role/DEBTNarrativeDetails", "longName": "9954496 - Disclosure - DEBT - Narrative (Details)", "shortName": "DEBT - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.fortrea.com/role/DEBTScheduleofDebtDetails", "longName": "9954497 - Disclosure - DEBT - Schedule of Debt (Details)", "shortName": "DEBT - Schedule of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DeferredFinanceCostsCurrentNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DeferredFinanceCostsCurrentNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails", "longName": "9954498 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING - Schedule of Derivative Instruments (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING - Schedule of Derivative Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-186", "name": "us-gaap:DerivativeAssetNotSubjectToMasterNettingArrangement", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-186", "name": "us-gaap:DerivativeAssetNotSubjectToMasterNettingArrangement", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "longName": "9954499 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING - Narrative (Details)", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-190", "name": "us-gaap:DerivativeNumberOfInstrumentsHeld", "unitRef": "derivative", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-190", "name": "us-gaap:DerivativeNumberOfInstrumentsHeld", "unitRef": "derivative", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYNarrativeDetails", "longName": "9954500 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS\u2019 EQUITY - Narrative (Details)", "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS\u2019 EQUITY - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails", "longName": "9954501 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS\u2019 EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)", "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS\u2019 EQUITY - Schedule of Accumulated Other Comprehensive Income (Loss) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-36", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R54": { "role": "http://www.fortrea.com/role/INCOMETAXESDetails", "longName": "9954502 - Disclosure - INCOME TAXES (Details)", "shortName": "INCOME TAXES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails", "longName": "9954503 - Disclosure - STOCK COMPENSATION PLANS - Narrative (Details)", "shortName": "STOCK COMPENSATION PLANS - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "ftre:ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ftre:ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails", "longName": "9954504 - Disclosure - STOCK COMPENSATION PLANS - Schedule of Stock Option Activity (Details)", "shortName": "STOCK COMPENSATION PLANS - Schedule of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-36", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-36", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails", "longName": "9954505 - Disclosure - STOCK COMPENSATION PLANS - Fair Value Estimates (Details)", "shortName": "STOCK COMPENSATION PLANS - Fair Value Estimates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-146", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-146", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails", "longName": "9954506 - Disclosure - STOCK COMPENSATION PLANS - Restricted Stock Units and Performance Shares (Details)", "shortName": "STOCK COMPENSATION PLANS - Restricted Stock Units and Performance Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-226", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-226", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails", "longName": "9954507 - Disclosure - STOCK COMPENSATION PLANS - Share-Based Compensation Expense (Details)", "shortName": "STOCK COMPENSATION PLANS - Share-Based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails", "longName": "9954508 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Allocation of General Corporate and Other Expenses (Details)", "shortName": "TRANSACTIONS WITH FORMER PARENT - Allocation of General Corporate and Other Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-239", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R61": { "role": "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails", "longName": "9954509 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Narrative (Details)", "shortName": "TRANSACTIONS WITH FORMER PARENT - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-255", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } }, "R62": { "role": "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails", "longName": "9954510 - Disclosure - TRANSACTIONS WITH FORMER PARENT - Net Transfers To and From Labcorp (Details)", "shortName": "TRANSACTIONS WITH FORMER PARENT - Net Transfers To and From Labcorp (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-8", "name": "ftre:NetTransfersFromToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "ftre:NetTransfersFromToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails", "longName": "9954511 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details)", "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails", "longName": "9954512 - Disclosure - BUSINESS SEGMENT INFORMATION - Narrative (Details)", "shortName": "BUSINESS SEGMENT INFORMATION - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": null }, "R65": { "role": "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails", "longName": "9954513 - Disclosure - BUSINESS SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details)", "shortName": "BUSINESS SEGMENT INFORMATION - Schedule of Segment Reporting Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-297", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ftre-20230930.htm", "unique": true } } }, "tag": { "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax benefits", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r419" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r196", "r197", "r198", "r229", "r492", "r544", "r553", "r560", "r561", "r562", "r563", "r564", "r565", "r568", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r581", "r582", "r583", "r584", "r585", "r587", "r589", "r590", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r612", "r687" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r557", "r559", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r581", "r582", "r583", "r584", "r599", "r600", "r601", "r602", "r605", "r606", "r607", "r608", "r627", "r629", "r633", "r634", "r684", "r686" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r159", "r290" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGING" ], "lang": { "en-us": { "role": { "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r135", "r451", "r458" ] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Supplemental Cash Flow Information", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r34", "r35", "r106", "r165", "r515", "r541", "r542" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r176", "r177", "r470", "r471", "r472", "r473", "r474", "r476" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r309", "r310", "r311", "r312", "r386", "r490", "r536", "r558", "r559", "r620", "r622", "r624", "r625", "r635", "r651", "r652", "r662", "r669", "r678", "r683", "r745", "r789", "r790", "r791", "r792", "r793", "r794" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETS" ], "lang": { "en-us": { "role": { "terseLabel": "GOODWILL AND INTANGIBLE ASSETS", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r121" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r43" ] }, "us-gaap_CapitalizedContractCostNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostNet", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total contract assets", "label": "Capitalized Contract Cost, Net", "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer." } } }, "auth_ref": [ "r274" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate swaps", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r653", "r691", "r692" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Options", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails", "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r724" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Stock compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r10" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer [Abstract]", "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.fortrea.com/role/REVENUES" ], "lang": { "en-us": { "role": { "terseLabel": "REVENUES", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r151", "r369", "r370", "r371", "r372", "r373", "r374", "r376", "r377", "r382" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r16", "r450" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Options Additional Disclosures", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental schedule of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes and other tax liabilities", "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r68" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r23", "r682" ] }, "us-gaap_DerivativeAssetNotSubjectToMasterNettingArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNotSubjectToMasterNettingArrangement", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset", "label": "Derivative Asset, Not Subject to Master Netting Arrangement", "documentation": "Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, not subject to a master netting arrangement." } } }, "auth_ref": [ "r19", "r657" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails", "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r724" ] }, "us-gaap_CapitalizedContractCostAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostAxis", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails", "http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized Contract Cost [Axis]", "label": "Capitalized Contract Cost [Axis]", "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer." } } }, "auth_ref": [ "r274" ] }, "us-gaap_CapitalizedContractCostTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostTable", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails", "http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized Contract Cost [Table]", "label": "Capitalized Contract Cost [Table]", "documentation": "Disclosure of information about cost capitalized in obtaining or fulfilling contract with customer." } } }, "auth_ref": [ "r274" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r41", "r157", "r655" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.fortrea.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r432" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r679" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails", "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails", "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r153", "r231", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r257", "r263", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r293", "r299", "r305", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r663", "r706", "r796" ] }, "us-gaap_CapitalizedContractCostDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostDomain", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails", "http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized Contract Cost [Domain]", "label": "Capitalized Contract Cost [Domain]", "documentation": "Cost capitalized in obtaining and fulfilling contract with customer." } } }, "auth_ref": [ "r274" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_CapitalizedContractCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostTableTextBlock", "presentation": [ "http://www.fortrea.com/role/REVENUESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Capitalized Contract Cost", "label": "Capitalized Contract Cost [Table Text Block]", "documentation": "Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer." } } }, "auth_ref": [ "r728" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost, recognition period", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r422" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as hedging instrument", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r16" ] }, "us-gaap_CapitalizedContractCostLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostLineItems", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails", "http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized Contract Cost [Line Items]", "label": "Capitalized Contract Cost [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r274" ] }, "us-gaap_CapitalizedContractCostAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostAmortization", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized assets, amortization", "label": "Capitalized Contract Cost, Amortization", "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer." } } }, "auth_ref": [ "r275" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r469" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails": { "parentTag": "ftre_AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/REVENUESRollforwardofAllowanceforCreditLossesDetails", "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: Allowance for credit losses", "periodStartLabel": "Allowance for credit losses as of December, 2022", "periodEndLabel": "Allowance for credit losses as of September 30, 2023", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r166", "r266", "r270" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r115" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Per share amount, basic (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r181", "r201", "r202", "r203", "r204", "r205", "r210", "r212", "r222", "r223", "r224", "r228", "r461", "r462", "r509", "r522", "r659" ] }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r41", "r115", "r188" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r235", "r236", "r247", "r252", "r253", "r259", "r261", "r263", "r378", "r379", "r492" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value per share (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r100" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable, aggregate intrinsic value (in dollar per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r65" ] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r27", "r156", "r191", "r267", "r313", "r314", "r316", "r317", "r318", "r320", "r322", "r324", "r325", "r446", "r448", "r449", "r463", "r682", "r743", "r787", "r788" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSecuredDebt", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from term loans", "label": "Proceeds from Issuance of Secured Debt", "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt." } } }, "auth_ref": [ "r38" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONSParenthetical", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party, Type [Domain]", "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r385", "r484", "r485", "r561", "r562", "r563", "r564", "r565", "r585", "r587", "r619" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r388", "r390", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by (used for) operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r292", "r298", "r595" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHARETables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r43" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r298", "r595" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r99", "r568" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount issued", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r88", "r90", "r327", "r478", "r665", "r666" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r99", "r568", "r586", "r801", "r802" ] }, "us-gaap_AdjustmentForAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentForAmortization", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization", "label": "Amortization", "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives." } } }, "auth_ref": [ "r11", "r58" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Other, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r112" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r698" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r263", "r672", "r748", "r796", "r797" ] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LetterOfCreditMember", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of credit", "label": "Letter of Credit [Member]", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value per share (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r99", "r354" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill acquired during the period", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r279", "r663" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r11", "r54", "r58" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r698" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r102", "r129", "r516", "r540", "r542", "r547", "r569", "r682" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate and other allocations", "verboseLabel": "Direct costs", "label": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r92", "r484" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stated interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r28", "r328" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r309", "r310", "r311", "r312", "r386", "r490", "r536", "r558", "r559", "r620", "r622", "r624", "r625", "r635", "r651", "r652", "r662", "r669", "r678", "r683", "r745", "r789", "r790", "r791", "r792", "r793", "r794" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 }, "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 }, "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income (loss)", "terseLabel": "Net income (loss)", "verboseLabel": "Net earnings (loss)", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r108", "r117", "r142", "r154", "r171", "r174", "r178", "r191", "r199", "r201", "r202", "r203", "r204", "r207", "r208", "r220", "r234", "r248", "r254", "r257", "r267", "r313", "r314", "r316", "r317", "r318", "r320", "r322", "r324", "r325", "r462", "r463", "r520", "r588", "r610", "r611", "r661", "r694", "r743" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r101", "r682", "r799" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r309", "r310", "r311", "r312", "r383", "r386", "r415", "r416", "r417", "r489", "r490", "r536", "r558", "r559", "r620", "r622", "r624", "r625", "r635", "r651", "r652", "r662", "r669", "r678", "r683", "r686", "r740", "r745", "r790", "r791", "r792", "r793", "r794" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r698" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENT" ], "lang": { "en-us": { "role": { "terseLabel": "TRANSACTIONS WITH FORMER PARENT", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r481", "r482", "r483", "r485", "r488", "r549", "r550", "r551", "r593", "r594", "r595", "r616", "r618" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r309", "r310", "r311", "r312", "r383", "r386", "r415", "r416", "r417", "r489", "r490", "r536", "r558", "r559", "r620", "r622", "r624", "r625", "r635", "r651", "r652", "r662", "r669", "r678", "r683", "r686", "r740", "r745", "r790", "r791", "r792", "r793", "r794" ] }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationPercentage", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining performance obligation, percentage", "label": "Revenue, Remaining Performance Obligation, Percentage", "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue." } } }, "auth_ref": [ "r703" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/INCOMETAXES" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r192", "r428", "r433", "r434", "r435", "r438", "r442", "r443", "r444", "r548" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total stock compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r419", "r427" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Capital expenditures", "label": "Payments to Acquire Productive Assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r144", "r777", "r778", "r779" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r91", "r92", "r591", "r592", "r595" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r25", "r191", "r267", "r313", "r314", "r316", "r317", "r318", "r320", "r322", "r324", "r325", "r446", "r448", "r449", "r463", "r566", "r660", "r696", "r743", "r787", "r788" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Line Items]", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r591", "r592", "r595" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Domain]", "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r30" ] }, "us-gaap_DerivativeNumberOfInstrumentsHeld": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNumberOfInstrumentsHeld", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of derivative instruments", "label": "Derivative, Number of Instruments Held", "documentation": "The number of derivative instruments of a particular group held by the entity." } } }, "auth_ref": [ "r75", "r76", "r558", "r627", "r628", "r630", "r686" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency forward contracts", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r574", "r578", "r583", "r601", "r607", "r631", "r632", "r633", "r686" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails", "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails", "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r231", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r257", "r263", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r299", "r305", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r663", "r706", "r796" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r780", "r781" ] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Technology", "label": "Technology-Based Intangible Assets [Member]", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r21" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Axis]", "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r484", "r485", "r786" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Secured debt", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r29", "r195", "r327", "r328", "r329", "r330", "r331", "r333", "r338", "r339", "r340", "r341", "r343", "r344", "r345", "r346", "r347", "r348", "r478", "r664", "r665", "r666", "r667", "r668", "r716" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r105", "r140", "r517", "r682", "r717", "r726", "r783" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r247", "r248", "r249", "r250", "r251", "r257" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r45", "r47", "r85", "r86", "r263", "r640" ] }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective interest rate", "label": "Line of Credit Facility, Interest Rate at Period End", "documentation": "The effective interest rate at the end of the reporting period." } } }, "auth_ref": [ "r24" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r24" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r45", "r47", "r85", "r86", "r263", "r543", "r640" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance obligation partially satisfied in previous period, revenue recognized", "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period", "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price." } } }, "auth_ref": [ "r375" ] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, fixed interest rate", "label": "Derivative, Fixed Interest Rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_BridgeLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BridgeLoanMember", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Swingline sub-facility", "label": "Bridge Loan [Member]", "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee stock options and awards", "terseLabel": "Stock Options", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r195", "r327", "r328", "r329", "r330", "r331", "r333", "r338", "r339", "r340", "r341", "r343", "r344", "r345", "r346", "r347", "r348", "r351", "r478", "r664", "r665", "r666", "r667", "r668", "r716" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r22", "r97", "r98", "r138", "r139", "r195", "r327", "r328", "r329", "r330", "r331", "r333", "r338", "r339", "r340", "r341", "r343", "r344", "r345", "r346", "r347", "r348", "r478", "r664", "r665", "r666", "r667", "r668", "r716" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.fortrea.com/role/REVENUESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Revenue by Segment and Geography", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r748" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r29", "r63", "r64", "r87", "r88", "r90", "r94", "r127", "r128", "r195", "r327", "r328", "r329", "r330", "r331", "r333", "r338", "r339", "r340", "r341", "r343", "r344", "r345", "r346", "r347", "r348", "r351", "r478", "r664", "r665", "r666", "r667", "r668", "r716" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONSParenthetical", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related party", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r193", "r194", "r484", "r485", "r486", "r487", "r561", "r562", "r563", "r564", "r565", "r585", "r587", "r619" ] }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "presentation": [ "http://www.fortrea.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unrecognized tax benefits, decrease", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns." } } }, "auth_ref": [ "r776" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "ftre_DirectCostsRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "DirectCostsRelatedPartyMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Direct costs", "label": "Direct Costs, Related Party [Member]", "documentation": "Direct Costs, Related Party" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt issuance costs", "label": "Payments of Debt Issuance Costs", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r40" ] }, "us-gaap_IntersegmentEliminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntersegmentEliminationMember", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intersegment eliminations", "label": "Intersegment Eliminations [Member]", "documentation": "Eliminating entries used in operating segment consolidation." } } }, "auth_ref": [ "r236", "r247", "r248", "r249", "r250", "r251", "r253", "r257" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r126", "r190", "r353", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r459", "r615", "r617", "r638" ] }, "ftre_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedInPeriod", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Converted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted in Period", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted in Period" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditMember", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "ftre_InterestAndIncomeTaxesPaidAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "InterestAndIncomeTaxesPaidAbstract", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid during period for:", "label": "Interest And Income Taxes Paid [Abstract]", "documentation": "Interest And Income Taxes Paid" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Per share amount, diluted (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r181", "r201", "r202", "r203", "r204", "r205", "r212", "r222", "r223", "r224", "r228", "r461", "r462", "r509", "r522", "r659" ] }, "ftre_SpecialPaymentToFormerParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "SpecialPaymentToFormerParent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Special payment to Former Parent", "label": "Special Payment To Former Parent", "documentation": "Special Payment To Former Parent" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermLinesOfCredit", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments on revolving credit facilities", "label": "Repayments of Long-Term Lines of Credit", "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r39" ] }, "ftre_EnablingServicesSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "EnablingServicesSegmentMember", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails", "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails", "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Enabling Services", "label": "Enabling Services Segment [Member]", "documentation": "Enabling Services Segment" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r379", "r670", "r671", "r672", "r673", "r674", "r675", "r676" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable and unbilled services", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r640" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETSParenthetical", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/EARNINGSLOSSPERSHARENarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, outstanding (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r15", "r100", "r568", "r586", "r801", "r802" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r379", "r670", "r671", "r672", "r673", "r674", "r675", "r676" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r400" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Principal payments of long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r39", "r546" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r49", "r50", "r51", "r52" ] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGES" ], "lang": { "en-us": { "role": { "terseLabel": "RESTRUCTURING AND OTHER CHARGES", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r294", "r295", "r297", "r300", "r306" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Total costs and expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r109" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r49", "r50", "r51", "r52" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes, net of refunds", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r42" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, 88.8 and 0.0 shares outstanding at September 30, 2023 and December 31, 2022, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r100", "r514", "r682" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Restructuring and Other Charges", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r59", "r60", "r61" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not designated as hedging instrument", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r16" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r29", "r62" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/REVENUESRollforwardofAllowanceforCreditLossesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Write-offs", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r273" ] }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowSupplementalDisclosuresTextBlock", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "SUPPLEMENTAL CASH FLOW INFORMATION", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r113" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Party Transactions", "label": "Schedule of Related Party Transactions [Table Text Block]", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Costs and expenses:", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of assets", "label": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r114" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings (loss) including impact of dilutive adjustments", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r183", "r211", "r216", "r217", "r218", "r219", "r221", "r224" ] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r297", "r302" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding, weighted average remaining contractual term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r130" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r684", "r685", "r686", "r688", "r689", "r690", "r693", "r720", "r721", "r782", "r798", "r801" ] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining performance obligation", "label": "Revenue, Remaining Performance Obligation, Amount", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r147" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable, weighted average remaining contractual term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r65" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format." } } }, "auth_ref": [ "r148" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "verboseLabel": "Current quarter foreign exchange adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent", "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r9", "r13", "r134" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average expected life (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r414" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r296", "r297", "r298", "r299", "r303", "r304", "r305" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Stock compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r69", "r70", "r389" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cancelled (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r409" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss before tax", "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent", "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r9", "r13", "r134" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r89", "r143", "r179", "r238", "r477", "r596", "r694", "r800" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of non-cash investing activities:", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r663" ] }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Direct costs, exclusive of depreciation and amortization (including costs incurred from related parties of $0.0, $21.6, $48.8 and $65.7 during the three and nine months ended September 30, 2023 and 2022, respectively)", "verboseLabel": "Costs incurred from related parties", "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization", "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization." } } }, "auth_ref": [ "r707", "r708" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.fortrea.com/role/DEBTTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r29", "r63", "r64", "r87", "r88", "r90", "r94", "r127", "r128", "r665", "r667", "r719" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses, exclusive of depreciation and amortization", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r111" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775" ] }, "us-gaap_RestructuringSettlementAndImpairmentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringSettlementAndImpairmentProvisions", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and other charges", "label": "Restructuring, Settlement and Impairment Provisions", "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss." } } }, "auth_ref": [ "r110" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r53", "r56" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized Gain (Loss) on Derivative Instruments", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r169", "r177", "r178", "r447", "r658", "r710" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain on derivative instruments", "verboseLabel": "Unrealized gain on derivative instrument", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent", "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r168" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r29" ] }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfCountriesInWhichEntityOperates", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of countries in which entity operates (more than)", "label": "Number of Countries in which Entity Operates", "documentation": "The number of countries in which the entity operates as of balance sheet date." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfOtherReceivables", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of receivables", "label": "Proceeds from Sale of Other Receivables", "documentation": "Amount of cash inflow from the sale of receivables classified as other." } } }, "auth_ref": [ "r37" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-Based Compensation Expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r68" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r10" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss, net of tax", "terseLabel": "Other comprehensive income, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r9", "r13", "r134", "r172", "r175" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Carrying Amount", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r122", "r493" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of employee awards (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r213", "r214", "r215", "r224", "r391" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in unearned revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r491", "r714" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Instruments", "label": "Schedule of Derivative Instruments [Table Text Block]", "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r16", "r73", "r74", "r76", "r77", "r79", "r81", "r83", "r84" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in accrued expenses and other", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r10" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r122", "r494" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONSParenthetical", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party, Type [Axis]", "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r385", "r484", "r485", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r561", "r562", "r563", "r564", "r565", "r585", "r587", "r619", "r786" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775" ] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotesMember", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior notes", "label": "Senior Notes [Member]", "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerAssetGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetGrossCurrent", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails": { "parentTag": "ftre_AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross unbilled services", "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current." } } }, "auth_ref": [ "r746", "r747" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHARE" ], "lang": { "en-us": { "role": { "terseLabel": "EARNINGS (LOSS) PER SHARE", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r209", "r225", "r226", "r227" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHARETables" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of Basic Earnings per Share to Diluted Earnings per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r723" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in Carrying Amount of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r663", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANS" ], "lang": { "en-us": { "role": { "terseLabel": "STOCK COMPENSATION PLANS", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r387", "r392", "r420", "r421", "r423", "r679" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned revenue, revenue recognized", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r381" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r263", "r672", "r748", "r796", "r797" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used for financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r185" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill, net", "periodStartLabel": "Balance as of December 31", "periodEndLabel": "Balance as of September 30", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r158", "r276", "r507", "r663", "r682", "r730", "r737" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used for investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r185" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r115", "r116", "r117" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r137", "r161", "r191", "r234", "r249", "r255", "r267", "r313", "r314", "r316", "r317", "r318", "r320", "r322", "r324", "r325", "r445", "r448", "r463", "r512", "r580", "r682", "r696", "r743", "r744", "r787" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r16" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails", "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Expense", "negatedTerseLabel": "Restructuring and other", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r11", "r301", "r303", "r741" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "terseLabel": "Segment operating income:", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r234", "r248", "r254", "r257", "r661" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r424", "r425", "r426", "r552", "r720", "r721", "r722", "r782", "r801" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r680" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r15", "r152", "r176", "r177", "r178", "r196", "r197", "r198", "r200", "r206", "r208", "r229", "r268", "r269", "r366", "r424", "r425", "r426", "r436", "r437", "r452", "r453", "r454", "r455", "r456", "r457", "r460", "r470", "r471", "r472", "r473", "r474", "r476", "r480", "r537", "r538", "r539", "r552", "r612" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for (benefit from) income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r145", "r150", "r207", "r208", "r242", "r431", "r439", "r524" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income (loss)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r36", "r173", "r175", "r180", "r508", "r521" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r640" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Transfer from Former Parent", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax", "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan." } } }, "auth_ref": [ "r8", "r106", "r170", "r384" ] }, "ftre_SeniorSecuredTermLoanAFacilityDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "SeniorSecuredTermLoanAFacilityDue2028Member", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior secured term loan A due 2028", "label": "Senior Secured Term Loan A Facility, Due 2028 [Member]", "documentation": "Senior Secured Term Loan A Facility, Due 2028" } } }, "auth_ref": [] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r195", "r236", "r247", "r248", "r249", "r250", "r251", "r253", "r257", "r313", "r314", "r315", "r316", "r318", "r319", "r321", "r323", "r324", "r743", "r744" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange gain (loss)", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r464", "r465", "r466", "r468", "r609" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r45", "r47", "r85", "r86", "r263", "r640", "r705" ] }, "ftre_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, thereafter", "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four", "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r44", "r45", "r47", "r48", "r85", "r136", "r640" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r195", "r236", "r247", "r248", "r249", "r250", "r251", "r253", "r257", "r313", "r314", "r315", "r316", "r318", "r319", "r321", "r323", "r324", "r743", "r744" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r750" ] }, "ftre_NumberOfCountriesWithPrimaryOfficeLocations": { "xbrltype": "integerItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "NumberOfCountriesWithPrimaryOfficeLocations", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of countries with primary office locations", "label": "Number Of Countries With Primary Office Locations", "documentation": "Number Of Countries With Primary Office Locations" } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Axis]", "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r55", "r57", "r493" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r479" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r35", "r784", "r785" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Components of Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r55", "r57" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityCommitmentFeePercentage", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment fee", "label": "Line of Credit Facility, Commitment Fee Percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r15", "r32", "r152", "r176", "r177", "r178", "r196", "r197", "r198", "r200", "r206", "r208", "r229", "r268", "r269", "r366", "r424", "r425", "r426", "r436", "r437", "r452", "r453", "r454", "r455", "r456", "r457", "r460", "r470", "r471", "r472", "r473", "r474", "r476", "r480", "r537", "r538", "r539", "r552", "r612" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r152", "r196", "r197", "r198", "r200", "r206", "r208", "r268", "r269", "r424", "r425", "r426", "r436", "r437", "r452", "r454", "r455", "r457", "r460", "r537", "r539", "r552", "r801" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Benefit Plan Adjustments", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r5", "r14", "r35", "r710", "r711", "r712" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation Adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r4", "r14", "r35", "r177", "r178", "r471", "r472", "r473", "r474", "r476", "r710" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r479" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATION" ], "lang": { "en-us": { "role": { "terseLabel": "BASIS OF FINANCIAL STATEMENT PREPARATION", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements." } } }, "auth_ref": [ "r96", "r118", "r119", "r133" ] }, "ftre_OtherGeographicalAreasMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "OtherGeographicalAreasMember", "presentation": [ "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Geographical Areas [Member]", "documentation": "Other Geographical Areas" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "totalLabel": "Net income (loss) before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r107", "r141", "r234", "r248", "r254", "r257", "r510", "r519", "r661" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate, non-segment", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r20", "r248", "r249", "r250", "r251", "r257", "r725" ] }, "ftre_ParentCompanyInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "ParentCompanyInvestmentMember", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Former Parent Investment", "label": "Parent Company Investment [Member]", "documentation": "Parent Company Investment" } } }, "auth_ref": [] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Direct costs", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r429", "r430" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r709" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration of Credit Risk", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r95", "r146" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Domain]", "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r750", "r751", "r752", "r753", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r2", "r14", "r35", "r453", "r456", "r480", "r537", "r538", "r710", "r711", "r712", "r720", "r721", "r722" ] }, "ftre_AccountsReceivablePurchaseProgramMaximumFacilityAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "AccountsReceivablePurchaseProgramMaximumFacilityAmount", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ARPP, maximum facility amount", "label": "Accounts Receivable Purchase Program, Maximum Facility Amount", "documentation": "Accounts Receivable Purchase Program, Maximum Facility Amount" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityNotSubjectToMasterNettingArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNotSubjectToMasterNettingArrangement", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Liability", "label": "Derivative Liability, Not Subject to Master Netting Arrangement", "documentation": "Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, not subject to a master netting arrangement." } } }, "auth_ref": [ "r19", "r657" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cancelled (in share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r409" ] }, "ftre_RestructuringAndOtherChargesRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "RestructuringAndOtherChargesRelatedPartyMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and other charges", "label": "Restructuring And Other Charges, Related Party [Member]", "documentation": "Restructuring And Other Charges, Related Party" } } }, "auth_ref": [] }, "ftre_SalesCommissionAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "SalesCommissionAssetsMember", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails", "http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales commission assets", "label": "Sales Commission Assets [Member]", "documentation": "Sales Commission Assets" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r417" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "ftre_SellingGeneralAndAdministrativeExpensesRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "SellingGeneralAndAdministrativeExpensesRelatedPartyMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, General And Administrative Expenses, Related Party [Member]", "documentation": "Selling, General And Administrative Expenses, Related Party" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "presentation": [ "http://www.fortrea.com/role/REVENUESRollforwardofAllowanceforCreditLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r407" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "ftre_DisclosureOfNonCashTransfersToFromParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "DisclosureOfNonCashTransfersToFromParentAbstract", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of non-cash transfers to (from) Parent:", "label": "Disclosure Of Non-Cash Transfers To (From) Parent: [Abstract]", "documentation": "Disclosure Of Non-Cash Transfers To (From) Parent:" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r407" ] }, "ftre_TransferToFromParentChangeInPropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "TransferToFromParentChangeInPropertyPlantAndEquipmentNet", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in property, plant and equipment, net", "label": "Transfer To (From) Parent, Change In Property, Plant And Equipment, Net", "documentation": "Transfer To (From) Parent, Change In Property, Plant And Equipment, Net" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Non-vested, beginning balance (in shares)", "periodEndLabel": "Non-vested, ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r404", "r405" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "ftre_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "OneCustomerMember", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One customer", "label": "One Customer [Member]", "documentation": "One Customer" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Other Charges [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r296", "r297", "r298", "r299", "r303", "r304", "r305" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Non-vested, beginning balance (in dollars per share)", "periodEndLabel": "Non-vested, ending balance (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r404", "r405" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve, by Type of Restructuring [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r296", "r297", "r303", "r304" ] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowElementsAbstract", "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r422" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r408" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r184", "r186", "r187" ] }, "ftre_LongTermDebtGrossCurrentMaturities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "LongTermDebtGrossCurrentMaturities", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/DEBTScheduleofDebtDetails": { "parentTag": "us-gaap_LongTermDebtCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of debt, gross", "label": "Long-Term Debt, Gross, Current Maturities", "documentation": "Long-Term Debt, Gross, Current Maturities" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShortTermBorrowingsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowingsAbstract", "presentation": [ "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current Portion of Long-Term Debt", "label": "Short-Term Debt [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r408" ] }, "ftre_SpecialPaymentToFormerParentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "SpecialPaymentToFormerParentMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Special Payment to Former Parent", "label": "Special Payment To Former Parent [Member]", "documentation": "Special Payment To Former Parent" } } }, "auth_ref": [] }, "ftre_CorporateAllocationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "CorporateAllocationsMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate allocations", "label": "Corporate Allocations [Member]", "documentation": "Corporate Allocations" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r45", "r47", "r85", "r86", "r263", "r640" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r176", "r177", "r470", "r471", "r472", "r473", "r474", "r476" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Financial Statement Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r17", "r18", "r66" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 }, "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r11", "r239" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value Estimates", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r131" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/INCOMETAXESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in unrecognized tax benefits, reasonably possible", "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible", "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit." } } }, "auth_ref": [ "r71" ] }, "ftre_LineOfCreditFacilityAnnualAgencyFee": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "LineOfCreditFacilityAnnualAgencyFee", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual agency fee", "label": "Line of Credit Facility, Annual Agency Fee", "documentation": "Line of Credit Facility, Agency Fee" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedShareActivityTableTextBlock", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Stock Units and Performance Shares", "label": "Schedule of Nonvested Share Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested shares." } } }, "auth_ref": [ "r67" ] }, "ftre_SubcontractServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "SubcontractServicesMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subcontract services", "label": "Subcontract Services [Member]", "documentation": "Subcontract Services" } } }, "auth_ref": [] }, "ftre_NoncashInvestingAndFinancingActivitiesChangeInAccruedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "NoncashInvestingAndFinancingActivitiesChangeInAccruedPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in accrued property, plant and equipment", "label": "Noncash Investing and Financing Activities, Change In Accrued Property, Plant And Equipment", "documentation": "Noncash Investing and Financing Activities, Change In Accrued Property, Plant And Equipment" } } }, "auth_ref": [] }, "ftre_ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cliff vesting period", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Cliff Vesting Period", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Cliff Vesting Period" } } }, "auth_ref": [] }, "ftre_ForeignExchangeGainLossRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "ForeignExchangeGainLossRelatedPartyMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTAllocationofGeneralCorporateandOtherExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange gain (loss)", "label": "Foreign Exchange Gain (Loss), Related Party [Member]", "documentation": "Foreign Exchange Gain (Loss), Related Party" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares authorized for future issuance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r681" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign currency impact", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r283" ] }, "ftre_SeniorSecuredRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "SeniorSecuredRevolvingCreditFacilityMember", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior secured revolving credit facility", "label": "Senior Secured Revolving Credit Facility [Member]", "documentation": "Senior Secured Revolving Credit Facility" } } }, "auth_ref": [] }, "ftre_ProceedsFromPaymentsToFormerParentCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "ProceedsFromPaymentsToFormerParentCompany", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Net transfers to Former Parent", "label": "Proceeds From (Payments To) Former Parent Company", "documentation": "Proceeds From (Payments To) Former Parent Company" } } }, "auth_ref": [] }, "ftre_FortreasOmnibusIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "FortreasOmnibusIncentivePlanMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fortrea\u2019s Omnibus Incentive Plan", "label": "Fortrea\u2019s Omnibus Incentive Plan [Member]", "documentation": "Fortrea\u2019s Omnibus Incentive Plan" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cancelled (in share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r403" ] }, "ftre_FacilityCostMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "FacilityCostMember", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Facility Costs", "label": "Facility Cost [Member]", "documentation": "Facility Cost" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails", "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding shares, diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r211", "r224" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r155", "r167", "r191", "r267", "r313", "r314", "r316", "r317", "r318", "r320", "r322", "r324", "r325", "r445", "r448", "r463", "r682", "r743", "r744", "r787" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unearned revenue", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r367", "r368", "r380" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollar per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r400" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average grant date fair value per option (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r410" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://www.fortrea.com/role/REVENUESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accounts Receivable, Unbilled Services and Unearned Revenue", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r33" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "ftre_IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Increase in accounts receivable and unbilled services, net", "label": "Increase (Decrease) In Accounts Receivable And Contract With Customer, Asset", "documentation": "Increase (Decrease) In Accounts Receivable And Contract With Customer, Asset" } } }, "auth_ref": [] }, "ftre_SeniorSecuredTermLoanBFacilityDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "SeniorSecuredTermLoanBFacilityDue2028Member", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior secured term loan B due 2030", "label": "Senior Secured Term Loan B Facility, Due 2028 [Member]", "documentation": "Senior Secured Term Loan B Facility, Due 2028" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in dollar per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r401" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREReconciliationofBasicEarningsperSharetoDilutedEarningsperShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding shares, basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r210", "r224" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding, aggregate intrinsic value (in dollar per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r65" ] }, "ftre_DeferredContractCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "DeferredContractCostsMember", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails", "http://www.fortrea.com/role/REVENUESSummaryofCapitalizedContractCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred contract costs", "label": "Deferred Contract Costs [Member]", "documentation": "Deferred Contract Costs" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cancelled (in dollar per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired." } } }, "auth_ref": [ "r403" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding, beginning (in shares)", "periodEndLabel": "Outstanding, ending (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r396", "r397" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Options, beginning (in dollar per share)", "periodEndLabel": "Options, ending (in dollar per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r396", "r397" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year one", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Exercise Price per Option", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r398" ] }, "ftre_ClinicalServicesSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "ClinicalServicesSegmentMember", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails", "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails", "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Clinical Services", "label": "Clinical Services Segment [Member]", "documentation": "Clinical Services Segment" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in dollar per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r398" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r196", "r197", "r198", "r229", "r492", "r544", "r553", "r560", "r561", "r562", "r563", "r564", "r565", "r568", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r581", "r582", "r583", "r584", "r585", "r587", "r589", "r590", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r612", "r687" ] }, "ftre_StockCompensationExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "StockCompensationExpenseMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock compensation expense", "label": "Stock Compensation Expense [Member]", "documentation": "Stock Compensation Expense" } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r700" ] }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheThreeMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year three", "label": "Share-Based Payment Arrangement, Tranche Three [Member]", "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.fortrea.com/role/DEBTScheduleofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt", "totalLabel": "Total short-term borrowings and current portion of long-term debt", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r162" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r416" ] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letters of credit outstanding", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "ftre_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsConvertedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Converted (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted in Period, Weighted Average Grant Date Fair Value", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Converted in Period, Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Shares", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "ftre_GeneralFinancingActivitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "GeneralFinancingActivitiesMember", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNarrativeDetails", "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General financing activities", "label": "General Financing Activities [Member]", "documentation": "General Financing Activities" } } }, "auth_ref": [] }, "ftre_NetTransfersFromToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "NetTransfersFromToParent", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/TRANSACTIONSWITHFORMERPARENTNetTransfersToandFromLabcorpDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total net transfers (to) from Former Parent", "label": "Net Transfers From (To) Parent", "documentation": "Net Transfers From (To) Parent" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate", "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement." } } }, "auth_ref": [ "r415" ] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails": { "parentTag": "ftre_AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r164", "r264", "r265", "r656" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSShareBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r388", "r390", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY", "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r100", "r103", "r104", "r120", "r570", "r586", "r613", "r614", "r682", "r696", "r717", "r726", "r783", "r801" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r701" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r78", "r80", "r81", "r82", "r557", "r559", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r581", "r582", "r583", "r584", "r599", "r600", "r601", "r602", "r605", "r606", "r607", "r608", "r627", "r629", "r633", "r634", "r657", "r684", "r686" ] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year two", "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSFairValueEstimatesDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails", "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSRestrictedStockUnitsandPerformanceSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit, outstanding balance", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r22", "r139", "r795" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/COMMITMENTSANDCONTINGENTLIABILITIES" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r124", "r307", "r308", "r641", "r742" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingent liabilities (Note 8)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r31", "r93", "r513", "r567" ] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r15", "r99", "r100", "r129", "r552", "r612", "r637", "r695" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r12", "r511", "r518", "r682" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r697" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNoncurrentNet", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/DEBTScheduleofDebtDetails": { "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt issuance discount and fees", "label": "Debt Issuance Costs, Noncurrent, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r89" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk, percentage", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r45", "r47", "r85", "r86", "r263" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/REVENUESRollforwardofAllowanceforCreditLossesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit loss expense", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r182", "r272" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of common stock (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r15", "r99", "r100", "r129", "r545", "r612", "r637" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash payments", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r297", "r713" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining performance obligation, period", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r148" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r699" ] }, "us-gaap_DeferredFinanceCostsCurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsCurrentNet", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/DEBTScheduleofDebtDetails": { "parentTag": "us-gaap_LongTermDebtCurrent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt issuance discount and fees", "label": "Debt Issuance Costs, Current, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r89" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r15", "r99", "r100", "r129", "r401" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer concentration risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r46", "r263" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets, net", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r160" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r296", "r297", "r303", "r304" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.fortrea.com/role/RESTRUCTURINGANDOTHERCHARGESDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Severance and Other Employee Costs", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableSale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableSale", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/REVENUESNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable sold", "label": "Accounts Receivable, Sale", "documentation": "Amount of decrease from sale of accounts receivable." } } }, "auth_ref": [ "r271" ] }, "us-gaap_OtherCostAndExpenseOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCostAndExpenseOperating", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATIONScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Corporate costs not allocated to segments", "label": "Other Cost and Expense, Operating", "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation." } } }, "auth_ref": [ "r110", "r523" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/BUSINESSSEGMENTINFORMATION" ], "lang": { "en-us": { "role": { "terseLabel": "BUSINESS SEGMENT INFORMATION", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r230", "r231", "r232", "r233", "r234", "r246", "r251", "r255", "r256", "r257", "r258", "r259", "r260", "r263" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r100", "r568" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Increase in prepaid expenses and other", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r10" ] }, "ftre_FortreasEmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "FortreasEmployeeStockPurchasePlanMember", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Purchase Plan", "label": "Fortrea's Employee Stock Purchase Plan [Member]", "documentation": "Fortrea's Employee Stock Purchase Plan" } } }, "auth_ref": [] }, "dei_EntityNumberOfEmployees": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityNumberOfEmployees", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of employees (more than)", "label": "Entity Number of Employees", "documentation": "Number of persons employed by the Entity" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r493" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other, net", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r117" ] }, "ftre_NetTransfersFromToParentExcludingSpecialPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "NetTransfersFromToParentExcludingSpecialPayment", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Net transfers (to) from Former Parent", "label": "Net Transfers From (To) Parent, Excluding Special Payment.", "documentation": "Net Transfers From (To) Parent, Excluding Special Payment." } } }, "auth_ref": [] }, "ftre_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedUponConversion", "presentation": [ "http://www.fortrea.com/role/STOCKCOMPENSATIONPLANSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares converted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued Upon Conversion", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued Upon Conversion" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ftre_LongTermDebtGrossExcludingCurrentMaturities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "LongTermDebtGrossExcludingCurrentMaturities", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/DEBTScheduleofDebtDetails": { "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt, gross", "label": "Long-Term Debt, Gross, Excluding Current Maturities", "documentation": "Long-Term Debt, Gross, Excluding Current Maturities" } } }, "auth_ref": [] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "Europe [Member]" } } }, "auth_ref": [ "r803", "r804", "r805", "r806" ] }, "ftre_A75SeniorNotesDue2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "A75SeniorNotesDue2030Member", "presentation": [ "http://www.fortrea.com/role/DEBTNarrativeDetails", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "7.5% senior notes due 2030", "label": "7.5% Senior Notes, Due 2030 [Member]", "documentation": "7.5% Senior Notes, Due 2030" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r288", "r289", "r290", "r291", "r493", "r494" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.fortrea.com/role/DEBT" ], "lang": { "en-us": { "role": { "terseLabel": "DEBT", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r125", "r189", "r326", "r332", "r333", "r334", "r335", "r336", "r337", "r342", "r349", "r350", "r352" ] }, "srt_NorthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NorthAmericaMember", "presentation": [ "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "North America", "label": "North America [Member]" } } }, "auth_ref": [ "r803", "r804", "r805", "r806" ] }, "ftre_AdjustmentsToAdditionalPaidInCapitalFormerParentInvestmentReclassification": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "AdjustmentsToAdditionalPaidInCapitalFormerParentInvestmentReclassification", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification of Former Parent investment to additional paid-in capital", "label": "Adjustments To Additional Paid In Capital, Former Parent Investment Reclassification", "documentation": "Adjustments To Additional Paid In Capital, Former Parent Investment Reclassification" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r55", "r57" ] }, "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS", "http://www.fortrea.com/role/DEBTNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of senior notes", "label": "Proceeds from Issuance of Senior Long-Term Debt", "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer)." } } }, "auth_ref": [ "r38" ] }, "ftre_NetTransfersToParentSpecialPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "NetTransfersToParentSpecialPayment", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCHANGESINEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Special payment to Former Parent", "label": "Net Transfers To Parent, Special Payment", "documentation": "Net Transfers To Parent, Special Payment" } } }, "auth_ref": [] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ftre_AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "AccountsReceivableAndContractWithCustomerAssetAfterAllowanceForCreditLossCurrent", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.fortrea.com/role/REVENUESScheduleofAccountsReceivableUnbilledServicesandUnearnedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable and unbilled services, net", "totalLabel": "Total", "label": "Accounts Receivable And Contract With Customer, Asset, After Allowance for Credit Loss, Current", "documentation": "Accounts Receivable And Contract With Customer, Asset, After Allowance for Credit Loss, Current" } } }, "auth_ref": [] }, "ftre_OnePharmaceuticalCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "OnePharmaceuticalCompanyMember", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One pharmaceutical company", "label": "One Pharmaceutical Company [Member]", "documentation": "One Pharmaceutical Company" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 }, "http://www.fortrea.com/role/DEBTScheduleofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS", "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, less current portion", "totalLabel": "Total long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r163" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r702" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r11", "r132", "r149", "r440", "r441", "r718" ] }, "ftre_TransferToFromParentChangeInRightOfUseLeaseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "TransferToFromParentChangeInRightOfUseLeaseAsset", "crdr": "credit", "presentation": [ "http://www.fortrea.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in right-of-use lease assets", "label": "Transfer To (From) Parent, Change In Right-Of-Use Lease Asset", "documentation": "Transfer To (From) Parent, Change In Right-Of-Use Lease Asset" } } }, "auth_ref": [] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r261", "r262", "r554", "r555", "r556", "r621", "r623", "r626", "r636", "r639", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r654", "r671", "r686", "r748", "r796" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsAbstract", "presentation": [ "http://www.fortrea.com/role/DEBTScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt", "label": "Long-Term Debt and Lease Obligation [Abstract]" } } }, "auth_ref": [] }, "ftre_NetParentInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.fortrea.com/20230930", "localname": "NetParentInvestment", "crdr": "credit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Former parent investment", "label": "Net Parent Investment", "documentation": "Net Parent Investment" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://www.fortrea.com/role/REVENUESTables" ], "lang": { "en-us": { "role": { "terseLabel": "Rollforward of Allowance for Credit Losses", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r727" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net benefit plan adjustments", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax", "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r6", "r106", "r677", "r749" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, 2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r123" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, 2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r123" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, 2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r123" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r698" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense):", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, 2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r123" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated amortization expense, remainder of year", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "presentation": [ "http://www.fortrea.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveIncomeLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax effect of adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r3", "r7", "r467", "r475" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use asset expense", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r715" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r698" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.fortrea.com/role/BASISOFFINANCIALSTATEMENTPREPARATIONDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r263", "r704" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSComponentsofIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r72" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Provision (benefit) for income tax related to items of comprehensive income", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r9", "r13", "r134" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r698" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.fortrea.com/role/REVENUESSummaryofRevenuebySegmentandGeographyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r261", "r262", "r554", "r555", "r556", "r621", "r623", "r626", "r636", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r654", "r671", "r686", "r748", "r796" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.fortrea.com/role/COVER" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r698" ] }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLongTermLinesOfCredit", "crdr": "debit", "calculation": { "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from revolving credit facilities", "label": "Proceeds from Long-Term Lines of Credit", "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer." } } }, "auth_ref": [ "r38" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r43" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGNarrativeDetails", "http://www.fortrea.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGScheduleofDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.fortrea.com/role/GOODWILLANDINTANGIBLEASSETSChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r663" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.fortrea.com/role/EARNINGSLOSSPERSHAREAntidilutiveSecuritiesExcludedfromComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r225" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.fortrea.com/role/CONDENSEDCONSOLIDATEDANDCOMBINEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (loss) per common share", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//230/tableOfContent" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12A" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r654": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r655": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r658": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r659": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r660": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r661": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r662": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r663": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r664": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r665": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r666": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r667": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r668": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r669": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r670": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r671": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r672": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r673": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r674": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r675": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r676": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r677": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r678": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r679": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r682": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r683": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r684": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r686": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r690": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r691": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r692": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r693": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r694": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r695": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r696": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r697": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r698": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r699": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r701": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 84 0001965040-23-000043-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001965040-23-000043-xbrl.zip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�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